
<html lang="en"     class="pb-page"  data-request-id="c38073e6-3b3d-4db8-a276-1fe1b4a6f12c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-20;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c01302;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis, Radiolabeling, and Biological Evaluation of the cis Stereoisomers of 1-Amino-3-Fluoro-4-(fluoro-18F)Cyclopentane-1-Carboxylic Acid as PET Imaging Agents" /></meta><meta name="dc.Creator" content="Thomas C.  Pickel" /></meta><meta name="dc.Creator" content="Ronald J.  Voll" /></meta><meta name="dc.Creator" content="Weiping  Yu" /></meta><meta name="dc.Creator" content="Zhaobin  Wang" /></meta><meta name="dc.Creator" content="Jonathon A  Nye" /></meta><meta name="dc.Creator" content="John  Bacsa" /></meta><meta name="dc.Creator" content="Jeffrey J.  Olson" /></meta><meta name="dc.Creator" content="Lanny S.  Liebeskind" /></meta><meta name="dc.Creator" content="Mark M.  Goodman" /></meta><meta name="dc.Description" content="The non-natural cyclic amino acids (1S,3R,4S)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([18F]9) and (1S,3S,4R)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([1..." /></meta><meta name="Description" content="The non-natural cyclic amino acids (1S,3R,4S)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([18F]9) and (1S,3S,4R)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([1..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 18, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01302" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01302" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01302" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01302" /></link>
        
    
    

<title>Synthesis, Radiolabeling, and Biological Evaluation of the cis Stereoisomers of 1-Amino-3-Fluoro-4-(fluoro-18F)Cyclopentane-1-Carboxylic Acid as PET Imaging Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01302" /></meta><meta property="og:title" content="Synthesis, Radiolabeling, and Biological Evaluation of the cis Stereoisomers of 1-Amino-3-Fluoro-4-(fluoro-18F)Cyclopentane-1-Carboxylic Acid as PET Imaging Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0013.jpeg" /></meta><meta property="og:description" content="The non-natural cyclic amino acids (1S,3R,4S)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([18F]9) and (1S,3S,4R)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([18F]28) have been prepared in 10 and 1.7% decay corrected radiochemical yield, respectively, and in greater than 99% radiochemical purity. Cell assays in rat 9L gliosarcoma, human U87 ΔEGFR glioblastoma, and human DU145 androgen-independent prostate carcinoma tumor cells indicated that both compounds are substrates for amino acid transport primarily by system L, with some transport taking place via system ASC. In rats with 9L gliosarcoma, [18F]9 and [18F]28 provided high tumor to normal brain tissue ratios, with maximal ratios of 3.5 and 4.1, respectively. Biodistribution studies in healthy rats confirmed that both compounds are BBB permeable and that bladder accumulation is low until at least 5 min post injection." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01302"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01302">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01302&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01302&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01302&amp;href=/doi/10.1021/acs.jmedchem.0c01302" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 12008-12022</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01294" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01315" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Radiolabeling, and Biological Evaluation of the <i>cis</i> Stereoisomers of 1-Amino-3-Fluoro-4-(fluoro-<sup>18</sup><i>F</i>)Cyclopentane-1-Carboxylic Acid as PET Imaging Agents</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Thomas C. Pickel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas C. Pickel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+C.++Pickel">Thomas C. Pickel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ronald J. Voll</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ronald J. Voll</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</div><div class="loa-info-affiliations-info">Center for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+J.++Voll">Ronald J. Voll</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weiping Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weiping Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</div><div class="loa-info-affiliations-info">Center for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weiping++Yu">Weiping Yu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhaobin Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhaobin Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurosurgery, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhaobin++Wang">Zhaobin Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathon A Nye</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathon A Nye</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</div><div class="loa-info-affiliations-info">Center for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathon+A++Nye">Jonathon A Nye</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Bacsa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Bacsa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Bacsa">John Bacsa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5681-4458" title="Orcid link">http://orcid.org/0000-0001-5681-4458</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey J. Olson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey J. Olson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurosurgery, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+J.++Olson">Jeffrey J. Olson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lanny S. Liebeskind</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lanny S. Liebeskind</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lanny+S.++Liebeskind">Lanny S. Liebeskind</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2223-6618" title="Orcid link">http://orcid.org/0000-0002-2223-6618</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Mark M. Goodman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark M. Goodman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</div><div class="loa-info-affiliations-info">Center for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#58353f37373c3539183d35372a21763d3c2d"><span class="__cf_email__" data-cfemail="335e545c5c575e5273565e5c414a1d565746">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+M.++Goodman">Mark M. Goodman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3438-1185" title="Orcid link">http://orcid.org/0000-0002-3438-1185</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01302&amp;href=/doi/10.1021%2Facs.jmedchem.0c01302" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 12008–12022</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 18, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 July 2020</li><li><span class="item_label"><b>Published</b> online</span>18 September 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 October 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01302" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01302</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D12008%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThomas%2BC.%2BPickel%252C%2BRonald%2BJ.%2BVoll%252C%2BWeiping%2BYu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D20%26contentID%3Dacs.jmedchem.0c01302%26title%3DSynthesis%252C%2BRadiolabeling%252C%2Band%2BBiological%2BEvaluation%2Bof%2Bthe%2Bcis%2BStereoisomers%2Bof%2B1-Amino-3-Fluoro-4-%2528fluoro-18F%2529Cyclopentane-1-Carboxylic%2BAcid%2Bas%2BPET%2BImaging%2BAgents%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D12022%26publicationDate%3DOctober%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01302"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">708</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01302" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Radiolabeling, and Biological Evaluation of the cis Stereoisomers of 1-Amino-3-Fluoro-4-(fluoro-18F)Cyclopentane-1-Carboxylic Acid as PET Imaging Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;C. Pickel&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;J. Voll&quot;},{&quot;first_name&quot;:&quot;Weiping&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Zhaobin&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jonathon&quot;,&quot;last_name&quot;:&quot;A Nye&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Bacsa&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;J. Olson&quot;},{&quot;first_name&quot;:&quot;Lanny&quot;,&quot;last_name&quot;:&quot;S. Liebeskind&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;M. Goodman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;12008-12022&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01302&quot;},&quot;abstract&quot;:&quot;The non-natural cyclic amino acids (1S,3R,4S)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([18F]9) and (1S,3S,4R)-1-amino-3-fluoro-4-(fluoro-18F)cyclopentane-1-carboxylic acid ([18F]28) have been prepared in 10 and 1.7% decay corrected radiochemical yield, respectively, and in greater than 99% radiochemical purity. Cell assays in rat 9L gliosarcoma, human U87 ΔEGFR glioblastoma, and human DU145 androgen-independent prostate carcinoma tumor cells indicated that both compounds are substrates for amino acid transport primarily by system L, with some transport taking place via system ASC. In rats with 9L gliosarcoma, [18F]9 and [18F]28 provided high tumor to normal brain tissue ratios, with maximal ratios of 3.5 and 4.1, respectively. Biodistribution studies in healthy rats confirmed that both compounds are BBB permeable and that bladder accumulation is low until at least 5 min post injection.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01302&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01302" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01302&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01302" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01302&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01302" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01302&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01302&amp;href=/doi/10.1021/acs.jmedchem.0c01302" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01302" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01302" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01302%26sid%3Dliteratum%253Aachs%26pmid%3D32946235%26genre%3Darticle%26aulast%3DPickel%26date%3D2020%26atitle%3DSynthesis%252C%2BRadiolabeling%252C%2Band%2BBiological%2BEvaluation%2Bof%2Bthe%2Bcis%2BStereoisomers%2Bof%2B1-Amino-3-Fluoro-4-%2528fluoro-18F%2529Cyclopentane-1-Carboxylic%2BAcid%2Bas%2BPET%2BImaging%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D20%26spage%3D12008%26epage%3D12022%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/jmcmar.2020.63.issue-20/20201022/jmcmar.2020.63.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The non-natural cyclic amino acids (1<i>S</i>,3<i>R</i>,4<i>S</i>)-1-amino-3-fluoro-4-(fluoro-<sup>18</sup><i>F</i>)cyclopentane-1-carboxylic acid (<b>[<sup>18</sup>F]9</b>) and (1<i>S</i>,3<i>S</i>,4<i>R</i>)-1-amino-3-fluoro-4-(fluoro-<sup>18</sup><i>F</i>)cyclopentane-1-carboxylic acid (<b>[<sup>18</sup>F]28</b>) have been prepared in 10 and 1.7% decay corrected radiochemical yield, respectively, and in greater than 99% radiochemical purity. Cell assays in rat 9L gliosarcoma, human U87 ΔEGFR glioblastoma, and human DU145 androgen-independent prostate carcinoma tumor cells indicated that both compounds are substrates for amino acid transport primarily by system L, with some transport taking place via system ASC. In rats with 9L gliosarcoma, <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b> provided high tumor to normal brain tissue ratios, with maximal ratios of 3.5 and 4.1, respectively. Biodistribution studies in healthy rats confirmed that both compounds are BBB permeable and that bladder accumulation is low until at least 5 min post injection.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the past several decades, positron emission tomography (PET) has become an essential imaging modality in clinical oncology for the visualization of various cancers. The accurate visualization of neoplasia via PET is contingent upon the ability of a particular PET tracer to preferentially accumulate in tumor cells in the presence of healthy tissue. Among the strategies identified for achieving selective uptake in neoplasia, tracers that mimic metabolic intermediates have proven to be the most successful.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> For example, 2-[<sup>18</sup>F]fluoro-2-deoxy-D-glucose ([<sup>18</sup>F]FDG), a substrate for glucose transporters, is the most widely used tracer for oncologic applications and has been applied to the visualization of a broad variety of neoplasia.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> However, there remain applications for which [<sup>18</sup>F]FDG-PET is poorly suited, owing to its high physiological uptake in the normal tissue of certain organs, such as the brain and bladder, as well as its propensity to concentrate in inflammatory lesions.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Consequently, PET imaging of brain and prostate cancers is often problematic, and the ability to adequately visualize these types of neoplasia remains a critical unmet need.</div><div class="NLM_p last">To address the shortcomings associated with [<sup>18</sup>F]FDG-PET, alternative metabolic tracers are of interest.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Like carbohydrates, amino acids (AAs) are involved in nearly all biological processes and are energy substrates necessary for cell growth, and most tumor cells display greater avidity for certain AAs relative to normal tissue, owing to the increased expression of amino acid transporters (AATs) in neoplastic cells.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Each of the ubiquitous AATs, which includes those from systems L (leucine preferring, sodium independent), A (alanine preferring, sodium dependent), and ASC (alanine, serine, cysteine, and threonine preferring, sodium dependent),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> is generally upregulated to some degree in neoplasia, though only system L transporter LAT1 mediates significant amino acid transport into the brain.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Accordingly, radiolabeled substrates for system L offer potential as radiopharmaceuticals. For example, <sup>11</sup>C-methionine, which is actively transported primarily by system L, has demonstrated efficacy over [<sup>18</sup>F]FDG in imaging glioma.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> However, the short half-life of the <sup>11</sup>C radionuclide (20 min) and the propensity of <sup>11</sup>C-methionine and natural AAs in general to be metabolized or engage in protein synthesis preclude their broad clinical use.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> By contrast, non-natural AAs offer a platform for the incorporation of the <sup>18</sup>F radionuclide and can be engineered for metabolic stability. Several decades ago, Washburn and co-workers investigated a series of <sup>14</sup>C labeled alicyclic alpha-amino acids as PET tracers and identified 1-aminocyclobutane carboxylic acid (ACBC)<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> and 1-aminocyclopentane carboxylic acid (ACPC)<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> as compounds with excellent in vivo stability and biological transport properties. Goodman and co-workers later described the synthesis and biological evaluation of several <sup>18</sup>F radiolabeled ACBC derivatives.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The transport of each compound was assessed in 9L gliosarcoma cells and determined to proceed via system ASC, with some contribution from system L. In rats bearing intracranial 9L gliosarcoma, each <sup>18</sup>F-FACBC derivative studied provided superior tumor to contralateral brain tissue uptake in comparison to [<sup>18</sup>F]FDG. Notably, <i>anti</i>-1-amino-3-(fluoro-<sup>18</sup>F)-cyclobutane carboxylic acid (<i>anti</i>-3-FACBC) received FDA approval for imaging nonprimary recurrent prostate cancer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In 2011, the first fluorinated ACPC, <i>anti</i>-1-amino-2-fluoro-cyclopentane-1-carboxylic acid ((R, S)-<i>anti</i>-2-FACPC), was reported as a racemic mixture.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In contrast to FACBC analogs, (<i>R</i>, <i>S</i>)-<i>anti</i>-2-FACPC displayed a greater affinity for transport by system L, with some transport occurring via system ASC. In the 9L gliosarcoma rat model, (<i>R</i>, <i>S</i>)-<i>anti</i>-2-FACPC provided a twofold increase in the tumor to contralateral brain tissue ratio relative to anti-3-FACBC. Despite these promising preclinical data, a pilot study in humans with the enantiomer (1<i>R</i>, 2<i>S</i>)-<i>anti</i>-2-FACPC, obtained by chiral HPLC purification, demonstrated that it concentrates in the bladder at early time points, limiting its utility in the detection of prostate tumors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We postulated that the inductive effect of the fluorine substituent beta to the amine and carboxylate moieties may contribute to the early bladder accumulation of (1<i>R</i>, 2<i>S</i>)-<i>anti</i>-2-FACPC. To alleviate this effect, we considered alternative fluorinated derivatives of FACPC wherein the fluorine atom is further removed from the amine and carboxylate moieties. While 1-amino-3-fluorocyclopentane carboxylic acid (3-FACPC) is a logical target based on the consideration presented above, we expected that the synthesis and isolation of a single stereoisomer would be challenging, given that there are two pairs of enantiomers (i.e., one for each of the 3-FACPC diastereomers). Conversely, the difluorinated ACPC derivative, 1-amino-3,4-difluorocyclopentanecarboxylic acid (3,4-DFACPC), exists as one set of <i>trans</i>-difluoro enantiomers and two discrete <i>meso</i>-<i>cis</i>-difluoro diastereomers, the latter of which would be synthetically accessible as single stereoisomers. Consequently, we aimed to prepare both <i>cis</i>-difluoro stereoisomers of 3,4-DFACPC and evaluate their utility as PET imaging agents, as described below.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">From the outset, we envisioned that both of the <i>cis</i> diastereomers of 3,4-DFACPC would be synthetically accessible from certain <i>N</i>- and <i>O</i>-protected derivatives of 1-aminocyclopent-3-ene-1-carboxylic acid.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a> Our initial efforts toward the synthesis of a derivative of this olefin began from hippuric acid, which was converted to the <i>N</i>-benzamide derivative of the desired cyclopentene <b>4</b> in a four-step sequence culminating in a Grubbs ring-closing metathesis from diene <b>3</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Treatment of <b>4</b> with <i>m</i>-CPBA provided the <i>syn</i>-epoxide <b>5</b> (throughout the manuscript, ″<i>syn</i>″ is relative to the <i>N</i>-atom) in 78% yield, and after another four-step sequence involving ring-opening fluorination of the corresponding racemic fluorohydrin and acidic deprotection to free the amine and carboxylic acid functionalities, the cold standard <b>9</b> was obtained in 4% overall yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The assignment of this compound as the <i>anti</i>-<i>cis</i>-3,4-DFACPC stereoisomer was confirmed via X-ray crystallography (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of <b>9.</b> Atom labels are as follows: white = hydrogen, black = carbon, red = oxygen, blue = nitrogen, light green = fluorine, and dark green = chlorine. CCDC: 2024890.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>anti</i>-<i>cis</i>-3,4-DFACPC Cold Standard (<b>9</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Though we were able to access difluorocyclopentane <b>9</b> using this route, we determined that the radiosynthesis of <b>[<sup>18</sup>F]9</b> would be complicated by the slow cleavage of the benzamide moiety. Alternatively, benzamide <b>6</b> can be converted to the corresponding <i>N</i>-Boc derivative, though this protecting group manipulation requires another three steps and proceeds in only 50% yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Boc Fluorohydrin (<b>12</b>) from <i>N</i>-Benzamide Fluorohydrin (<b>9</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consequently, we employed an alternative route to cyclopentene <b>15</b>, originally reported by Kurth,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> which provided the <i>N</i>-Boc protected cyclopentene <b>16</b> in only four steps from glycine ethyl ester hydrochloride. Compound <b>16</b> was treated with <i>m</i>-CPBA to afford a 5:1 mixture of <i>syn</i> and <i>anti</i>-epoxides, which were readily separated by flash chromatography. Once separated, <i>syn</i> epoxide <b>17</b> was converted to racemic fluorohydrin <b>12</b> in the presence of triethylamine trihydrofluoride and then treated with triflic anhydride to afford racemic triflate <b>19</b>, which is the radiolabeling precursor to <i>anti</i>-<i>cis</i>-3,4-DFACPC (<b>[<sup>18</sup>F]9</b>), in 28% yield over seven steps (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Triflate Precursor (<b>19</b>) to <b>[<sup>18</sup>F]9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next turned our attention to the synthesis of <i>syn</i>-<i>cis</i>-3,4-DFACPC. It was anticipated that this compound may be accessible from <i>anti</i>-epoxide <b>18</b>, the minor diastereomer generated from the epoxidation of cyclopentene <b>15</b>. However, we found that racemic triflate <b>21</b> was highly unstable, and our attempts to isolate it or use it in subsequent reactions without isolation met with failure (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Failed Route to <i>syn</i>-<i>cis</i>-3,4-DFACPC</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given that racemic triflate <b>19</b>, in which the <i>N</i>-Boc and triflate moieties exist in a <i>syn</i> disposition, is chromatographically stable, we speculated that the <i>anti</i> stereochemical relationship between the <i>N</i>-Boc and triflate moieties in <b>21</b> might give rise to an intramolecular decay pathway stemming from the nucleophilicity of the Boc group. Consequently, as shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, we targeted the synthesis of an analogous triflate with the less nucleophilic <i>N</i>-phthaloyl protecting group. To this end, cyclopentene <b>15</b> was treated with phthalic anhydride to give phthalimide <b>22</b> in 67% yield. Epoxidation of <b>22</b> was affected with <i>m</i>-CPBA, affording a 2.6:1 mixture of <i>syn</i> and <i>anti</i> diastereomers that were separable by flash chromatography, and the <i>anti</i>-epoxide <b>23</b> was isolated in 25% yield. After ring-opening fluorination of epoxide <b>23</b>, the resultant racemic fluorohydrin <b>25</b> was treated with triflic anhydride to give a stable, crystalline racemic triflate (<b>26</b>), which is the precursor to [<sup>18</sup>F]<i>syn</i>-<i>cis</i>-DFACPC, in 85% yield. Fluorination of this triflate proved challenging, owing to the propensity of this compound to undergo elimination rather than substitution. Ultimately, CsF in <i>t</i>BuOH proved to be a viable fluorination system,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> providing difluoride <b>27</b> in 18% yield. Acidic deprotection of difluoride <b>27</b> afforded <i>syn</i>-<i>cis</i>-3,4-DFACPC (<b>28</b>), although this reaction required several hours at elevated temperature to reach completion and therefore would not be suitable for the radiosynthesis of [<sup>18</sup>F]<b>28</b>. After surveying a variety of conditions, it was found that the phthalimide and ethyl ester protecting groups could be rapidly and efficiently cleaved by treating <b>27</b> with 2 M NaOH for 5 min at 140 °C followed by addition of an equal volume of conc. HCl for a further 15 min at 140 °C, affording <b>28</b> in 88% yield (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The stereochemical assignment of <b>28</b> was confirmed via X-ray crystallography (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <i>syn</i>-<i>cis</i>-3,4-DFACPC (<b>28</b>). Atom labels are as follows: white = hydrogen, black = carbon, red = oxygen, blue = nitrogen, light green = fluorine, and dark green = chlorine. CCDC: 2024887.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>syn</i>-<i>cis</i>-3,4-DFACPC (<b>28</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Radiochemistry</h3><div class="NLM_p">The synthesis of <i>anti</i>-<i>cis</i>-3,4-[<sup>18</sup>F]-DFACPC (<b>[<sup>18</sup>F]9</b>) was accomplished under the conditions previously reported for the automated synthesis of [<sup>18</sup>F]FACBC.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Triflate precursor <b>19</b> (9 mg) was radiofluorinated by no-carrier-added nucleophilic substitution using dried K[<sup>18</sup>F]F, potassium carbonate, and Kryptofix 222 in acetonitrile followed by deprotection with 6 N HCl (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). The crude mixture obtained from the labeling reaction was loaded directly onto a purification assembly consisting of an ion retard resin cartridge, alumina cartridge, and HLB Oasis reverse phase cartridge and eluted with saline solution into fractions. The fractions containing the highest concentrations of <b>[<sup>18</sup>F]9</b> were pooled and used directly in subsequent in vivo and in vitro studies. The radiochemical decay-corrected yield (dcy) was 10% (50 mCi) based on a synthesis time of 70 min. Radiometric TLC of <b>[<sup>18</sup>F]9</b> showed a single radiolabeled product in a radiochemical purity >99% (see the Supporting Information: <a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figure S35</a>), with an R<sub>f</sub> corresponding to compound <b>9</b>. The specific activity of <b>[<sup>18</sup>F]9</b> in the dose vial was not measured, although given that 9 mg of the triflate precursor was employed in the radiosynthesis, the maximum amount of unlabeled material in the final dose would not exceed 180 μg/mCi.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>[<sup>18</sup>F]9</b> (<i>anti</i>-<i>cis</i>-3,4-[<sup>18</sup>F]-DFACPC)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Conversely, the synthesis of <i>syn-cis</i>-3,4-DFACPC (<b>[<sup>18</sup>F]28</b>) did not proceed under the established [<sup>18</sup>F]FACBC synthesis conditions, likely owing to the propensity of triflate precursor <b>26</b> to eliminate, as observed in the cold chemistry. However, the milder fluorination protocol described by Kim and coworkers,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> employing CsF in a mixture of <i>t</i>BuOH and MeCN with Kryptofix 222, was effective in the radiolabeling of triflate <b>26</b> to provide <b>[<sup>18</sup>F]27</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Once generated, <b>[<sup>18</sup>F]27</b>, as a solution in acetonitrile, was passed through two alumina cartridges to remove residual [<sup>18</sup>F<sup>–</sup>] and then concentrated. The concentrate was treated with 2 M NaOH in a sealed vial at 140 °C and then with concentrated HCl, also at 140 °C. On completion, the mixture was evaporated under air flow and taken up in water and then passed through an HLB Oasis cartridge and two alumina cartridges. The eluent was collected in fractions, the most concentrated of which were pooled to provide a 1.7% dcy (8.4 mCi) based on a synthesis time of 135 min. Radiometric HPLC analysis indicated the presence of a single radiolabeled product with >99% radiochemical purity (see the Supporting Information: <a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figure S36</a>). Again, the specific activity of the <b>[<sup>18</sup>F]28</b> thus prepared was not measured, though given that 20 mg of triflate precursor <b>26</b> was used for the labeling reaction and a radiochemical yield of 8.4 mCi was obtained, the amount of unlabeled material remaining in the dose vial would not exceed 2.3 mg/mCi.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>[<sup>18</sup>F]28</b> (<i>syn</i>-<i>cis</i>-3,4-[<sup>18</sup>F]-DFACPC)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cellular Transport Assays</h3><div class="NLM_p">The cellular transport of <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b> in rat 9L gliosarcoma, human U87 ΔEGFR glioblastoma, and human DU145 androgen-independent prostate carcinoma tumor cells was evaluated in the presence and absence of transport inhibitors. Non-natural amino acid 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) was employed as a system L inhibitor, 2-(methylamino)-2-methylproprionic acid (MeAIB) was used to inhibit system A, and a 1:1:1 mixture of alanine, cysteine, and serine was used to inhibit system ASC. The uptake data were normalized and expressed as mean percent uptake relative to the condition without inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Uptake data for <i>anti</i>-3-[<sup>18</sup>F]-FACBC were also collected under identical conditions to provide a control as well as to facilitate comparison to a clinically validated tracer. The uptake of <b>[<sup>18</sup>F]9</b> in 9L and DU145 cells is consistent with a mode of transport facilitated chiefly by system L (80 and 81% uptake inhibition by BCH in 9L and DU145 cells, respectively), with some degree of transport taking place via system ASC (61 and 77% uptake inhibition by alanine, serine, and cysteine in 9L and DU145 cells, respectively). The selectivity of <b>[<sup>18</sup>F]9</b> for system L was diminished in U87 ΔEGFR cells (50% uptake inhibition by BCH), while transport by system ASC was relatively greater (78% uptake inhibition by alanine, serine, and cysteine), indicating a preference for transport by ASC in this cell line (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Across all cell lines, <b>[<sup>18</sup>F]28</b> demonstrated a preference for system L (80, 55, and 86% inhibition by BCH in 9L, U87 ΔEGFR, and DU145 cells, respectively), though some reduction of transport under ASC inhibition was also observed (43, 43, and 68% uptake inhibition by alanine, serine, and cysteine in 9L, U87 ΔEGFR, and DU145 cells, respectively). Uptake of <i>anti</i>-3-[<sup>18</sup>F]-FACBC indicated a strong preference for transport by system ASC, consistent with what has been reported previously.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> The absolute uptake of <b>[<sup>18</sup>F]9</b> was greater than that of <b>[<sup>18</sup>F]28</b> in each of the cell lines studied, suggesting that the <i>anti</i>-<i>cis</i>, rather than <i>syn</i>-<i>cis</i>, difluoro stereochemical arrangement provides a superior substrate for facilitated amino acid transport in the cell lines studied. Notably, <b>[<sup>18</sup>F]9</b> displayed absolute uptake values consistent with <i>anti</i>-3-[<sup>18</sup>F]-FACBC in each cell line, including in DU145 cells (human androgen-independent prostate carcinoma cells) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. 9L Cell Uptake of <b>[<sup>18</sup>F]9</b>, <b>[<sup>18</sup>F]28</b>, and [<sup>18</sup>F]-FACBC with and without Inhibitors after 30 min of Incubation<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tracer</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">9L</th><th class="colsep0 rowsep0" align="center">% inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]9</td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">23.4 ± 3.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">4.71 ± 0.25*</td><td class="colsep0 rowsep0" align="left">80%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">23.7 ± 2.1<sup>**</sup></td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">9.11 ± 1.1*</td><td class="colsep0 rowsep0" align="left">61%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]28</td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">7.82 ± 0.37</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">2.11 ± 0.04*</td><td class="colsep0 rowsep0" align="left">73%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">9.96 ± 0.27*</td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">4.43 ± 0.19*</td><td class="colsep0 rowsep0" align="left">43%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]-FACBC<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">23.2 ± 2.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">12.4 ± 1.7*</td><td class="colsep0 rowsep0" align="left">47%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">26.3 ± 4.3*</td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">6.19 ± 0.75*</td><td class="colsep0 rowsep0" align="left">73%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data are presented as percent ligand uptake of the initial dose per 0.5 million cells (%ID/5 × 10<sup>5</sup> cells) ± standard deviation (<i>n</i> = 3–4) and normalized for the dose and number of cells. <i>p</i> values represent comparisons of uptake in the presence of inhibitors to control uptake using two-tailed paired t-tests. <i>p</i> < 0.05 is considered statistically significant. * <i>p</i> < 0.05. <sup>**</sup><i>p</i> ≥ 0.05.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">[<sup>18</sup>F]-FACBC denotes anti-3-[<sup>18</sup>F]-FACBC</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. U87 ΔEGFR Cell Uptake of <b>[<sup>18</sup>F]9</b>, <b>[<sup>18</sup>F]28</b>, and [<sup>18</sup>F]-FACBC with and without Inhibitors after 30 min of Incubation<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tracer</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">U87 ΔEGFR</th><th class="colsep0 rowsep0" align="center">% inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]9</td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">7.53 ± 1.2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">3.75 ± 0.26*</td><td class="colsep0 rowsep0" align="left">50%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">7.92 ± 0.84<sup>**</sup></td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">1.64 ± 0.29*</td><td class="colsep0 rowsep0" align="left">78%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]28</td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">4.29 ± 0.29</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">1.93 ± 0.11*</td><td class="colsep0 rowsep0" align="left">55%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">4.27 ± 0.24<sup>**</sup></td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">2.44 ± 0.16*</td><td class="colsep0 rowsep0" align="left">43%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]-FACBC<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">6.19 ± 1.22</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">3.95 ± 0.90*</td><td class="colsep0 rowsep0" align="left">37%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">7.18 ± 0.74<sup>**</sup></td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">1.36 ± 0.15*</td><td class="colsep0 rowsep0" align="left">78%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data are presented as percent ligand uptake of the initial dose per 0.5 million cells (%ID/5 × 10<sup>5</sup> cells) ± standard deviation (<i>n</i> = 3–4) and normalized for the dose and number of cells. <i>p</i> values represent comparisons of uptake in the presence of inhibitors to control uptake using two-tailed paired t-tests. <i>p</i> < 0.05 is considered statistically significant. *<i>p</i> < 0.05. <sup>**</sup><i>p</i> ≥ 0.05.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">[<sup>18</sup>F]-FACBC denotes anti-3-[<sup>18</sup>F]-FACBC</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. DU145 Cell Uptake of <b>[<sup>18</sup>F]9</b>, <b>[<sup>18</sup>F]28</b>, and [<sup>18</sup>F]-FACBC with and without Inhibitors after 30 min of Incubation<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tracer</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">DU145</th><th class="colsep0 rowsep0" align="center">% inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]9</td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">17.7 ± 3.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">3.42 ± 0.31*</td><td class="colsep0 rowsep0" align="left">81%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">20.5 ± 4.0*</td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">4.10 ± 0.33*</td><td class="colsep0 rowsep0" align="left">77%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]28</td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">12.2 ± 0.46</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">1.70 ± 0.09*</td><td class="colsep0 rowsep0" align="left">86%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">14.5 ± 0.65*</td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">3.85 ± 0.19*</td><td class="colsep0 rowsep0" align="left">68%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]-FACBC<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">20.2 ± 3.4</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BCH</td><td class="colsep0 rowsep0" align="char" char="±">8.84 ± 0.31*</td><td class="colsep0 rowsep0" align="left">56%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MeAIB</td><td class="colsep0 rowsep0" align="char" char="±">19.8 ± 2.9<sup>**</sup></td><td class="colsep0 rowsep0" align="left">2%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ASC</td><td class="colsep0 rowsep0" align="char" char="±">2.58 ± 0.22*</td><td class="colsep0 rowsep0" align="left">87%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data are presented as percent ligand uptake of the initial dose per 0.5 million cells (%ID/5 × 10<sup>5</sup> cells) ± standard deviation (<i>n</i> = 3–4) and normalized for the dose and number of cells. <i>p</i> values represent comparisons of uptake in the presence of inhibitors to control uptake using two-tailed paired t-tests. <i>p</i> < 0.05 is considered statistically significant. * <i>p</i> < 0.05. <sup>**</sup><i>p</i> ≥ 0.05.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">[<sup>18</sup>F]-FACBC denotes anti-3-[<sup>18</sup>F]-FACBC</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biodistribution Studies in Rats with Intracranial 9L Tumors</h3><div class="NLM_p">The tissue distribution of <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b> was evaluated by microPET following tail vein injection of each compound into Fischer rats bearing intracranial 9L gliosarcoma tumors (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). <b>[<sup>18</sup>F]9</b> tumor tissue uptake reached equilibrium quickly and remained relatively steady over the course of the 60-min study, ranging from 2.05 ± 0.44 to 2.13 ± 0.62 %ID/g (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). In contrast, maximal <b>[<sup>18</sup>F]28</b> tumor uptake was observed within the first 4.5 min of the study (1.21 ± 0.22 %ID/g) and decreased to 0.78 ± 0.04 %ID/g by 60 min post injection (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). In contra-lateral normal brain tissue, <b>[<sup>18</sup>F]9</b> gave an uptake value of 0.59 ± 0.12 ID/g at 4.4 min post injection and continued to accumulate over the course of the study, reaching 0.95 ± 0.23 %ID/g at 60 min. <b>[<sup>18</sup>F]28</b> uptake in contra-lateral normal brain tissue reached 0.37 ± 0.02 at 32.5 min post injection and remained steady through the end of the study. Consequently, despite the nearly twofold greater activity in tumor tissue of <b>[<sup>18</sup>F]9</b> compared to <b>[<sup>18</sup>F]28</b>, the relatively low normal brain uptake of the latter compound results in a higher tumor (T) to normal brain tissue ratio (T/N) at each timepoint. Maximal T/N is observed at 4.5 min post-injection with both <b>[<sup>18</sup>F]9</b> (T/N = 3.5) and <b>[<sup>18</sup>F]28</b> (T/N = 4.1), though both compounds provide statistically significant differences (<i>p</i> < 0.05) in uptake between normal brain and tumor tissue with L/N > 2 at each timepoint.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative PET image acquired with <b>[<sup>18</sup>F]9, s</b>ummed from 30–60 min post injection. Activity is expressed in standard uptake values (SUV).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative PET image acquired with <b>[<sup>18</sup>F]28, s</b>ummed from 30–60 min post injection. Activity is expressed in standard uptake values (SUV).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biodistribution as Percent of Injected Dose per Gram (%ID/g) of Radioactivity in Tissues of 9L Tumor-Bearing Fischer Rats Following Intravenous Administration of <b>[<sup>18</sup>F]9</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center">4.5 min</th><th class="colsep0 rowsep0" align="center">32.5 min</th><th class="colsep0 rowsep0" align="center">52.5 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">2.70 ± 0.50</td><td class="colsep0 rowsep0" align="left">2.05 ± 0.44</td><td class="colsep0 rowsep0" align="left">1.75 ± 0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">2.54 ± 0.63</td><td class="colsep0 rowsep0" align="left">1.49 ± 0.34</td><td class="colsep0 rowsep0" align="left">1.33 ± 0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">1.83 ± 0.58</td><td class="colsep0 rowsep0" align="left">1.08 ± 0.25</td><td class="colsep0 rowsep0" align="left">0.99 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">0.69 ± 0.23</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.25</td><td class="colsep0 rowsep0" align="left">1.03 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.12*</td><td class="colsep0 rowsep0" align="left">0.92 ± 0.24*</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.23*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor (T)</td><td class="colsep0 rowsep0" align="left">2.05 ± 0.44*</td><td class="colsep0 rowsep0" align="left">2.13 ± 0.62*</td><td class="colsep0 rowsep0" align="left">2.04 ± 0.59*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="left">2.79 ± 0.69</td><td class="colsep0 rowsep0" align="left">1.81 ± 0.45</td><td class="colsep0 rowsep0" align="left">1.67 ± 0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spine</td><td class="colsep0 rowsep0" align="left">1.64 ± 0.54</td><td class="colsep0 rowsep0" align="left">1.32 ± 0.34</td><td class="colsep0 rowsep0" align="left">1.28 ± 0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">T/N<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Data are reported as mean percent dose per gram ± standard deviation (<i>n</i> = 5) at each time point. p values represent comparisons of uptake in the 9L tumor and normal brain using one-way ANOVA tests. <i>p</i> < 0.05 is considered statistically significant. * <i>p</i> < 0.001.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">T/N denotes the tumor to brain ratio<i>.</i> See the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figure S39</a>) for additional time-activity data</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biodistribution as Percent of Injected Dose per Gram (%ID/g) of Radioactivity in Tissues of 9L Tumor-Bearing Fischer Rats Following Intravenous Administration of <b>[<sup>18</sup>F]28</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center">4.5 min</th><th class="colsep0 rowsep0" align="center">32.5 min</th><th class="colsep0 rowsep0" align="center">52.5 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">1.40 ± 0.19</td><td class="colsep0 rowsep0" align="left">0.57 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.51 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">1.24 ± 0.24</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.52 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.48 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.42 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">0.48 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.57 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">0.28 ± 0.02*</td><td class="colsep0 rowsep0" align="left">0.37 ± 0.02*</td><td class="colsep0 rowsep0" align="left">0.36 ± 0.01*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor(T)</td><td class="colsep0 rowsep0" align="left">1.21 ± 0.22*</td><td class="colsep0 rowsep0" align="left">0.91 ± 0.07*</td><td class="colsep0 rowsep0" align="left">0.78 ± 0.04*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.67 ± 0.14</td><td class="colsep0 rowsep0" align="left">0.63 ± 0.19</td><td class="colsep0 rowsep0" align="left">0.58 ± 0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spine</td><td class="colsep0 rowsep0" align="left">0.70 ± 0.23</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.50 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">T/N<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Data are reported as mean percent dose per gram ± standard deviation (<i>n</i> = 4) at each time point. <i>p</i> values represent comparisons of uptake in the 9L tumor and normal brain using one-way ANOVA tests. <i>p</i> < 0.05 is considered statistically significant. * <i>p</i> < 0.001.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last"><i>n</i> = 3. See the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figure S40</a>) for additional time-activity data.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">T/N denotes the tumor to brain ratio.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Biodistribution Studies in Normal Rats</h3><div class="NLM_p">The integrity of the blood–brain barrier (BBB) is an important consideration in PET imaging studies where intracranial tumors are studied, since neoplasia can disrupt the function of the BBB and provide an alternative mode of entry into the brain.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Biodistribution studies in normal rats allow for the BBB permeability of a given tracer to be assessed in the absence of any potential obfuscations. The normal brain uptake of <b>[<sup>18</sup>F]9</b> ranged from 0.59 ± 0.12 to 0.95 ± 0.23 %ID/g in tumor bearing rats and from 0.65 ± 0.19 to 0.87 ± 0.10 %ID/g in normal rats (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). <b>[<sup>18</sup>F]28</b> gave uptake values ranging from 0.28 ± 0.02 to 0.36 ± 0.01 %ID/g in tumor bearing rats and 0.37 ± 0.04 to 0.50 ± 0.04 %ID/g in normal rats (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). These data demonstrate that <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b> are transported into the brain to a similar extent in both tumor bearing and normal rats, indicating that these compounds are BBB permeable and that heterogeneity of the BBB was not a factor in the 9L bearing tumor rat studies. Another element to consider is the extent of tracer accumulation in the bladder, since high bladder activity can obscure the prostate, which is an important structure to accurately visualize due to the prevalence of primary prostate cancer. As was observed with <i>anti</i>-2-FACPC, <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b> display considerable accumulation in the bladder at 32.5 min post injection. However, after 4.4 min post injection, <b>[<sup>18</sup>F]9</b> bladder activity is 0.46 ± 0.18 %ID/g, which is comparable with anti-3-[<sup>18</sup>F]-FACBC bladder activity at the same timepoint (0.51 ± 0.13 %ID/g) (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Similarly, <b>[<sup>18</sup>F]28</b> shows relatively low bladder activity at 4.4-min post injection (0.62 ± 0.64 %ID/g). Based on these data, it appears that at early timepoints, <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b> accumulation in the bladder was sufficiently low to permit the imaging of tumors in the pelvic region.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Biodistribution of Radioactivity in Tissues of Normal Fischer Rats Following Intravenous Administration of <b>[<sup>18</sup>F]9</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center" char="±">4.4 min</th><th class="colsep0 rowsep0" align="center" char="±">35.6 min</th><th class="colsep0 rowsep0" align="center" char="±">53.4 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">2.73 ± 0.77</td><td class="colsep0 rowsep0" align="char" char="±">1.76 ± 0.36</td><td class="colsep0 rowsep0" align="char" char="±">1.51 ± 0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="char" char="±">2.86 ± 0.86</td><td class="colsep0 rowsep0" align="char" char="±">1.26 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">1.13 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">1.81 ± 0.45</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">0.86 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">9.55 ± 2.14</td><td class="colsep0 rowsep0" align="char" char="±">15.5 ± 1.74</td><td class="colsep0 rowsep0" align="char" char="±">12.5 ± 1.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bladder</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">15.8 ± 13.5</td><td class="colsep0 rowsep0" align="char" char="±">30.2 ± 15.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.66 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="char" char="±">0.65 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">0.82 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">0.87 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.55</td><td class="colsep0 rowsep0" align="char" char="±">1.00 ± 0.26</td><td class="colsep0 rowsep0" align="char" char="±">0.95 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bowel</td><td class="colsep0 rowsep0" align="char" char="±">1.32 ± 0.31</td><td class="colsep0 rowsep0" align="char" char="±">0.75 ± 0.26</td><td class="colsep0 rowsep0" align="char" char="±">0.66 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testes</td><td class="colsep0 rowsep0" align="char" char="±">0.78 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">0.92 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">0.87 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spine</td><td class="colsep0 rowsep0" align="char" char="±">1.62 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">1.23 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">1.18 ± 0.14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Data are reported as mean percent dose per gram ± standard deviation (<i>n</i> = 3) at each time point. See the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figure S37</a>) for additional time-activity data.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Biodistribution of Radioactivity in Tissues of Normal Fischer Rats Following Intravenous Administration of <b>[<sup>18</sup>F]28</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center" char="±">4.4 min</th><th class="colsep0 rowsep0" align="center" char="±">35.6 min</th><th class="colsep0 rowsep0" align="center" char="±">53.4 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">1.44 ± 0.60</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">0.60 ± 0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="char" char="±">1.37 ± 0.50</td><td class="colsep0 rowsep0" align="char" char="±">0.73 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">0.61 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">1.10 ± 0.49</td><td class="colsep0 rowsep0" align="char" char="±">0.56 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">0.52 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">3.06 ± 1.40</td><td class="colsep0 rowsep0" align="char" char="±">3.81 ± 2.90</td><td class="colsep0 rowsep0" align="char" char="±">3.32 ± 2.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bladder</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.64</td><td class="colsep0 rowsep0" align="char" char="±">7.35 ± 4.84</td><td class="colsep0 rowsep0" align="char" char="±">13.5 ± 11.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.55 ± 0.33</td><td class="colsep0 rowsep0" align="char" char="±">0.61 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">0.61 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain *</td><td class="colsep0 rowsep0" align="char" char="±">0.37 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.52 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.50 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bowel</td><td class="colsep0 rowsep0" align="char" char="±">0.85 ± 0.48</td><td class="colsep0 rowsep0" align="char" char="±">0.43 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testes <sup>**</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.42 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">0.58 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">0.81 ± 0.35</td><td class="colsep0 rowsep0" align="char" char="±">0.74 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">0.71 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spine</td><td class="colsep0 rowsep0" align="char" char="±">0.77 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.07</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Data are reported as mean percent dose per gram ± standard deviation (<i>n</i> = 4) at each time point. * <i>n</i> = 2. <sup>**</sup><i>n</i> = 3. See the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figure S38</a>) for additional time-activity data.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Biodistribution of Radioactivity in Tissues of Normal Fischer Rats Following Intravenous Administration of Anti-3-[<sup>18</sup>F]-FACBC<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center" char="±">4.4 min</th><th class="colsep0 rowsep0" align="center" char="±">35.6 min</th><th class="colsep0 rowsep0" align="center" char="±">53.4 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">2.24 ± 0.46</td><td class="colsep0 rowsep0" align="char" char="±">1.78 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">1.65 ± 0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="char" char="±">2.43 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">1.41 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">1.59 ± 0.42</td><td class="colsep0 rowsep0" align="char" char="±">1.06 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">1.06 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">3.72 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">2.36 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">1.94 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bladder</td><td class="colsep0 rowsep0" align="char" char="±">0.51 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">0.82 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.49 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.98 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="char" char="±">0.56 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.68 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">2.30 ± 0.69</td><td class="colsep0 rowsep0" align="char" char="±">1.70 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">1.63 ± 0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bowel</td><td class="colsep0 rowsep0" align="char" char="±">1.11 ± 0.49</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">0.68 ± 0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testes</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.83 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spine</td><td class="colsep0 rowsep0" align="char" char="±">1.80 ± 0.44</td><td class="colsep0 rowsep0" align="char" char="±">1.46 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">1.47 ± 0.20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Data are reported as mean percent dose per gram ± standard deviation (<i>n</i> = 2) at each time point</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The cold synthesis and [<sup>18</sup>F] radiolabeling of both diastereomers of cis-3,4-DFACPC have been reported. The radiochemical yields of the <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b> were modest (10 and 1.7% decay corrected radiochemical yield, respectively), though both compounds were obtained in high radiochemical purity. In vitro inhibition experiments with 9L, U87 ΔEGFR, and DU145 cell lines suggested that <i>cis</i>-3,4-DFACPCs undergo transport primarily by system L, with some transport occurring through system ASC. In each cell line, <b>[<sup>18</sup>F]9</b> showed a higher degree of uptake than <b>[<sup>18</sup>F]28</b>, though both compare well with FACBC. In vivo biodistribution studies demonstrated that both stereoisomers of <i>cis</i>-3,4-DFACPC show high uptake in 9L gliosarcoma intracranial tumors with relatively low normal tissue uptake. Furthermore, in contrast to <i>anti</i>-2-FACPC, both <i>cis</i>-3,4-DFACPC isomers showed low bladder uptake at early timepoints, suggesting that these compounds may also be viable for imaging prostate cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Information</h3><div class="NLM_p last">All solvents were purchased from Fisher Scientific or Sigma Aldrich and dried over 4 Å mol sieves (8–12 mesh, Sigma Aldrich). Unless otherwise noted, all commercially available reagents and substrates were used directly as received. Ultra-High Purity dry air was purchased from nexAir LLC. Thin-layer chromatography was performed on Merck silica gel plates and visualized by UV light and/or potassium permanganate. <sup>1</sup>H NMR and <sup>13</sup>C and <sup>19</sup>F NMR spectra were recorded on Bruker 600, Varian INOVA 600, INOVA 500, and INOVA 400 spectrometers. Residual solvent resonances were treated as internal reference signals. <sup>19</sup>F spectra were referenced to either trifluoroacetic acid (−76.55 ppm) or fluorobenzene (−113.15 ppm). IR spectra were recorded on a Nicolet iS10 FT-IR spectrometer, and the absorption peaks were reported in cm<sup>–1</sup>. The purification of products was performed via flash chromatography<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> unless otherwise noted. A Thomas capillary melting point apparatus was used to determine the melting points (uncorrected). High-resolution mass spectra were obtained from the Emory University Mass Spec Facility Inc. X-ray crystal structure data were obtained from Dr. John Bacsa of the Emory University X-ray Crystallography Center. The [<sup>18</sup>F]fluoride was produced at Emory University Center for Systems Imaging with an 11 MeV Siemens RDS 111 negative-ion cyclotron (Knoxville, TN) by the <sup>18</sup>O(p, n) <sup>18</sup>F reaction using [<sup>18</sup>O]H<sub>2</sub>O (95%). Alumina N SepPaks and HLB Oasis cartridges were purchased from Waters, Inc. (Milford, MA). The ion retardation (IR) chromatography columns and the IR resin AG 11A8 (50–100 mesh) were purchased from BioRad Laboratories (Hercules, CA). Trap/release cartridges model DW-TRC were purchased from D&W, Inc. (Oakdale, TN). Radiometric TLC was performed with the same type of silica plate from Whatman and analyzed using a Raytest system (model Rita Star, Germany). Isolated radiochemical yields were determined using a dose-calibrator (Capintec CRC-712 M). Analytical HPLC experiments were performed with a Waters Breeze HPLC system equipped with a Bioscan flowcount radioactivity detector and an inline UV detector set to monitor wavelengths 210, 230, and 254 nm (Astec chirobiotic T column, Sigma-Aldrich part number 12021AST; mobile phase: MeOH). All animal experiments were carried out under humane conditions and were approved by the Institutional Animal Use and Care Committee (IUCAC) and Radiation Safety Committees at Emory University. The purity of all reported compounds is at least 95%, as assessed by <sup>1</sup>H NMR, radiometric TLC, or radiometric HPLC, unless otherwise noted.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemistry</h3><div class="NLM_p">2-Phenyloxazol-5(4<i>H</i>)-one (<b>1</b>),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> ethyl (<i>E</i>)-2-((4-bromobenzylidene)amino)acetate (<b>13</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> ethyl (<i>Z</i>)-1-((4-bromobenzylidene)amino)cyclopent-3-ene-1-carboxylate (<b>14</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and ethyl 1-aminocyclopent-3-ene-1-carboxylate (<b>15</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were prepared according to previously reported procedures.</div><div class="NLM_p"><b>4,4-Diallyl-2-phenyloxazol-5(4<i>H</i>)-one (2)</b> was prepared from 2-phenyloxazol-5(4<i>H</i>)-one with a slight modification to a reported procedure.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> containing a magnetic stir bar and a solution of 2-phenyloxazol-5(4<i>H</i>)-one (74.1 g, 459.8 mmol, 1 equiv) in DMF (1 L, 0.5 M), NaI (3.45 g, 23.0 mmol, 0.05 equiv) and allyl bromide (79.5 mL, 111.3 g, 920 mmol, 2 equiv) were added sequentially. Diisopropylethylamine (DIPEA) (160.3 mL, 118.9 g, 920 mmol, 2 equiv) was then added dropwise. Immediately upon addition of DIPEA, the reaction began to exotherm and developed a dark green color. Upon complete addition of DIPEA, the reaction was left to stir at room temperature overnight. The reaction was diluted with ethyl acetate (1 L) and washed with 5 × 500 mL portions of brine. The organic layers were collected, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give an orange oil that was used without further purification.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <b>Ethyl 2-Allyl-2-Benzamidopent-4-Enoate</b> (<b>3</b>)</h3><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> containing a magnetic stir bar and EtOH (100 mL), sodium (0.11 g, 4.6 mmol, 0.01 equiv) was added. The mixture was stirred until the evolution of H<sub>2</sub> gas ceased at which time crude <b>4,4-diallyl-2-phenyloxazol-5(4<i>H</i>)-one</b> (<b>2</b>) was added as a solution in EtOH (100 mL). After stirring for 3 h at room temperature, the reaction was concentrated, and the remaining oily residue was taken up in CH<sub>2</sub>Cl<sub>2</sub> (DCM) and washed with one portion of H<sub>2</sub>O and one portion of brine. The organics were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give an orange oil. The oil was taken up in a minimum quantity of hot hexanes, gravity filtered, and stored at 0 °C overnight, resulting in the formation of pale-yellow crystals. The supernatant was removed by vacuum filtration, and the crystals were washed with cold hexanes and then freed of residual solvents in vacuo. Pale yellow crystalline solid, 74.8 g, 260.3 mmol, 54% yield over three steps from 480 mmol of hippuric acid. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.83–7.72 (m, 2H), 7.54–7.47 (m, 1H), 7.47–7.39 (m, 2H), 7.12 (s, 1H), 5.72–5.57 (m, 2H), 5.24–4.84 (m, 4H), 4.27 (q, <i>J</i> = 7.1 Hz, 2H), 3.41 (dd, <i>J</i> = 13.7, 7.4 Hz, 2H), 2.61 (dd, <i>J</i> = 13.7, 7.4 Hz, 2H), 1.32 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, chloroform-<i>d</i>) δ 173.4, 166.5, 135.2, 132.4, 131.6, 128.7, 127.0, 119.3, 64.7, 62.2, 39.3, 14.4. IR (neat, cm<sup>–1</sup>): 3254, 1740, 1632. HRMS (ESI) Calcd. for C<sub>17</sub>H<sub>22</sub>O<sub>3</sub>N (M + H)<sup>+</sup>: 288.15942. Found: 288.15959. Melting point: 54–55 °C.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <b>Ethyl 1-Benzamidocyclopent-3-Ene-1-Carboxylate</b> (<b>4</b>)</h3><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> containing a magnetic stir bar and a solution of <b>ethyl 2-allyl-2-benzamidopent-4-enoate</b> (<b>3</b>) (3.60 g, 12.6 mmol, 1 equiv) in toluene (60 mL, 0.2 M), dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene](2-isopropoxyphenylmethylene)ruthenium(II) (120 mg, 0.192 mmol, 0.015 equiv) was added and the mixture was stirred at room temperature for 10 h. The contents of the reaction vessel were filtered over Celite, and the filtrate was concentrated. The resulting black solid was subjected to silica gel flash chromatography, eluting the desired compound with 30% EtOAc in a hexane gradient (<i>R</i><sub>f</sub> = 0.3). White solid, 3.08 g, 11.88 mmol, 94% yield. Alternatively, the crude material can be purified by crystallization from EtOAc/hexanes. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.81–7.76 (m, 2H), 7.55–7.47 (m, 1H), 7.47–7.40 (m, 2H), 6.78 (s, 1H), 5.71 (s, 2H), 4.25 (q, <i>J</i> = 7.1 Hz, 2H), 3.15 (d, <i>J</i> = 15.2 Hz, 2H), 2.82 (d, <i>J</i> = 15.2 Hz, 2H), 1.26 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 174.0, 167.0, 134.3, 131.8, 128.7, 128.1, 127.1, 64.5, 61.8, 44.8, 14.3. IR (neat, cm<sup>–1</sup>): 3381, 3284, 1732, 1718, 1654, 1631. HRMS (ESI) Calcd. for C<sub>15</sub>H<sub>18</sub>O<sub>3</sub>N (M + H)<sup>+</sup>: 260.12812. Found: 260.12823. Melting point: 101–102 °C.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <b>Ethyl (1<i>R</i>,3<i>R</i>,5<i>S</i>)-3-Benzamido-6-Oxabicyclo[3.1.0]Hexane-3-Carboxylate</b> (<b>5</b>)</h3><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> containing a magnetic stir bar and <b>ethyl 1-benzamidocyclopent-3-ene-1-carboxylate</b> (<b>4</b>) (2.00 g, 7.71 mmol, 1.0 equiv) suspended in toluene (60 mL, 0.1 M), <i>meta</i>-chloroperoxybenzoic acid (2.60 g, 11.57 mmol, 1.5 equiv) was added at once. The reaction was stirred at room temperature for 24 h. Saturated aqueous sodium bicarbonate (30 mL) was added, and the mixture was stirred for another 30 min, and then it was diluted with 60 mL of DCM. The organics were separated and washed with another 30 mL portion of saturated aqueous sodium bicarbonate and then with brine. The organics were collected, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification of the crude oily residue was achieved by silica gel flash chromatography, eluting the desired compound with a 60/40 EtOAc hexane gradient (<i>R</i><sub>f</sub> = 0.3). White solid, 1.66 g, 6.04 mmol, 78% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.79–7.71 (m, 2H), 7.54–7.46 (m, 1H), 7.46–7.39 (m, 2H), 6.53 (s, 1H), 4.21 (q, <i>J</i> = 7.1 Hz, 2H), 3.68 (s, 2H), 2.57 (d, <i>J</i> = 15.8 Hz, 2H), 2.44 (d, <i>J</i> = 15.5 Hz, 2H), 1.24 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 171.5, 166.4, 133.9, 131.8, 128.7, 127.2, 62.2, 61.9, 56.9, 38.8, 14.3. IR (neat, cm<sup>–1</sup>): 3361, 1721, 1651. HRMS (ESI) Calcd. for C<sub>15</sub>H<sub>18</sub>O<sub>4</sub>N (M + H)<sup>+</sup>: 276.12303. Found: 276.12315. Melting point: 110–112 °C.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <b>Racemic Ethyl 1-Benzamido-3-Fluoro-4-Hydroxycyclopentane-1-Carboxylate</b> (<b>6</b>)</h3><div class="NLM_p last">A plastic vial under N<sub>2</sub> containing a magnetic stir bar and a solution of <b>ethyl-3-benzamido-6-oxabicyclo[3.1.0]hexane-3-carboxylate</b> (<b>5</b>) (1.60 g, 5.81 mmol) in DCM (40 mL, 0.1 M) was chilled with an ice water bath. To this solution, HF pyridine (2 mL) was added dropwise with a plastic syringe. The mixture was stirred for 2 h at 0 °C and then slowly poured onto a slurry of ice and saturated aqueous sodium bicarbonate. Once the evolution of gas had ceased, the mixture was transferred to a separatory funnel and the organic layer was collected. The aqueous phase was washed 2 times with 20 mL of DCM, and the organic layers were combined and collectively dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The resulting residue was purified by silica gel flash chromatography, eluting the desired compound with a 60/40 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.3). Tan oil, 924 mg, 3.13 mmol, 54% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.83–7.75 (m, 3H), 7.58–7.51 (m, 1H), 7.49–7.43 (m, 2H), 5.65 (d, <i>J</i> = 9.5 Hz, 1H), 5.15 (ddd, <i>J</i> = 51.3, 5.1, 1.5 Hz, 1H), 4.52–4.41 (m, 1H), 4.32 (qd, <i>J</i> = 7.1, 2.4 Hz, 2H), 3.01–2.83 (m, 2H), 2.50 (dd, <i>J</i> = 24.0, 15.9 Hz, 1H), 2.27 (d, <i>J</i> = 15.4 Hz, 1H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 174.5, 166.6, 133.9, 132.3, 128.9, 127.1, 99.7 (d, <i>J</i> = 181.3 Hz), 77.0, 65.2, 63.0, 44.5, 40.87 (d, <i>J</i> = 21.9 Hz), 14.08. <sup>19</sup>F NMR (376 MHz, chloroform-<i>d,</i> trifluoroacetic acid reference standard) δ −179.6 (dddd, <i>J</i> = 51.0, 34.7, 23.8, 11.0 Hz). IR (neat, cm<sup>–1</sup>): 3354, 1728, 1636. HRMS (ESI) Calcd. for C<sub>15</sub>H<sub>19</sub>O<sub>4</sub>NF (M + H)<sup>+</sup>: 296.12926. Found: 296.12940.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <b>Racemic Ethyl-1-Benzamido-3-Fluoro-4-(((Trifluoromethyl)Sulfonyl)Oxy)Cyclopentane-1-Carboxylate</b> (<b>7</b>)</h3><div class="NLM_p last">A scintillation vial under N<sub>2</sub> containing a stir bar and racemic <b>ethyl-1-benzamido-3-fluoro-4-hydroxycyclopentane-1-carboxylate</b> (<b>6</b>) (400 mg, 1.35 mmol, 1 equiv) and pyridine (240 μL, 2.97 mmol, 2.2 equiv) in DCM (5 mL) was cooled to 0 °C. A separate vial containing trifluoromethanesulfonic anhydride (385 μL, 2.70 mmol, 2.0 equiv) in DCM (1.5 mL) was cooled to 0 °C, and this mixture was added dropwise to the fluorohydrin solution with vigorous stirring. The mixture was stirred at 0 °C for 15 min and then diluted with hexanes (10 mL). A white powder precipitated and was filtered, and the supernatant was concentrated at 0 °C. The crude residue was purified with a silica plug, eluting the desired compound with a 30/70 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.3). Colorless oil, 481 mg, 1.13 mmol, 83% yield. Note that these compounds are thermally unstable. They should be isolated from the reaction mixture as quickly as possible and used immediately or stored as a solution in benzene at <0 °C. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.78–7.74 (m, 2H), 7.57–7.51 (m, 1H), 7.48–7.43 (m, 2H), 5.62 (ddd, <i>J</i> = 8.4, 6.3, 5.2 Hz, 1H), 5.50 (dtd, <i>J</i> = 15.7, 7.8, 5.3 Hz, 1H), 4.34 (qd, <i>J</i> = 7.1, 4.7 Hz, 2H), 2.90–2.78 (m, 3H), 2.51 (ddd, <i>J</i> = 23.3, 15.0, 6.5 Hz, 1H), 1.34 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ 172.8, 166.9, 133.5, 132.4, 129.0, 118.6 (q, <i>J</i> = 320 Hz), 94.1 (d, <i>J</i> = 188 Hz), 89.8 (d, <i>J</i> = 25 Hz), 63.3, 61.9 (d, <i>J</i> = 5.0 Hz), 39.5 (d, <i>J</i> = 22 Hz), 38.2 (d, <i>J</i> = 3.4 Hz), 14.1. <sup>19</sup>F NMR (376 MHz, chloroform-<i>d,</i> fluorobenzene reference standard) δ −74.5 (s, 3F), −184.7 (ddd, <i>J</i> = 53.6, 23.7, 12.4 Hz, 1F). IR (neat, cm<sup>–1</sup>): 3301, 1737, 1636. HRMS (ESI) Calcd. for C<sub>16</sub>H<sub>18</sub>O<sub>6</sub>NF<sub>4</sub>S (M + H)<sup>+</sup>: 428.07855. Found: 428.07894.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <b>Ethyl (1<i>S</i>,3<i>R</i>,4<i>S</i>)-1-Benzamido-3,4-Difluorocyclopentane-1-Carboxylate</b> (<b>8</b>)</h3><div class="NLM_p last">To a scintillation vial under N<sub>2</sub> containing a stir bar and a mixture of racemic <b>ethyl-1-benzamido-3-fluoro-4-(((trifluoromethyl)sulfonyl)oxy)cyclopentane-1-carboxylate</b> (<b>7</b>) (370 mg, 1.09 mmol, 1 equiv) in THF (10 mL, 0.1 M), triethylamine trihydrofluoride (0.60 mL, 10.9 mmol, 10.0 equiv) was added at once and the reaction was stirred overnight at room temperature. The reaction was diluted with DCM (20 mL) and washed with two portions of saturated aqueous sodium bicarbonate (10 mL) and then brine (10 mL). The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 20/80 EtOAc/hexane gradient (R<sub>f</sub> = 0.4). Colorless oil, 67 mg, 0.23 mmol, 26% yield. <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 7.78–7.71 (m, 2H), 7.53 (t, <i>J</i> = 7.2 Hz, 1H), 7.45 (t, <i>J</i> = 7.7 Hz, 2H), 7.33 (s, 1H), 5.65–5.37 (m, 2H), 4.32 (q, <i>J</i> = 7.1 Hz, 2H), 2.88–2.71 (m, 2H), 2.58 (ddd, <i>J</i> = 18.8, 14.7, 5.5 Hz, 2H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, chloroform-<i>d</i>) δ 173.6, 167.3, 133.7, 132.3, 128.9, 127.0, 92.2 (dd, <i>J</i> = 188.7, 15.1 Hz), 63.1, 61.7 (t, <i>J</i> = 4.8 Hz), 40.3–40.1 (four-line multiplet, magnetic inequivalence), 14.1. <sup>19</sup>F NMR (376 MHz, chloroform-<i>d,</i> fluorobenzene reference standard) δ −198.5 – −198.9 (m). IR (neat, cm<sup>–1</sup>): 3312, 1739, 1632. HRMS (ESI) Calcd. for C<sub>15</sub>H<sub>18</sub>O<sub>3</sub>NF<sub>2</sub> (M + H)<sup>+</sup>: 298.12493. Found 298.12509.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <b>(1<i>S</i>,3<i>R</i>,4<i>S</i>)-1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid Hydrochloride</b> (<b>9</b>)</h3><div class="NLM_p last">To a scintillation vial open to air containing a stir bar and <b>ethyl (1 <i>s</i>,3<i>R</i>,4<i>S</i>)-1-benzamido-3,4-difluorocyclopentane-1-carboxylate</b> (<b>8</b>) (33 mg, 0.111 mmol), concentrated aqueous HCl (1 mL) was added. The vial was sealed with a plastic cap and allowed to stir at 90 °C for 10 h. Upon cooling to room temperature, colorless crystals formed spontaneously. These crystals were collected by filtration, washed with diethyl ether, and freed of residual solvents in vacuo. Colorless crystals, 20.1 mg, 0.100 mmol, 90% yield. <sup>1</sup>H NMR (400 MHz, Deuterium Oxide) δ 5.40–5.17 (m, 2H), 2.81 (ddt, <i>J</i> = 18.4, 15.9, 5.1 Hz, 1H), 2.40 (ddd, <i>J</i> = 18.5, 14.2, 5.4 Hz, 2H). <sup>13</sup>C NMR (125 MHz, deuterium oxide) δ 173.3, 91.3 (dd, <i>J</i> = 186.9, 15.6 Hz), 60.3 (t, <i>J</i> = 4.2 Hz), 37.7–37.4 (four-line multiplet, magnetic inequivalence). <sup>19</sup>F NMR (376 MHz, deuterium oxide, trifluoroacetic acid reference standard) δ −201.3 – −201.6 (m). IR (neat, cm<sup>–1</sup>): 3196, 3067, 1712. HRMS (ESI) Calcd. for C<sub>6</sub>H<sub>9</sub>O<sub>2</sub>NClF<sub>2</sub> (M-H)<sup>−</sup>: 200.02954. Found 200.03002. Melting point: 242–244 °C (decomposes).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Racemic 1-Amino-3-Fluoro-4-Hydroxycyclopentane-1-Carboxylic Acid Hydrochloride (10)</h3><div class="NLM_p last">To a mixture of racemic <b>ethyl-1-benzamido-3-fluoro-4-hydroxycyclopentane-1-carboxylate</b> (<b>3.06</b>) (800 mg, 2.71 mmol) in a scintillation vial with a magnetic stir bar and open to air, concentrated aqueous HCl was added (3.0 mL). The vial was sealed with a plastic cap and heated to 90 °C overnight. The reaction was removed from heat, concentrated in vacuo, and washed with ether. A white solid (519 mg) was obtained that was carried forward without further purification. <sup>1</sup>H NMR (600 MHz, deuterium oxide) δ 5.12 (d, <i>J</i> = 49.8 Hz, 1H), 4.59–4.45 (m, 1H), 2.77–2.46 (m, 3H), 2.12 (d, <i>J</i> = 14.8 Hz, 1H). <sup>13</sup>C NMR (125 MHz, deuterium oxide) δ 173.7, 97.1 (d, <i>J</i> = 179.9 Hz), 74.8 (d, <i>J</i> = 26.7 Hz), 63.3, 40.5 (d, <i>J</i> = 23.5), 40.5.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <b>Racemic Ethyl (1<i>S</i>,3<i>R</i>,4<i>R</i>)-1-Amino-3-Fluoro-4-Hydroxycyclopentane-1-Carboxylate</b> (<b>11</b>)</h3><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> fitted with a reflux condenser and stir bar and containing a crude mixture of racemic <b>1-amino-3-fluoro-4-hydroxycyclopentane-1-carboxylic acid hydrochloride</b> (<b>10</b>) (519 mg) in dry ethanol, H<sub>2</sub>SO<sub>4</sub> (0.1 mL) was added, and the reaction was heated to reflux for 10 h. Ethanol was removed in vacuo, and the crude residue was taken up in water (10 mL) and washed with three portions of DCM (10 mL). The organic layers were discarded, and the aqueous phase was treated with 30 mL of saturated aqueous sodium bicarbonate and then extracted with three portions of DCM (30 mL). The organics were collected, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. A pale-yellow oil (320 mg) was obtained, which was carried forward without further purification. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 5.13 (dddd, <i>J</i> = 51.6, 6.0, 2.7, 1.8 Hz, 1H), 4.28 (dd, <i>J</i> = 9.2, 4.6 Hz, 1H), 4.19 (q, <i>J</i> = 7.2 Hz, 2H), 2.53–2.32 (m, 2H), 2.22 (dddd, <i>J</i> = 25.2, 15.7, 6.0, 2.1 Hz, 1H), 1.82 (d, <i>J</i> = 13.9 Hz, 1H), 1.28 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>) δ 175.8, 99.3 (d, <i>J</i> = 180.8 Hz), 77.2 (d, <i>J</i> = 27.7 Hz), 64.5, 61.9, 44.4 (d, <i>J</i> = 24.6 Hz), 42.9, 14.3.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <b>Racemic Ethyl-1-((<i>tert</i>-Butoxycarbonyl)Amino)-3-Fluoro-4-Hydroxycyclopentane-1-Carboxylate</b> (<b>12</b>)</h3><div class="NLM_p">To a scintillation vial under N<sub>2</sub> containing crude racemic <b>ethyl-1-amino-3-fluoro-4 hydroxycyclopentane-1-carboxylate</b> (<b>11</b>) (320 mg) in 10 mL of a 1:1 mixture of THF and water (10 mL), di-<i>tert</i>-butyl dicarbonate (290 mg, 1.32 mmol) was added. The mixture was stirred at room temperature for 8 h and then extracted with 3 portions of DCM (20 mL). The organic layers were combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 40/60 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.3). White solid, 401 mg, 1.38 mmol, 51% yield over three steps.</div><div class="NLM_p last">Alternatively, <b>ethyl (1<i>R</i>,3<i>r</i>,5<i>S</i>)-3-((<i>tert</i>-butoxycarbonyl)amino)-6-oxabicyclo[3.1.0]hexane-3-carboxylate</b> (<b>17</b>) (820 mg, 3.02 mmol, 1.0 equiv) was suspended in 3 mL of benzene and stirred under high vacuum to allow for the azeotropic distillation of residual water. Once all of the benzene was removed, this compound was then added to a thick-walled glass tube with a stir bar, and the tube was purged with N<sub>2</sub>. Triethylamine (4.2 mL, 30.2 mmol, 10.0 equiv) and triethylamine trihydrofluoride were added (2.5 mL, 15.1 mmol, 5.0 equiv) sequentially, and the tube was sealed with a screw cap and then heated to 130 °C for 8 h. After cooling to room temperature, DCM (30 mL) and saturated aqueous sodium bicarbonate (30 mL) were added, and the biphasic mixture was stirred vigorously for several min. The mixture was transferred to a seperatory funnel, the organics were separated, and the aqueous phase was washed with DCM (30 mL). The organics were combined, washed with brine (30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 40/60 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.3). Off-white solid, 755 mg, 2.59 mmol, 86% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 5.82 (s, 1H), 5.16–4.91 (m, 1H), 4.63 (s, 1H), 4.36 (dq, <i>J</i> = 14.9, 7.1 Hz, 1H), 4.24 (q, <i>J</i> = 7.1 Hz, 2H), 2.81 (dd, <i>J</i> = 15.5, 6.5 Hz, 1H), 2.72–2.41 (m, 2H), 2.07 (d, <i>J</i> = 15.1 Hz, 1H), 1.43 (s, 9H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, chloroform-<i>d</i>) δ 173.9, 155.0, 99.3 (d, <i>J</i> = 181 Hz), 81.0, 76.7 (d, <i>J</i> = 27 Hz), 64.5, 62.5, 43.9, 41.4 (d, <i>J</i> = 18.8 Hz), 28.4, 14.1. <sup>19</sup>F NMR (282 MHz, chloroform-<i>d</i>, fluorobenzene reference standard) δ −179.2. IR (CDCl<sub>3</sub>, cm<sup>–1</sup>): 3374, 1717, 1695. HRMS (ESI) Calcd. for C<sub>13</sub>H<sub>23</sub>O<sub>5</sub>NF (M + H)<sup>+</sup>: 292.15548. Found: 292.15567. Melting point: 48–51 °C.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <b>Ethyl 1-((<i>tert</i>-Butoxycarbonyl)Amino)Cyclopent-3-Ene-1-Carboxylate</b> (<b>16</b>)</h3><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> containing a stir bar and <b>ethyl 1-aminocyclopent-3-ene-1-carboxylate</b> (<b>15</b>) (2.01 g, 12.95 mmol, 1.0 equiv) in a 1:1 mixture of THF and water (40 mL, 0.3 M), di-tert-butyl dicarbonate (3.11 g, 14.24 mmol, 1.1 equiv) was added, and the mixture was stirred at room temperature for 8 h. EtOAc was added (100 mL), and the organic layer was separated, washed with brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 15/85 EtOAc/hexane gradient (R<sub>f</sub> = 0.4). White solid, 3.08 g, 12.06 mmol, 93% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 5.64 (s, 2H), 5.10 (d, <i>J</i> = 13.1 Hz, 1H), 4.20 (q, <i>J</i> = 7.1 Hz, 2H), 3.08–3.01 (m, 2H), 2.60 (d, <i>J</i> = 17.2 Hz, 2H), 1.42 (s, 9H), 1.26 (t, <i>J</i> = 7.1 Hz, 3H).<sup>13</sup>C NMR (150 MHz, chloroform-<i>d</i>) δ 174.4, 155.0, 127.8, 79.9, 64.3, 61.6, 45.0, 28.4, 14.3. IR (neat, cm<sup>–1</sup>): 3272, 3139, 1733, 1698. HRMS (ESI) Calcd. for C<sub>13</sub>H<sub>22</sub>O<sub>4</sub>N (M + H)<sup>+</sup>:256.15433. Found 256.15430. Melting point: 75–76 °C. Known compound; spectroscopic data match the literature, lit. Melting point: 82 °C.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <b>Ethyl (1<i>R</i>,3<i>r</i>,5<i>S</i>)-3-((<i>tert</i>-Butoxycarbonyl)Amino)-6-Oxabicyclo[3.1.0]Hexane-3-Carboxylate</b> (<b>17</b>)</h3><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> containing a stir bar and <b>ethyl 1-((<i>tert-</i>butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylate</b> (<b>16</b>) (550 mg, 2.16 mmol, 1.0 equiv) in toluene (20 mL, 0.1 M), <i>meta</i>-chloroperoxybenzoic acid (725 mg, 3.23 mmol, 1.5 equiv) was added in one portion. The reaction was stirred at room temperature for 24 h. Saturated aqueous sodium bicarbonate (15 mL) was added, and the mixture was stirred for another 30 min, and then, it was diluted with 30 mL of DCM. The organics were separated and washed with another 15 mL portion of saturated aqueous sodium bicarbonate and then with brine (15 mL). The organics were collected, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification of the crude oily residue was achieved by silica gel flash chromatography, eluting the desired compound with a 30/70 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.3). White solid, 446 mg, 1.64 mmol, 76% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 5.02 (s, 1H), 4.19 (q, <i>J</i> = 7.1 Hz, 2H), 3.61 (s, 2H), 2.46 (d, <i>J</i> = 15.3 Hz, 2H), 2.27 (d, <i>J</i> = 15.3 Hz, 2H), 1.41 (s, 9H), 1.24 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 172.3, 154.6, 80.0, 62.3, 61.8, 57.0, 38.8, 28.4, 14.2. IR (neat, cm<sup>–1</sup>): 3380, 1735, 1709. HRMS (ESI) Calcd. for C<sub>13</sub>H<sub>22</sub>O<sub>5</sub>N (M + H)<sup>+</sup>: 272.14925. Found 272.14922. Melting point: 62–63 °C.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <b>Ethyl (1<i>R</i>,3<i>s</i>,5<i>S</i>)-3-((<i>tert</i>-Butoxycarbonyl)Amino)-6-Oxabicyclo[3.1.0]Hexane-3-Carboxylate</b> (<b>18</b>)</h3><div class="NLM_p last">To a round-bottom flask under N<sub>2</sub> containing a stir bar and <b>ethyl 1-((<i>tert-</i>butoxycarbonyl)amino)cyclopent-3-ene-1-carboxylate</b> (<b>16</b>) (550 mg, 2.16 mmol, 1.0 equiv) in toluene (20 mL, 0.1 M), <i>meta</i>-chloroperoxybenzoic acid (725 mg, 3.23 mmol, 1.5 equiv) was added in one portion. The reaction was stirred at room temperature for 24 h. Saturated aqueous sodium bicarbonate (15 mL) was added, and the mixture was stirred for another 30 min, and then, it was diluted with 30 mL of DCM. The organics were separated and washed with another 15 mL portion of saturated aqueous sodium bicarbonate and then with brine (15 mL). The organics were collected, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification of the crude oily residue was achieved by silica gel flash chromatography, eluting the desired compound with a 30/70 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.25). White solid, 85 mg, 0.313 mmol, 15% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 5.08 (s, 1H), 4.20 (q, <i>J</i> = 7.1 Hz, 2H), 3.57 (s, 2H), 2.88 (d, <i>J</i> = 14.8 Hz, 2H), 2.08 (d, <i>J</i> = 14.8 Hz, 2H), 1.42 (s, 9H), 1.27 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 173.1, 154.6, 80.4, 64.0, 61.9, 56.8, 38.8, 28.4, 14.2. IR (neat, cm<sup>–1</sup>): 3358, 1734, 1701. HRMS (ESI) Calcd. for C<sub>13</sub>H<sub>22</sub>O<sub>5</sub>N (M + H)<sup>+</sup>: 272.14925. Found 272.14920. Melting point: 108–109 °C.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <b>Racemic Ethyl-1-((<i>tert</i>-Butoxycarbonyl)Amino)-3-Fluoro-4 (((Trifluoromethyl)Sulfonyl)Oxy)Cyclopentane-1-Carboxylate</b> (<b>19</b>)</h3><div class="NLM_p last">A scintillation vial under N<sub>2</sub> containing a stir bar and a mixture of racemic <b>1-((<i>tert</i>-butoxycarbonyl)amino)-3-fluoro-4-hydroxycyclopentane-1-carboxylate</b> (<b>12</b>) (70 mg, 0.24 mmol, 1 equiv) and pyridine (40 μL, 0.53 mmol, 2.2 equiv) in DCM (1.5 mL) was cooled to 0 °C. A separate vial containing trifluoromethanesulfonic anhydride (70 μL, 0.48 mmol, 2.0 equiv) in DCM (1.5 mL) was cooled to 0 °C, and this mixture was added dropwise to the fluorohydrin solution with vigorous stirring. The mixture was stirred at 0 °C for 15 min and then diluted with hexanes (3 mL). A white powder precipitated and was filtered, and the supernatant was concentrated at 0 °C. The crude residue was purified with a silica plug, eluting the desired compound with a 20/80 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.3). Colorless oil, 75 mg, 0.177 mmol, 74% yield. Note that these compounds are thermally unstable, decomposing over the course of one evening at room temperature. Care should be taken to purify these compounds as quickly as possible at which point they should be used immediately or taken up in benzene and stored at <0 °C. <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 5.54–5.25 (m, 3H), 4.27 (q, <i>J</i> = 7.1 Hz, 2H), 2.95–2.35 (m, 4H), 1.44 (d, 9H), 1.31 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ 172.4, 154.6, 118.6 (q, <i>J</i> = 319 Hz), 94.6 (d, <i>J</i> = 188 Hz), 92.2, 89.9 (d, <i>J</i> = 26 Hz), 62.8, 58.1, 40.2 (d, <i>J</i> = 22 Hz), 39.2, 28.4, 14.1. <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>, fluorobenzene reference standard) δ −74.6 (s, 3F), −184.6 (m, 1F). IR (CDCl<sub>3</sub>, cm<sup>–1</sup>): 3353, 1716. HRMS (ESI) Calcd. for C<sub>14</sub>H<sub>22</sub>O<sub>7</sub>NF<sub>4</sub>S (M + H)<sup>+</sup>: 424.10476. Found: 424.10539.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <b>Racemic 1-((<i>tert</i>-Butoxycarbonyl)Amino)-3-Fluoro-4-Hydroxycyclopentane-1-Carboxylate</b> (<b>20</b>)</h3><div class="NLM_p last">A thick-walled glass tube purged with N<sub>2</sub>, containing a stir bar and <b>ethyl (1<i>R</i>,3<i>s</i>,5<i>S</i>)-3-((<i>tert</i>-butoxycarbonyl)amino)-6-oxabicyclo[3.1.0]hexane-3-carboxylate</b> (<b>18</b>) (350 mg, 1.20 mmol, 1.0 equiv), was treated with 3 mL of benzene and stirred under high vacuum to allow for the azeotropic distillation of residual water. Once all of the benzene was removed, triethylamine (1.79 mL, 12.9 mmol, 10.0 equiv) and triethylamine trihydrofluoride (1.05 mL, 6.45 mmol, 5.0 equiv) were added sequentially. The tube was sealed with a screw cap, and the mixture was heated to 130 °C for 8 h. After cooling to room temperature, DCM (20 mL) and saturated aqueous sodium bicarbonate (20 mL) were added, and the biphasic mixture was stirred vigorously for several min. The mixture was transferred to a separatory funnel, and the organics were separated, and the aqueous phase was washed with DCM (20 mL). The organics were combined, washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 40/60 EtOAc/hexane gradient (R<sub>f</sub> = 0.3). Colorless oil, 68 mg, 0.252 mmol, 21% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 5.13 (s, 1H), 4.96 (dd, <i>J</i> = 51.0, 4.7 Hz, 1H), 4.49–4.34 (m, 1H), 4.30–4.16 (m, 2H), 3.16 (d, <i>J</i> = 7.4 Hz, 1H), 2.68 (ddd, <i>J</i> = 35.4, 15.8, 5.0 Hz, 1H), 2.58 (d, <i>J</i> = 15.9 Hz, 1H), 2.35 (ddd, <i>J</i> = 14.8, 6.2, 2.1 Hz, 1H), 2.16 (dd, <i>J</i> = 23.2, 15.7 Hz, 1H), 1.43 (s, 9H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, chloroform-<i>d</i>) δ 176.4, 155.9, 98.7 (d, <i>J</i> = 178.9 Hz), 80.4, 76.0 (d, <i>J</i> = 27.2 Hz), 64.0, 62.6, 44.4, 42.7 (d, <i>J</i> = 22.3 Hz), 28.4, 14.9. <sup>19</sup>F NMR (282 MHz, chloroform-<i>d,</i> fluorobenzene reference standard) δ −176.5 – −179.3 (m). IR (neat, cm<sup>–1</sup>): 3348, 1737, 1692. HRMS (ESI) Calcd. for C<sub>13</sub>H<sub>23</sub>O<sub>5</sub>NF (M + H)<sup>+</sup>: 292.15548. Found: 292.15551.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Ethyl 1-(1,3-Dioxoisoindolin-2-yl)Cyclopent-3-Ene-1-Carboxylate (22)</h3><div class="NLM_p last">To a two necked round-bottom flask under N<sub>2</sub>, fitted with a dean stark apparatus, and containing a stir bar, <b>ethyl 1-aminocyclopent-3-ene-1-carboxylate</b> (<b>15</b>) (7.01 g, 45.2 mmol, 1.0 equiv) and toluene (200 mL), phthalic anhydride (7.35 g, 49.7 mmol, 1.1 equiv) was added. The mixture was heated to 110 °C for 24 h. The mixture was cooled to room temperature and diluted with 200 mL of DCM. The organics were <b>washed with water (100 mL)</b> and brine (100 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>, before being filtered and concentrated in vacuo. The crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 15/85 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.3). White needles, 8.66 g, 30.4 mmol, 67% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.83–7.78 (m, 2H), 7.74–7.67 (m, 2H), 5.76 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 3.43 (d, <i>J</i> = 16.0 Hz, 2H), 3.27 (d, <i>J</i> = 16.1 Hz, 2H), 1.20 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ 172.5, 168.8, 134.2, 132.0, 127.9, 123.3, 68.3, 62.0, 42.4, 14.1. IR (neat, cm<sup>–1</sup>): 1775, 1707. HRMS (ESI) Calcd. for C<sub>16</sub>H<sub>16</sub>O<sub>4</sub>N (M + H)<sup>+</sup>: 286.10738. Found: 286.10765. Melting point (crystallized from diethyl ether): 57–59 °C.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl (1<i>R</i>,3<i>s</i>,5<i>S</i>)-3-(1,3-Dioxoisoindolin-2-yl)-6-Oxabicyclo[3.1.0]Hexane-3-Carboxylate (23)</h3><div class="NLM_p last">To a round-bottom flask containing a stir bar and <b>ethyl 1-(1,3-dioxoisoindolin-2-yl)cyclopent-3-ene-1-carboxylate</b> (<b>22</b>) (4.00 g, 14.02 mmol, 1.0 equiv) in toluene (140 mL), <i>meta</i>-chloroperoxybenzoic acid was added (5.20 g, 21.03 mmol, 1.5 equiv), and the mixture was stirred at room temperature for 12 h. The reaction was quenched by the addition of saturated aqueous sodium bicarbonate (100 mL), diluted with DCM (150 mL), and stirred for several min. The phases were separated, and the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Analysis of the proton NMR of the crude mixture suggests that a mixture of syn and anti-epoxides was formed in a 1:0.4 ratio. The crude residue was taken up in a minimum quantity of refluxing diethyl ether, allowed to stand for several hours at room temperature, and then chilled to 0 °C overnight. Crystalline white blocks were obtained, which were determined to be a mixture of <i>syn</i> and <i>anti</i>-epoxide diastereomers (1:0.4) by proton NMR. The desired anti diastereomer was obtained by column chromatography eluting with a 30/70 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.2). White solid, 1.06 g, 3.51 mmol, 25% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.83–7.77 (m, 2H), 7.75–7.69 (m, 2H), 4.24 (q, <i>J</i> = 7.1 Hz, 2H), 3.63 (s, 2H), 3.33 (d, <i>J</i> = 14.8 Hz, 2H), 2.66 (d, <i>J</i> = 14.8 Hz, 2H), 1.26 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ 170.4, 168.0, 134.4, 131.6, 123.4, 65.7, 62.2, 55.7, 36.0, 14.1. IR (neat, cm<sup>–1</sup>): 1778, 1719. HRMS (ESI) Calcd. for C<sub>16</sub>H<sub>16</sub>O<sub>5</sub>N (M + H)<sup>+</sup>: 302.10230. Found: 302.10261. Melting point (crystallized from diethyl ether): 128 °C.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Ethyl (1<i>R</i>,3<i>r</i>,5<i>S</i>)-3-(1,3-Dioxoisoindolin-2-yl)-6-Oxabicyclo[3.1.0]Hexane-3-Carboxylate (24)</h3><div class="NLM_p last">Ethyl (1R,3r,5S)-3-(1,3-dioxoisoindolin-2-yl)-6-oxabicyclo[3.1.0]hexane-3-carboxylate was prepared as described above and purified by column chromatography, eluting with a 30/70 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.25). White solid, 2.74 g, 9.09 mmol, 65% yield. <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 7.81–7.75 (m, 2H), 7.70–7.65 (m, 2H), 4.16 (q, <i>J</i> = 7.1 Hz, 2H), 3.65 (s, 2H), 3.48 (d, <i>J</i> = 15.1 Hz, 2H), 2.49 (d, <i>J</i> = 14.9 Hz, 2H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ 171.6, 168.4, 134.1, 131.8, 123.2, 66.2, 62.4, 56.1, 36.4, 14.1. IR (neat, cm<sup>–1</sup>): 1778, 1732, 1721, 1712. HRMS (ESI) Calcd. for C<sub>16</sub>H<sub>16</sub>O<sub>5</sub>N (M + H)<sup>+</sup>: 302.10230. Found: 302.10256. Melting point (crystallized from diethyl ether): 115 °C.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Racemic Ethyl-1-(1,3-Dioxoisoindolin-2-yl)-3-Fluoro-4-Hydroxycyclopentane-1-Carboxylate (25)</h3><div class="NLM_p last">A scintillation vial purged with N<sub>2</sub> and containing a stir bar and <b>ethyl (1<i>R</i>,3<i>s</i>,5<i>S</i>)-3-(1,3-dioxoisoindolin-2-yl)-6-oxabicyclo[3.1.0]hexane-3-carboxylate</b> (<b>23</b>) (942 mg, 3.13 mmol) was treated with 10 mL of benzene and stirred under high vacuum to allow for the azeotropic distillation of residual water. Once all of the benzene was removed, triethylamine trihydrofluoride (5 mL) was added. The mixture was heated to 110 °C for 8 h. After cooling to room temperature, DCM (50 mL) and saturated aqueous sodium bicarbonate (50 mL) were added and the biphasic mixture was stirred vigorously for several min. The mixture was transferred to a separatory funnel, and the organics were separated, and the aqueous phase was washed with DCM (50 mL). The organics were combined, washed with brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 40/60 EtOAc/hexane gradient (<i>R</i><sub>f</sub> = 0.4). Colorless oil, 429 mg, 1.34 mmol, 43% yield. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.89–7.80 (m, 2H), 7.79–7.71 (m, 2H), 5.06 (ddt, <i>J</i> = 51.5, 5.1, 2.4 Hz, 1H), 4.59–4.36 (m, 1H), 4.20 (q, <i>J</i> = 7.1 Hz, 2H), 3.41 (d, <i>J</i> = 8.3 Hz, 1H), 3.40–3.26 (m, 1H), 3.19 (ddd, <i>J</i> = 15.2, 6.4, 2.1 Hz, 1H), 2.97 (ddd, <i>J</i> = 32.5, 16.2, 5.3 Hz, 1H), 2.69 (dd, <i>J</i> = 15.3, 2.8 Hz, 1H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ 174.7, 168.7, 134.5, 131.8, 123.5, 99.0 (d, <i>J</i> = 179.6 Hz), 75.8 (d, <i>J</i> = 27.2 Hz), 67.3, 63.2, 42.7 (d, <i>J</i> = 1.7 Hz), 40.1 (d, <i>J</i> = 23.3 Hz), 14.1. <sup>19</sup>F NMR (282 MHz, chloroform-<i>d,</i> fluorobenzene reference standard) δ −176.8 – −177.3 (m). IR (neat, cm<sup>–1</sup>): 3467, 1779, 1713. HRMS (ESI) Calcd. for C<sub>16</sub>H<sub>17</sub>O<sub>5</sub>NF (M + H)<sup>+</sup>: 322.10853. Found: 322.10881.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <b>Racemic Ethyl-1-(1,3-Dioxoisoindolin-2-yl)-3-Fluoro-4-(((Trifluoromethyl)Sulfonyl)Oxy)Cyclopentane-1-Carboxylate</b>. (26)</h3><div class="NLM_p last">A scintillation vial under N<sub>2</sub> containing a stir bar, racemic <b>ethyl-1-(1,3-dioxoisoindolin-2-yl)-3-fluoro-4-hydroxycyclopentane-1-carboxylate</b> (<b>25</b>) (170 mg, 0.529 mmol, 1 equiv), and pyridine (94 μL, 1.17 mmol, 2.2 equiv) in DCM (2.5 mL) was cooled to 0 °C. A separate vial containing trifluoromethanesulfonic anhydride (200 μL, 1.06 mmol, 2.0 equiv) in DCM (2.5 mL) was cooled to 0 °C, and this mixture was added dropwise to the fluorohydrin solution with vigorous stirring. The mixture was stirred at 0 °C for 15 min and then diluted with hexanes (5 mL). A white powder precipitated and was filtered, and the supernatant was concentrated in vacuo. The resulting crude residue was purified by silica gel flash chromatography, eluting the desired compound with a 15/85 EtOAc/hexane gradient (R<sub>f</sub> = 0.2). White solid, 203 mg, 0.448 mmol, 85% yield. <sup>1</sup>H NMR (400 MHz, C<sub>6</sub>D<sub>6</sub>) δ 7.47–7.28 (m, 2H), 6.86–6.72 (m, 2H), 5.72–5.54 (m, 1H), 5.07–4.78 (m, 1H), 3.85–3.70 (m, 2H), 3.43 (dd, <i>J</i> = 15.4, 8.4 Hz, 1H), 2.95 (ddd, <i>J</i> = 21.6, 15.4, 6.6 Hz, 1H), 2.71 (ddd, <i>J</i> = 20.5, 15.4, 5.1 Hz, 1H), 2.55 (dd, <i>J</i> = 15.4, 5.8 Hz, 1H), 0.76 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, C<sub>6</sub>D<sub>6</sub>) δ 170.2, 168.2, 134.2, 131.8, 128.4, 123.3, 119.2 (q, <i>J</i> = 319.7 Hz), 96.0 (d, <i>J</i> = 185.3 Hz), 90.4 (d, <i>J</i> = 29.4 Hz), 66.0 (d, <i>J</i> = 3.1 Hz), 62.8, 39.6 (d, <i>J</i> = 3.4 Hz), 39.4 (d, <i>J</i> = 22.6 Hz), 13.7. <sup>19</sup>F NMR (282 MHz, chloroform-<i>d,</i> fluorobenzene reference standard) δ −75.5, −181.9 (s, 3F), (dq, <i>J</i> = 51.4, 20.2 Hz, 1F). IR (neat, cm<sup>–1</sup>): 1774, 1736, 1720, 1709. HRMS (ESI) Calcd. for C<sub>17</sub>H<sub>16</sub>O<sub>7</sub>NF<sub>4</sub>S (M + H)<sup>+</sup>: 454.05781. Found: 454.05808. Melting point: 91–94 °C.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Ethyl (1<i>r</i>,3<i>R</i>,4<i>S</i>)-1-(1,3-Dioxoisoindolin-2-yl)-3,4-Difluorocyclopentane-1-Carboxylate (27)</h3><div class="NLM_p last">To a scintillation vial under N<sub>2</sub> containing a stir bar and racemic <b>ethyl-1-(1,3-dioxoisoindolin-2-yl)-3-fluoro-4-(((trifluoromethyl)sulfonyl)oxy)cyclopentane-1-carboxylate</b> (<b>26</b>) (261 mg, 0.576 mmol), <i>tert</i>-butanol (1 mL) was added. Cesium fluoride (262 mg, 1.73 mmol) was then added under a stream of N<sub>2</sub>, and the reaction was stirred at room temperature for 28 h. The mixture was concentrated under reduced pressure, then diluted with DCM (5 mL), and washed with water (5 mL). The phases were separated, and the aqueous phase was washed with another portion of DCM (5 mL). The organics were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The resulting crude residue was purified by preparative thin layer chromatography, eluting the desired compound with a 15/85 EtOAc/hexane gradient (R<sub>f</sub> = 0.3). Colorless oil, 34 mg, 0.105 mmol, 18% yield. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.89–7.81 (m, 2H), 7.78–7.71 (m, 2H), 5.31–5.02 (m, 2H), 4.17 (q, <i>J</i> = 7.1 Hz, 2H), 3.33–3.11 (m, 2H), 3.11–2.92 (m, 2H), 1.18 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ 172.4, 168.7, 134.5, 131.8, 123.5, 90.5 (dd, <i>J</i> = 188.6, 15.7), 63.4 (t, <i>J</i> = 5.2 Hz), 62.9, 38.5–38.1 (four-line multiplet, magnetic inequivalence), 14.1. <sup>19</sup>F NMR (282 MHz, chloroform-<i>d,</i> fluorobenzene reference standard) δ −198.6 – −199.2 (m). IR (neat, cm<sup>–1</sup>): 1780, 1717. HRMS (ESI) Calcd. for C<sub>16</sub>H<sub>16</sub>O<sub>4</sub>NF<sub>2</sub> (M + H)<sup>+</sup>: 324.10419. Found: 324.10473.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (1<i>r</i>,3<i>R</i>,4<i>S</i>)-1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid Hydrochloride (28)</h3><div class="NLM_p">To a scintillation vial open to air containing a stir bar and <b>ethyl (1<i>r</i>,3<i>R</i>,4<i>S</i>)-1-(1,3-dioxoisoindolin-2-yl)-3,4-difluorocyclopentane-1-carboxylate</b> (<b>27</b>) (19 mg, 0.059 mmol), 2 M NaOH (0.5 mL) was added. The vial was sealed with a plastic cap and allowed to stir at 140 °C for 5 min. Upon cooling to room temperature, concentrated HCl (2 mL) was added, and the mixture was again heated to 140 °C. After heating for 15 min, the solvent was removed under air flow at 140 °C and the concentrated residue was allowed to cool to room temperature. The mixture was taken up in water, loaded onto a Biotage SNAP Ultra C18 column, and then eluted with water to separate the compound of interest from NaCl. Once the fractions containing the amino acid were collected and concentrated, coeluted phthalic acid was removed by trituration with ether (3 × 5 mL). The remaining solid was freed of residual water and ether in vacuo. White solid, 10.4 mg, 0.052 mmol, 88% yield.</div><div class="NLM_p">Alternatively, to a scintillation vial open to air containing a stir bar and <b>ethyl (1<i>r</i>,3<i>R</i>,4<i>S</i>)-1-(1,3-dioxoisoindolin-2-yl)-3,4-difluorocyclopentane-1-carboxylate</b> (<b>27</b>) (21 mg, 0.065 mmol), concentrated HCl was added and the mixture was heated to 100 °C for 16 h. During this time, colorless crystals deposited along the bottom of the scintillation vial. The reaction mixture was decanted from the crystalline material, and the crystals were triturated with ether (3 × 5 mL). Colorless crystals, 4.5 mg, 0.022 mmol, 34% yield.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, deuterium oxide) δ 5.38–5.17 (m, 2H), 2.73 (ddd, <i>J</i> = 22.9, 15.6, 5.3 Hz, 2H), 2.36 (tt, <i>J</i> = 17.4, 4.5 Hz, 2H). <sup>13</sup>C NMR (125 MHz, deuterium oxide) δ 173.7, 92.2 (dd, <i>J</i> = 184.9, 15.7 Hz), 60.5, 37.8–37.5 (four-line multiplet, magnetic inequivalence). <sup>19</sup>F NMR (282 MHz, deuterium oxide, trifluoroacetic acid reference standard) δ −199.4 – −199.9 (m). IR (neat, cm<sup>–1</sup>): 3045 (broad), 1718. HRMS (ESI) Calcd. for C<sub>6</sub>H<sub>10</sub>O<sub>2</sub>NF<sub>2</sub> (M + H)<sup>+</sup>: 166.06741. Found: 166.06740. Melting point: 251–252 °C (decomposes: effervesces and takes on brown color).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Radiochemistry</h3><div id="sec4_25_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>anti-cis</i>-3,4-[<sup>18</sup>F]-DFACPC ([<sup>18</sup>F]9)</h4><div class="NLM_p last">The preparation of <b>[<sup>18</sup>F]9</b> was based on the previously reported automated synthesis of anti-[<sup>18</sup>F]FACBC.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To a glass vessel containing a solution of Cryptand 222 in MeCN (5.0 mg/mL) (1.0 mL), was added 790 mCi of no-carrier-added [<sup>18</sup>F]HF through a trap/release (T/R) cartridge by using a solution of K<sub>2</sub>CO<sub>3</sub>/H<sub>2</sub>O (1.5 mg/mL) (0.6 mL). The solvent was removed at 110 °C with a nitrogen flow, and additional MeCN (3.5 mL) was added followed by evaporation of the solvent with a nitrogen flow to remove residual H<sub>2</sub>O. Triflate precursor <b>19</b> (9 mg, 0.021 mmol) in dry MeCN (1 mL) was added to the vial, and the reaction mixture was heated at 110 °C for 10 min. The intermediate product was treated with 6 N HCl (0.5 mL) at 110 °C for 10 min and purified by passing through an IR column assembly consisting of a 7 mm × 120 mm bed of an AG 11A8 IR resin column, a neutral alumina SepPak (preconditioned with water), and an HLB Oasis reverse phase cartridge (preconditioned with water). <b>[<sup>18</sup>F]9</b> eluted in series through the assembly with three successive portions of sterile saline (∼4.0 mL) into dose vials and was ready for in vitro and in vivo studies. Evidence of the identity of <b>[<sup>18</sup>F]9</b> was achieved by comparing the <i>R</i><sub>f</sub> of the radioactive product visualized with radiometric TLC with the <i>R</i><sub>f</sub> of the authentic cold compound visualized with ninhydrin stain, using the solvent system MeCN/H<sub>2</sub>O/CH<sub>3</sub>OH = 2:1:1 (<i>R</i><sub>f</sub> = 0.6, Whatman silica gel plates). The only peak present on radiometric TLC analysis corresponded to <b>[<sup>18</sup>F]9</b>, and the radiochemical purity of the product exceeded 99% (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figures S3–41</a>). The pH of the final dose solution was tested with pH paper and found to be 6–7. The isolated radiochemical yield was 50 mCi in 12 mL of saline as determined using a dose calibrator, affording a 10% decay corrected radiochemical yield based on a synthesis time of approximately 70 min, which proceeded immediately upon the end of cyclotron bombardment.</div></div><div id="sec4_25_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>syn-cis</i>-3,4-[<sup>18</sup>F]-DFACPC ([<sup>18</sup>F]28)</h4><div class="NLM_p last">The preparation of <b>[<sup>18</sup>F]28</b> was based on the previously reported automated synthesis of anti-[<sup>18</sup>F]FACBC.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To a glass vessel containing a solution of Cryptand 222 in MeCN (22 mg/mL) (1.0 mL), was added 1460 mCi of no-carrier-added [<sup>18</sup>F]HF through a trap/release (T/R) cartridge by using a solution of Cs<sub>2</sub>CO<sub>3</sub>/H<sub>2</sub>O (20 mg mg/mL) (0.6 mL). The solvent was removed at 110 °C with a nitrogen flow, and additional MeCN (3.5 mL) was added followed by evaporation of the solvent with a nitrogen flow to remove residual H<sub>2</sub>O. Triflate precursor <b>26</b> (20 mg, 0.044 mmol) in dry <i>t</i>BuOH (0.5 mL) and MeCN (0.5 mL) was added to the vial, and the reaction mixture was heated at 110 °C for 10 min. The reaction mixture was diluted with 2 mL of acetonitrile, passed through two neutral alumina SepPaks (preconditioned with acetonitrile), and eluted with 10 mL of acetonitrile into a vented vial in a hot cell. The solvent was removed from the vial under a flow of nitrogen at 140 °C. 2 M NaOH (0.5 mL) was added to the vial, which was sealed with a Teflon septum capped with an aluminum crimp top, and the mixture was heated to 140 °C for 5 min. The vial was cooled, and 2 mL of concentrated HCl was added, and the sealed vial was again heated for 15 min at 140 °C. Then, vial was vented, and the solvent was removed under inert gas flow at 140 °C. The resultant solid was taken up in H<sub>2</sub>O (5 mL) and cannulated through a chain composed of one Waters HLB Oasis cartridge and two alumina SepPaks (both preconditioned with water). A second aliquot of water (5 mL) was passed through the chain, and the eluent containing <b>[<sup>18</sup>F]28</b> was collected in a dose vial. The contents of the dose solution were assessed by analytical HPLC, (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">Figures S3–43</a>). HPLC analysis indicated that <b>[<sup>18</sup>F]28</b> was obtained in >99% radiochemical purity. The pH of the final dose solution was tested with pH paper and found to be 6–7. The isolated radiochemical yield was 8.4 mCi in 5 mL of water as determined using a dose calibrator, affording a 1.7% decay corrected radiochemical yield based on a synthesis time of approximately 135 min, which proceeded 35 min after the end of cyclotron bombardment (total time from end of bombardment to measurement of radiochemical yield was 170 min).</div></div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Cells and Culture</h3><div class="NLM_p last">The cancer cells used in the study include 9L gliosarcoma (rat), DU145 androgen-independent prostate carcinoma (human), and U87 glioblastoma tumor cell lines (human). Cells were cultured as described previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The tumor cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal calf serum, 100 U/mL penicillin, and 100 μg/mL streptomycin, maintained in T-150 tissue culture flasks under humidified incubator conditions (37 °C, 5% CO<sub>2</sub>/95% air) and were routinely passaged at confluence.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Cells thus prepared would be used in cell uptake and inhibition assays and in mice tumor implantations.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Amino Acid Uptake and Inhibition Assays</h3><div class="NLM_p last">Amino acid uptake and inhibition experiments were performed as described previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> At the time of the experiments, the medium was exchanged to amino-acid-free Hank’s balanced salt solution (HBSS) and cells were adjusted to a final concentration of 5 × 10<sup>7</sup> cells/mL. The following standard condition applied to each study (refer to supplementary data for optimization information). Approximately 5 × 10<sup>5</sup> cells were exposed to 5 μCi of <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b>, respectively, in 0.1 mL of amino acid/serum-free HBSS in the absence (control condition) or presence of transport inhibitors for 30 min under incubator conditions (37 °C, 5% CO<sub>2</sub>/95% air) in 1.5 mL conical tubes. Final concentrations (10 mM) of MeAIB were used to inhibit uptake mediated by system A AATs. Final concentrations (10 mM) of 2-amino-bicyclo[2.2.1]heptane-2-carboxylic acid (BCH) were used to inhibit uptake mediated by system L AATs. The combination of 10 mM alanine-cysteine-serine (ACS, 3.3 mM of each amino acid) was used for uptake inhibition of system ACS AATs. After incubation, cells were twice centrifuged (75 G for 5 min) and rinsed with ice-cold HBSS to remove residual activity in the supernatant. Each assay condition was performed in triplicate. The activity in tubes was counted in a Packard Cobra II Auto-Gamma counter, the raw counts were decay corrected, and the activity per cell number was determined from the average of the triplicate. The data from these studies were expressed and normalized as percent uptake of the initial dose per 0.5 million cells (% ID/5 × 10<sup>5</sup> cells) ± standard deviation (SD).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Tumor Induction and Animal Preparation</h3><div class="NLM_p last">Rat 9L gliosarcoma cells for intracranial implantation experiments were cultured and prepared the same way as the uptake and inhibition assays and then were washed with phosphate buffer solution (PBS) and obtained a final concentration of 5 × 10<sup>4</sup>/5 μL in PBS. Rat 9L gliosarcoma cells were implanted into the brains of male Fischer 344 rats (160–210 g) as described previously.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Briefly, following anesthesia with an intramuscular injection of ketamine (60 mg/mL) and xylazine (7.5 mg/mL) solution, rats were placed in a stereotactic head holder and were injected with 5 μL suspension of rat 9L gliosarcoma cells (5 × 10<sup>4</sup> cells per rat) in a location 3 mm right of midline and 1 mm anterior to the bregma at 4 mm deep to the outer table. The injection was performed over the course of 2 min, and the needle was withdrawn over the course of 1 min to minimize the backflow of tumor cells. The burr hole and scalp incision were closed, and the animals were returned to their original cages after recovering from the procedure. Intracranial tumors developed that produced weight loss, apathy, and hunched posture in the tumor-bearing rats. Typically, among 25 animals implanted with tumor cells, 20 would develop tumors visible to the naked eye upon dissection in approximately 10–12 days and were used in the study.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Anesthesia</h3><div class="NLM_p last">Anesthesis was carried out as described previously.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Rats were anesthetized using isoflurane gas. Anesthesia was initiated 10 min ahead of imaging experiments by placing the animal in a cage ventilated with oxygen containing 1–2% isoflurane. Body temperature was held at 37 °C using a temperature-controlled warm air convection system.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Injection of the Radiotracer</h3><div class="NLM_p last">The tracer was administered as described previously.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A catheter placed in the tail vein prior to imaging experiments was filled with isotonic sodium chloride solution. The tracer was diluted with saline to a final volume of 0.4 mL and injected via the catheter.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Rodent Biodistribution Studies</h3><div class="NLM_p last">The microPET imaging process was carried out as described previously.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> After anesthesia and placement of the tail vein catheter, the animal was placed with its body located at the center of the field of view. The rats were injected through the tail vein catheter with 200–250 μCi of <b>[<sup>18</sup>F]9</b> or <b>[<sup>18</sup>F]28</b> in 0.4 mL of isotonic saline (pH = 6–7). PET Imaging MicroPET data were acquired with a Siemens Inveon PET/CT system (Siemens Medical Solutions, Knoxville, TN, USA). Radioactivity in the syringe was measured before and after the tracer was injected into the tail vein catheter using a Capintec CRC 15R (Capintec Inc., 6 Arrow Road Ramsey, NJ) dose calibrator. Data acquisition was performed for 60 min starting immediately following tracer injection. After PET imaging, all animals underwent computed tomography (CT) transmission imaging in the same position as the acquired PET data. The PET emission data were normalized and corrected for decay and dead time. The images were reconstructed with an ordered-subset expectation maximization algorithm, using attenuation correction from CT, into fifteen 1-min frames followed by nine 5-min frames. The image volume consisted of 128 × 128 × 159 voxels, each of a size of 0.78 × 0.78 × 0.80 mm. PET and CT images were co-registered using ASIPro and processed using software written by the authors. Regions-of-interest (ROIs) were placed on the fused PET/CT data including the tumor, in the right hemisphere of the brain, and contralateral region in the left hemisphere. The time-activity curves represent the mean activity in the regions-of-interest over time.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01302" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01302?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01302</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, and when possible, <sup>19</sup>F NMR spectra for all previously unreported compounds, X-ray crystallography data for compounds <b>[<sup>19</sup>F]9</b> and <b>[<sup>19</sup>F]28</b>, time-activity curves for PET data in Tables 4, 5, 6, and 7, radiometric TLC data for compound <b>[<sup>18</sup>F]9</b> and radiometric HPLC data for <b>[<sup>18</sup>F]28</b>, and molecular formula strings; X-ray data for <b>[<sup>19</sup>F]9</b> and <b>[<sup>19</sup>F]28</b> has been deposited with the CSD, and atomic coordinates are provided in the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf">jm0c01302_si_001.pdf (12.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_002.csv">jm0c01302_si_002.csv (0.77 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01302" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark M. Goodman</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3438-1185" title="Orcid link">http://orcid.org/0000-0002-3438-1185</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e9848e86868d8488a98c84869b90c78c8d9c"><span class="__cf_email__" data-cfemail="38555f57575c5559785d55574a41165d5c4d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas C. Pickel</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Biotherapeutic and Medicinal Science, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald J. Voll</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiping Yu</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhaobin Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurosurgery, School of Medicine, Emory
University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathon A Nye</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology and Imaging Sciences, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Systems Imaging, Emory University, 1841 Clifton Rd NE, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Bacsa</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5681-4458" title="Orcid link">http://orcid.org/0000-0001-5681-4458</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey J. Olson</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurosurgery, School of Medicine, Emory
University, 1364 Clifton Road NE, Atlanta, Georgia 30322, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lanny S. Liebeskind</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2223-6618" title="Orcid link">http://orcid.org/0000-0002-2223-6618</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge The Winship Cancer Institute’s Discovery and Developmental Therapeutics (DDT) Seed Grant Program and thank Mr. Eddy Ortega and Dr. Nagaraju Karre for their contributions to the development of a viable synthetic route to <b>[<sup>18</sup>F]9</b> and <b>[<sup>18</sup>F]28</b>, Dr. Jaekeun Park for his contribution in the microPET studies and Ron Crowe, BCNP, and the Radiopharmacy at the Emory University Center for Systems Imaging for production of F-18 fluoride.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">amino acid</p></td></tr><tr><td class="NLM_term">AAT</td><td class="NLM_def"><p class="first last">amino acid transporter</p></td></tr><tr><td class="NLM_term">ACBC</td><td class="NLM_def"><p class="first last">1-amino-cyclobutanecarboxylic acid</p></td></tr><tr><td class="NLM_term">ACPC</td><td class="NLM_def"><p class="first last">1-aminocyclopentanecarboxylic acid</p></td></tr><tr><td class="NLM_term"><i>anti</i>-3-FACBC</td><td class="NLM_def"><p class="first last"><i>anti</i>-1-amino-3-(fluoro-<sup>18</sup>F)-cyclobutane carboxylic acid</p></td></tr><tr><td class="NLM_term">(R, S)-<i>anti</i>-2-FACPC</td><td class="NLM_def"><p class="first last"><i>anti</i>-1-amino-2-fluoro-cyclopentane-1-carboxylic acid</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood brain barrier</p></td></tr><tr><td class="NLM_term">BCH</td><td class="NLM_def"><p class="first last">2-aminobicyclo[2.2.1]heptane-2-carboxylic acid</p></td></tr><tr><td class="NLM_term">Boc<sub>2</sub>O</td><td class="NLM_def"><p class="first last">di-<i>tert</i>-butyl dicarbonate</p></td></tr><tr><td class="NLM_term">CsF</td><td class="NLM_def"><p class="first last">cesium fluoride</p></td></tr><tr><td class="NLM_term">CT</td><td class="NLM_def"><p class="first last">computed tomography</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">N,N′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DCY</td><td class="NLM_def"><p class="first last">decay-corrected yield</p></td></tr><tr><td class="NLM_term">dd</td><td class="NLM_def"><p class="first last">doublet of doublets</p></td></tr><tr><td class="NLM_term">ddt</td><td class="NLM_def"><p class="first last">doublet of doublet of triplets</p></td></tr><tr><td class="NLM_term">3,4-DFACPC</td><td class="NLM_def"><p class="first last">1-amino-3,4-difluorocyclopentanecarboxylic acid</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle’s Medium</p></td></tr><tr><td class="NLM_term">dq</td><td class="NLM_def"><p class="first last">doublet of quartets</p></td></tr><tr><td class="NLM_term">dtd</td><td class="NLM_def"><p class="first last">doublet of triplets of doublets</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N-HF</td><td class="NLM_def"><p class="first last">triethylamine trihydrofluoride</p></td></tr><tr><td class="NLM_term">3-FACPC</td><td class="NLM_def"><p class="first last">1-amino-3-fluorocyclopentane carboxylic acid</p></td></tr><tr><td class="NLM_term">[<sup>18</sup>F]FDG</td><td class="NLM_def"><p class="first last">2-[<sup>18</sup>F]fluoro-2-deoxy-D-glucose</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hank’s balanced salt solution</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">HF-pyridine</td><td class="NLM_def"><p class="first last">pyridine hydrofluoride</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>SO<sub>4</sub></td><td class="NLM_def"><p class="first last">sulfuric acid</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">infrared spectroscopy</p></td></tr><tr><td class="NLM_term">KF</td><td class="NLM_def"><p class="first last">potassium fluoride</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr><tr><td class="NLM_term"><i>m</i>-CPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">MeAIB</td><td class="NLM_def"><p class="first last">2-(methylamino)-2-methylproprionic acid</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MgSO<sub>4</sub></td><td class="NLM_def"><p class="first last">magnesium sulfate</p></td></tr><tr><td class="NLM_term">NaH</td><td class="NLM_def"><p class="first last">sodium hydride</p></td></tr><tr><td class="NLM_term">NaHCO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium bicarbonate</p></td></tr><tr><td class="NLM_term">NaI</td><td class="NLM_def"><p class="first last">sodium iodide</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term"><i>N</i>-Boc</td><td class="NLM_def"><p class="first last"><i>N-tert-</i>butoxycarbonyl</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance spectroscopy</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffer solution</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">qd</td><td class="NLM_def"><p class="first last">quartet of doublets</p></td></tr><tr><td class="NLM_term">ROI</td><td class="NLM_def"><p class="first last">region-of-interest</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term"><i>t</i>BuOH</td><td class="NLM_def"><p class="first last"><i>tert</i>-butanol</p></td></tr><tr><td class="NLM_term">Tf<sub>2</sub>O</td><td class="NLM_def"><p class="first last">trifluoromethanesulfonic anhydride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography imaging of cancer biology: current status and future prospects</span>. <i>Semin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1053/j.seminoncol.2010.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1053%2Fj.seminoncol.2010.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=21362517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC3M3jtVSlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=70-86&author=K.+Chenauthor=X.+Chen&title=Positron+emission+tomography+imaging+of+cancer+biology%3A+current+status+and+future+prospects&doi=10.1053%2Fj.seminoncol.2010.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography imaging of cancer biology: current status and future prospects</span></div><div class="casAuthors">Chen Kai; Chen Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Positron emission tomography (PET) is one of the most rapidly growing areas of medical imaging, with many applications in the clinical management of patients with cancer.  The principal goal of PET imaging is to visualize, characterize, and measure biological processes at the cellular, subcellular, and molecular levels in living subjects using noninvasive procedures.  PET imaging takes advantage of the traditional diagnostic imaging techniques and introduces positron-emitting probes to determine the expression of indicative molecular targets at different stages of cancer progression.  Although [(18)F]fluorodeoxyglucose ([(18)F]FDG)-PET has been widely utilized for staging and restaging of cancer, evaluation of response to treatment, differentiation of post-therapy alterations from residual or recurrent tumor, and assessment of prognosis, [(18)F]FDG is not a target-specific PET tracer.  Over the last decade, numerous target-specific PET tracers have been developed and evaluated in preclinical and clinical studies.  This review provides an overview of the current status and trends in the development of non-[(18)F]FDG PET probes in oncology and their application in the investigation of cancer biology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAGONGFVJZmzToTC3aBaesfW6udTcc2ebMk0GkYGsV37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3jtVSlsg%253D%253D&md5=04fa5dbe375a168456211153d2ed29ee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2010.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2010.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DPositron%2520emission%2520tomography%2520imaging%2520of%2520cancer%2520biology%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DSemin.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3D70%26epage%3D86%26doi%3D10.1053%2Fj.seminoncol.2010.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilien, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grafton, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bading, J. R.</span></span> <span> </span><span class="NLM_article-title">PET and [<sup>18</sup>F]-FDG in oncology: a clinical update</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1016/0969-8051(96)00074-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2F0969-8051%2896%2900074-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=8940714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADyaK2s%252FpsFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=717-735&author=P.+S.+Contiauthor=D.+L.+Lilienauthor=K.+Hawleyauthor=J.+Kepplerauthor=S.+T.+Graftonauthor=J.+R.+Bading&title=PET+and+%5B18F%5D-FDG+in+oncology%3A+a+clinical+update&doi=10.1016%2F0969-8051%2896%2900074-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PET and [18F]-FDG in oncology: a clinical update</span></div><div class="casAuthors">Conti P S; Lilien D L; Hawley K; Keppler J; Grafton S T; Bading J R</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine and biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">717-35</span>
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    </div><div class="casAbstract">Positron emission tomography (PET) has become a very useful adjunct to anatomic imaging techniques, adding unique information to the characterization of disease.  The whole-body PET FDG technique developed over the last few years has surpassed most expectations with respect to its utility in clinical oncology.  The large spectrum of neoplasms that now can be studied with this approach makes it an essential clinical imaging tool in diagnosis and management for many patients with cancer.  The metabolic information provided by this technique is complementary to results from standard clinical and morphological examinations.  It may be anticipated that through application of the multi-modality imaging approach, significant advances in medical care will come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnIJlXbpBSxkNHe_gFldTbfW6udTcc2ebMk0GkYGsV37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FpsFersw%253D%253D&md5=a4694fe552d570b4cb91969efdb75441</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2896%2900074-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252896%252900074-1%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DP.%2BS.%26aulast%3DLilien%26aufirst%3DD.%2BL.%26aulast%3DHawley%26aufirst%3DK.%26aulast%3DKeppler%26aufirst%3DJ.%26aulast%3DGrafton%26aufirst%3DS.%2BT.%26aulast%3DBading%26aufirst%3DJ.%2BR.%26atitle%3DPET%2520and%2520%255B18F%255D-FDG%2520in%2520oncology%253A%2520a%2520clinical%2520update%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1996%26volume%3D23%26spage%3D717%26epage%3D735%26doi%3D10.1016%2F0969-8051%2896%2900074-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelloff, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shaughnessy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyton, K. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankoff, D. A.</span></span> <span> </span><span class="NLM_article-title">Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2808</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-2626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1158%2F1078-0432.CCR-04-2626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=15837727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2785-2808&author=G.+J.+Kelloffauthor=J.+M.+Hoffmanauthor=B.+Johnsonauthor=H.+I.+Scherauthor=B.+A.+Siegelauthor=E.+Y.+Chengauthor=B.+D.+Chesonauthor=J.+O%E2%80%99Shaughnessyauthor=K.+Z.+Guytonauthor=D.+A.+Mankoff&title=Progress+and+promise+of+FDG-PET+imaging+for+cancer+patient+management+and+oncologic+drug+development&doi=10.1158%2F1078-0432.CCR-04-2626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development</span></div><div class="casAuthors">Kelloff, Gary J.; Hoffman, John M.; Johnson, Bruce; Scher, Howard I.; Siegel, Barry A.; Cheng, Edward Y.; Cheson, Bruce D.; O'Shaughnessy, Joyce; Guyton, Kathryn Z.; Mankoff, David A.; Shankar, Lalitha; Larson, Steven M.; Sigman, Caroline C.; Schilsky, Richard L.; Sullivan, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2785-2808</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  2-[18F]Fluoro-2-deoxyglucose positron emission tomog. (FDG-PET) assesses a fundamental property of neoplasia, the Warburg effect.  This mol. imaging technique offers a complementary approach to anat. imaging that is more sensitive and specific in certain cancers.  FDG-PET has been widely applied in oncol. primarily as a staging and restaging tool that can guide patient care.  However, because it accurately detects recurrent or residual disease, FDG-PET also has significant potential for assessing therapy response.  In this regard, it can improve patient management by identifying responders early, before tumor size is reduced; nonresponders could discontinue futile therapy.  Moreover, a redn. in the FDG-PET signal within days or weeks of initiating therapy (e.g., in lymphoma, non-small cell lung, and esophageal cancer) significantly correlates with prolonged survival and other clin. end points now used in drug approvals.  These findings suggest that FDG-PET could facilitate drug development as an early surrogate of clin. benefit.  This article reviews the scientific basis of FDG-PET and its development and application as a valuable oncol. imaging tool.  Its potential to facilitate drug development in seven oncol. settings (lung, lymphoma, breast, prostate, sarcoma, colorectal, and ovary) is addressed.  Recommendations include initial validation against approved therapies, retrospective analyses to define the magnitude of change indicative of response, further prospective validation as a surrogate of clin. benefit, and application as a phase II/III trial end point to accelerate evaluation and approval of novel regimens and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPazHqWsA0srVg90H21EOLACvtfcHk0lipXxHORk27bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejsbY%253D&md5=21f119abac76df4a875dd570bb459af8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2626%26sid%3Dliteratum%253Aachs%26aulast%3DKelloff%26aufirst%3DG.%2BJ.%26aulast%3DHoffman%26aufirst%3DJ.%2BM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DSiegel%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DE.%2BY.%26aulast%3DCheson%26aufirst%3DB.%2BD.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DJ.%26aulast%3DGuyton%26aufirst%3DK.%2BZ.%26aulast%3DMankoff%26aufirst%3DD.%2BA.%26atitle%3DProgress%2520and%2520promise%2520of%2520FDG-PET%2520imaging%2520for%2520cancer%2520patient%2520management%2520and%2520oncologic%2520drug%2520development%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2785%26epage%3D2808%26doi%3D10.1158%2F1078-0432.CCR-04-2626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barentsz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudkerk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mali, W.</span></span> <span> </span><span class="NLM_article-title">Commonly used imaging techniques for diagnosis and staging</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3234</span>– <span class="NLM_lpage">3244</span>, <span class="refDoi"> DOI: 10.1200/JCO.2006.06.5946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1200%2FJCO.2006.06.5946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=16829647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1yiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=3234-3244&author=J.+Barentszauthor=S.+Takahashiauthor=W.+Oyenauthor=R.+Musauthor=P.+De+Mulderauthor=R.+Reznekauthor=M.+Oudkerkauthor=W.+Mali&title=Commonly+used+imaging+techniques+for+diagnosis+and+staging&doi=10.1200%2FJCO.2006.06.5946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Commonly used imaging techniques for diagnosis and staging</span></div><div class="casAuthors">Barentsz, Jelle; Takahashi, Satoru; Oyen, Wim; Mus, Roel; De Mulder, Pieter; Reznek, Rodney; Oudkerk, Matthijs; Mali, Wim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3234-3244</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Imaging plays a vital role in the management of patients with cancer.  Not only is it important for diagnosis, indicating sites of abnormality, and guiding biopsies, but it is also crucial in assessing disease extent and thereby detg. treatment.  In this review, conventional imaging techniques such as ultrasound, computed tomog., magnetic resonance imaging, and [18F]fluorodeoxyglucose-positron emission tomog. are described, with attention to their mechanisms of action, and their strengths and weaknesses in diagnosis and staging of tumors.  New developments are addressed and radiation safety issues are highlighted.  In addn., we describe current and expected future uses of imaging techniques in oncol.  Given that each technique has its inherent strengths and weaknesses, the combination of the methods will result in improved diagnosis, staging, and treatment prediction and monitoring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnLV4WFVwpbVg90H21EOLACvtfcHk0lhFywD2i6q2FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1yiu7c%253D&md5=eed2539d199114b4015310f0df382c88</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.06.5946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.06.5946%26sid%3Dliteratum%253Aachs%26aulast%3DBarentsz%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DOyen%26aufirst%3DW.%26aulast%3DMus%26aufirst%3DR.%26aulast%3DDe%2BMulder%26aufirst%3DP.%26aulast%3DReznek%26aufirst%3DR.%26aulast%3DOudkerk%26aufirst%3DM.%26aulast%3DMali%26aufirst%3DW.%26atitle%3DCommonly%2520used%2520imaging%2520techniques%2520for%2520diagnosis%2520and%2520staging%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D3234%26epage%3D3244%26doi%3D10.1200%2FJCO.2006.06.5946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCready, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguignon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maziere, B.</span></span> <span> </span><span class="NLM_article-title">FDG accumulation and tumor biology</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1016/S0969-8051(97)00226-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2FS0969-8051%2897%2900226-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=9639291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1cXjtV2ksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=317-322&author=E.+Pauwelsauthor=M.+Ribeiroauthor=J.+Stootauthor=V.+McCreadyauthor=M.+Bourguignonauthor=B.+Maziere&title=FDG+accumulation+and+tumor+biology&doi=10.1016%2FS0969-8051%2897%2900226-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FDG accumulation and tumor biology</span></div><div class="casAuthors">Pauwels, E. K. J.; Ribeiro, M. J.; Stoot, J. H. M. B.; Mccready, V. R.; Bourguignon, M.; Maziere, B.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-322</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 54 refs.  The tumoral uptake of fluorine-18-deoxyglucose (FDG) is based upon enhanced glycolysis.  Following injection, FDG is phosphorylated and trapped intracellularly.  An important mechanism to transport FDG into the transformed cell is based upon the action of glucose transporter proteins; furthermore, highly active hexokinase bound to tumor mitochondria helps to trap FDG into the cell.  In addn., enhanced FDG uptake may be due to relative hypoxia in tumor masses, which activates the anaerobic glycolytic pathway.  In spite of these processes, FDG uptake is relatively aspecific since all living cells need glucose.  Clin. use is therefore recommended in carefully selected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokP4a7X2C8AbVg90H21EOLACvtfcHk0lhFywD2i6q2FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtV2ksbo%253D&md5=58f882cdf05fe58e66a825f4586e5341</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2897%2900226-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252897%252900226-6%26sid%3Dliteratum%253Aachs%26aulast%3DPauwels%26aufirst%3DE.%26aulast%3DRibeiro%26aufirst%3DM.%26aulast%3DStoot%26aufirst%3DJ.%26aulast%3DMcCready%26aufirst%3DV.%26aulast%3DBourguignon%26aufirst%3DM.%26aulast%3DMaziere%26aufirst%3DB.%26atitle%3DFDG%2520accumulation%2520and%2520tumor%2520biology%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1998%26volume%3D25%26spage%3D317%26epage%3D322%26doi%3D10.1016%2FS0969-8051%2897%2900226-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhajosula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solnes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhajosula, B.</span></span> <span> </span><span class="NLM_article-title">A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?</span>. <i>Semin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1053/j.semnuclmed.2011.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1053%2Fj.semnuclmed.2011.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=21624560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC3MrmtFKrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=246-264&author=S.+Vallabhajosulaauthor=L.+Solnesauthor=B.+Vallabhajosula&title=A+broad+overview+of+positron+emission+tomography+radiopharmaceuticals+and+clinical+applications%3A+what+is+new%3F&doi=10.1053%2Fj.semnuclmed.2011.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?</span></div><div class="casAuthors">Vallabhajosula Shankar; Solnes Lilja; Vallabhajosula Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">246-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Positron emission tomography (PET)/computed tomography (CT) is a rapidly expanding imaging modality, thanks to the availability of compact medical cyclotrons and automated chemistry synthesis modules for the production of PET radiopharmaceuticals.  Despite the availability of many radiotracers, [(18)F]fluorodeoxyglucose (FDG) is currently the most widely used radiopharmaceutical in PET, and the field of molecular imaging is anxiously awaiting the introduction of new PET radiopharmaceuticals for routine clinical use.  During the last five years, several proprietary PET radiopharmaceuticals have been developed by major companies, and these new agents are in different stages of clinical evaluation.  These new PET drugs are designed for imaging brain beta amyloid, myocardial perfusion, amino acid transport, angiogenesis, and tumor antigen expression.  In addition, the National Cancer Institute, Society of Nuclear Medicine Clinical Trials Network, and the American College of Radiology Imaging Network have been conducting multicenter clinical trials with several nonproprietary PET drugs such as sodium [(18)F]fluoride, [(18)F]fluorothymidine, [(18)F]fluoromisonidazole, and (64)Cu-labeled diacetyl-bis (N(4)-methylthiosemicarbazone.  All new PET radiopharmaceuticals, like any other drugs, must be manufactured under current good manufacturing practices as required by the Food and Drug Administration before clinical evaluation (phases I, II, and III) and submission of new drug application.  This review briefly describes the chemistry, mechanisms(s) of localization, and clinical application of both proprietary and nonproprietary new PET drugs under multicenter clinical evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSx0TQEvkbtqmHOrQ6qeX-mfW6udTcc2eZ91ZIZFG5p17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrmtFKrsQ%253D%253D&md5=54f2b8a6143405e6bdac4a8360aefec9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2011.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2011.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhajosula%26aufirst%3DS.%26aulast%3DSolnes%26aufirst%3DL.%26aulast%3DVallabhajosula%26aufirst%3DB.%26atitle%3DA%2520broad%2520overview%2520of%2520positron%2520emission%2520tomography%2520radiopharmaceuticals%2520and%2520clinical%2520applications%253A%2520what%2520is%2520new%253F%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D41%26spage%3D246%26epage%3D264%26doi%3D10.1053%2Fj.semnuclmed.2011.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jager, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaalburg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langen, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piers, D. A.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled amino acids: basic aspects and clinical applications in oncology</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=11337520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFOqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=432-445&author=P.+L.+Jagerauthor=W.+Vaalburgauthor=J.+Pruimauthor=E.+G.+de+Vriesauthor=K.-J.+Langenauthor=D.+A.+Piers&title=Radiolabeled+amino+acids%3A+basic+aspects+and+clinical+applications+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled amino acids: basic aspects and clinical applications in oncology</span></div><div class="casAuthors">Jager, Pieter L.; Vaalburg, Willem; Pruim, Jan; De Vries, Elisabeth G. E.; Langen, Karl-Josef; Piers, D. Albertus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">432-445</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  As the applications of metabolic imaging are expanding, radiolabeled amino acids may gain increased clin. interest.  This review first describes the basic aspects of amino acid metab., then continues with basic aspects of radiolabeled amino acids, and finally describes clin. applications, with an emphasis on diagnostic value.  A special focus is on 11C-methionine, 11C-tyrosine, and 123I-iodomethyltyrosine, because these have been most used clin., although their common affinity for the L-transport systems may limit generalization to other classes of amino acids.  The theoretic and preclin. background of amino acid imaging is sound and supports clin. applications.  The fact that amino acid imaging is less influenced by inflammation may be advantageous in comparison with 18F-FDG PET imaging, although tumor specificity is not abs.  In brain tumor imaging, the use of radiolabeled amino acids is established, the diagnostic accuracy of amino acid imaging seems adequate, and the diagnostic value seems advantageous.  The general feasibility of amino acid imaging in other tumor types has sufficiently been shown, but more research is required in larger patient series and in well-defined clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjW7aS26BMpLVg90H21EOLACvtfcHk0liqLQMRTD7V1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFOqt7k%253D&md5=38a3cae2a881bc7b4eee0d6d44521ab2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJager%26aufirst%3DP.%2BL.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3DPruim%26aufirst%3DJ.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%26aulast%3DLangen%26aufirst%3DK.-J.%26aulast%3DPiers%26aufirst%3DD.%2BA.%26atitle%3DRadiolabeled%2520amino%2520acids%253A%2520basic%2520aspects%2520and%2520clinical%2520applications%2520in%2520oncology%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D432%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled amino acids for oncologic imaging</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.2967/jnumed.112.113100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.2967%2Fjnumed.112.113100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=23708197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Witr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1007-1010&author=C.+Huangauthor=J.+McConathy&title=Radiolabeled+amino+acids+for+oncologic+imaging&doi=10.2967%2Fjnumed.112.113100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled amino acids for oncologic imaging</span></div><div class="casAuthors">Huang, Chaofeng; McConathy, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">A review.  Radiolabeled amino acids (AAs) are an important class of imaging agents for PET and SPECT that target the increased levels of AA transport by many tumor cells.  System L AA transport has been a major focus of tracer development, and work in this field has led to several tracers that are effective for imaging brain tumors.  Emerging data also support the use of certain radiolabeled Ms for neuroendocrine tumors and prostate cancer.  Recently, new 18F-labeled AAs have been developed that target transporters other than system L, including system A, glutamine, xCT, and cationic AA transporters.  This review provides an overview of this class of mol. imaging agents and highlights the current status of oncol. imaging with radiolabeled AAs in terms of tracer considerations and key clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquSsTwSABzP7Vg90H21EOLACvtfcHk0liqLQMRTD7V1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Witr%252FK&md5=31c0e6c7273ebe4e956a7f51ffb9b283</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.113100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.113100%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcConathy%26aufirst%3DJ.%26atitle%3DRadiolabeled%2520amino%2520acids%2520for%2520oncologic%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1007%26epage%3D1010%26doi%3D10.2967%2Fjnumed.112.113100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, H. N.</span></span> <span> </span><span class="NLM_article-title">Role of amino acid transport and countertransport in nutrition and metabolism</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1152/physrev.1990.70.1.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1152%2Fphysrev.1990.70.1.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=2404290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK3cXpsF2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1990&pages=43-77&author=H.+N.+Christensen&title=Role+of+amino+acid+transport+and+countertransport+in+nutrition+and+metabolism&doi=10.1152%2Fphysrev.1990.70.1.43"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Role of amino acid transport and countertransport in nutrition and metabolism</span></div><div class="casAuthors">Christensen, Halvor N.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-77</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    </div><div class="casAbstract">A review with 195 refs., on general aspects of amino acid transport (specificity, interaction between transport systems), and factors that detn. amino acid flow among tissues including dietary influences on brain nutrition by amino acids and maternofetal transport of amino acids.  The question of attenuation of transcription as a basis for regulation of amino acid transport across biomembranes is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgX3LhFUAyjbVg90H21EOLACvtfcHk0liqLQMRTD7V1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXpsF2hsQ%253D%253D&md5=f0a0ab8f5a91504173f321c7238d497c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1990.70.1.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1990.70.1.43%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DH.%2BN.%26atitle%3DRole%2520of%2520amino%2520acid%2520transport%2520and%2520countertransport%2520in%2520nutrition%2520and%2520metabolism%26jtitle%3DPhysiol.%2520Rev.%26date%3D1990%26volume%3D70%26spage%3D43%26epage%3D77%26doi%3D10.1152%2Fphysrev.1990.70.1.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boado, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardridge, W. M.</span></span> <span> </span><span class="NLM_article-title">Selective expression of the large neutral amino acid transporter at the blood–brain barrier</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">12079</span>– <span class="NLM_lpage">12084</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.21.12079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1073%2Fpnas.96.21.12079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10518579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVGjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12079-12084&author=R.+J.+Boadoauthor=J.+Y.+Liauthor=M.+Nagayaauthor=C.+Zhangauthor=W.+M.+Pardridge&title=Selective+expression+of+the+large+neutral+amino+acid+transporter+at+the+blood%E2%80%93brain+barrier&doi=10.1073%2Fpnas.96.21.12079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Selective expression of the large neutral amino acid transporter at the blood-brain barrier</span></div><div class="casAuthors">Boado, Ruben J.; Li, Jian Yi; Nagaya, Marie; Zhang, Crystal; Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12079-12084</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amino acid supply in brain is regulated by the activity of the large neutral amino acid transporter (LAT) at the brain capillary endothelial cell, which forms the blood-brain barrier (BBB) in vivo.  Bovine BBB poly(A)+ RNA was isolated from 2.0 kg of fresh bovine brain and size fractionated on a sucrose d. gradient, and a size-fractionated bovine BBB cDNA library in the pSPORT vector was prepd.  The full-length cDNA encoding the bovine BBB LAT was isolated from this library, and the predicted amino acid sequence was 89-92% identical to the LAT1 isoform.  The bovine BBB LAT1 mRNA produced a 10-fold enhancement in tryptophan transport into frog oocytes coinjected with bovine BBB LAT1 mRNA and the mRNA for 4F2hc, which encodes the heavy chain of the heterodimer.  Tryptophan transport into the mRNA-injected oocytes was sodium independent and was specifically inhibited by other large neutral amino acids, and the Km of tryptophan transport was 31.5 ± 5.5 μM.  Northern blotting with the bovine BBB LAT1 cDNA showed that the LAT1 mRNA is 100-fold higher in isolated bovine brain capillaries compared with C6 rat glioma cells or rat brain, and the LAT1 mRNA was not detected in rat liver, heart, lung, or kidney.  These studies show that the LAT1 transcript is selectively expressed at the BBB compared with other tissues, and the abundance of the LAT1 mRNA at the BBB is many-fold higher than that of transcripts such as the 4F2hc antigen, actin, or the Glut1 glucose transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT5sHBGe-IgrVg90H21EOLACvtfcHk0liqLQMRTD7V1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVGjtrw%253D&md5=ea63480977562f0ac0f4b9f7d20726c2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.21.12079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.21.12079%26sid%3Dliteratum%253Aachs%26aulast%3DBoado%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DNagaya%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DSelective%2520expression%2520of%2520the%2520large%2520neutral%2520amino%2520acid%2520transporter%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D96%26spage%3D12079%26epage%3D12084%26doi%3D10.1073%2Fpnas.96.21.12079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massager, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandesteene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levivier, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of <sup>18</sup>F-FDG and <sup>11</sup>C-methionine for PET-guided stereotactic brain biopsy of gliomas</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=15299051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFSmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1293-1298&author=B.+Pirotteauthor=S.+Goldmanauthor=N.+Massagerauthor=P.+Davidauthor=D.+Wiklerauthor=A.+Vandesteeneauthor=I.+Salmonauthor=J.+Brotchiauthor=M.+Levivier&title=Comparison+of+18F-FDG+and+11C-methionine+for+PET-guided+stereotactic+brain+biopsy+of+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas</span></div><div class="casAuthors">Pirotte, Benoit; Goldman, Serge; Massager, Nicolas; David, Philippe; Wikler, David; Vandesteene, Arlette; Salmon, Isabelle; Brotchi, Jacques; Levivier, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1293-1298</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">We compared the contributions of the labeled tracers 11C-methionine (Met) and 18F-FDG for PET-guided stereotactic biopsy of brain gliomas.  Methods: In 32 patients with glioma, stereotactic Met PET and 18F-FDG PET were integrated in the planning of stereotactic brain biopsy.  PET images were analyzed to det. which tracer offered the best information for target definition.  The stereotactic coregistration of PET images allowed accurate comparison of the level, distribution, and extent of uptake for both tracers according to tumor location and grade.  Results: A histol. diagnosis was obtained for all patients.  All gliomas had an area of abnormal Met uptake, and 27 showed abnormal 18F-FDG uptake.  18F-FDG was used for target selection when its uptake was higher in tumor than in gray matter (14 gliomas).  Seven were in the basal ganglia or brain stem.  Met was used for target selection when there was no 18F-FDG uptake or when 18F-FDG uptake was equiv. to that in the gray matter (18 gliomas).  Thirteen were in the cortex.  Sixty-one of the 70 stereotactic trajectories obtained from the 32 patients were based on PET-defined targets and had an area of abnormal Met uptake.  These 61 Met-pos. trajectories always yielded a diagnosis of tumor.  All nondiagnostic trajectories (n = 9) were obtained in areas with no increased uptake of Met.  In all patients with increased uptake of both tracers, the focus of highest Met uptake corresponded to the focus of highest 18F-FDG uptake.  However, the extent of uptake of both tracers was variable.  Conclusion: Distributions of highest Met and 18F-FDG uptake are similar in brain gliomas.  Because Met provides a more sensitive signal, it is the mol. of choice for single-tracer PET-guided neurosurgical procedures in gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmcL6JafqJOLVg90H21EOLACvtfcHk0ljxSKdvRY4DWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFSmur0%253D&md5=6ff4c7e981a979f8daac1bb73904cf6b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DGoldman%26aufirst%3DS.%26aulast%3DMassager%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DP.%26aulast%3DWikler%26aufirst%3DD.%26aulast%3DVandesteene%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DI.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DLevivier%26aufirst%3DM.%26atitle%3DComparison%2520of%252018F-FDG%2520and%252011C-methionine%2520for%2520PET-guided%2520stereotactic%2520brain%2520biopsy%2520of%2520gliomas%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D45%26spage%3D1293%26epage%3D1298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palanichamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span> <span> </span><span class="NLM_article-title">Diagnostic and prognostic significance of methionine uptake and methionine positron emission tomography imaging in gliomas</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">257</span>, <span class="refDoi"> DOI: 10.3389/fonc.2017.00257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.3389%2Ffonc.2017.00257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=29164057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC1M3jvVeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=257&author=K.+Palanichamyauthor=A.+Chakravarti&title=Diagnostic+and+prognostic+significance+of+methionine+uptake+and+methionine+positron+emission+tomography+imaging+in+gliomas&doi=10.3389%2Ffonc.2017.00257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnostic and Prognostic Significance of Methionine Uptake and Methionine Positron Emission Tomography Imaging in Gliomas</span></div><div class="casAuthors">Palanichamy Kamalakannan; Chakravarti Arnab</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">The present most common image diagnostic tracer in clinical practice for glioma is (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for brain tumors diagnosis and prognosis.  PET is a promising molecular imaging technique, which provides real-time information on the metabolic behavior of the tracer.  The diffusive nature of glioblastoma (GBM) and heterogeneity often make the radiographic detection by FDG-PET inaccurate, and there is no gold standard.  FDG-PET often leads to several controversies in making clinical decisions due to their uptake by normal surrounding tissues, and pose a challenge in delineating treatment-induced necrosis, edema, inflammation, and pseudoprogression.  Thus, it is imperative to find new criteria independent of conventional morphological diagnosis to demarcate normal and tumor tissues.  We have provided proof of concept studies for (11)C methionine-PET (MET-PET) imaging of gliomas, along with prognostic and diagnostic significance.  MET-PET is not widely used in the United States, though clinical trials from Japan and Germany suggesting the diagnostic ability of MET-PET imaging are superior to FDG-PET imaging for brain tumors.  A major impediment is the availability of the onsite cyclotron and isotopic carbon chemistry facilities.  In this article, we have provided the scientific rationale and advantages of the use of MET-PET as GBM tracers.  We extend our discussion on the expected pitfalls of using MET-PET and ways to overcome them by incorporating a translational component of profiling gene status in the methionine metabolic pathway.  This translational correlative component to the MET-PET clinical trials can lead to a better understanding of the existing controversies and can enhance our knowledge for future randomization of GBM patients based on their tumor gene signatures to achieve better prognosis and treatment outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRx9429BdJqznthwrmtH4OBfW6udTcc2ebD9QNauQCuObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3jvVeltQ%253D%253D&md5=a86b4e55195a92b7f6cef62b1e3c0f48</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2017.00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2017.00257%26sid%3Dliteratum%253Aachs%26aulast%3DPalanichamy%26aufirst%3DK.%26aulast%3DChakravarti%26aufirst%3DA.%26atitle%3DDiagnostic%2520and%2520prognostic%2520significance%2520of%2520methionine%2520uptake%2520and%2520methionine%2520positron%2520emission%2520tomography%2520imaging%2520in%2520gliomas%26jtitle%3DFront.%2520Oncol.%26date%3D2017%26volume%3D7%26spage%3D257%26doi%3D10.3389%2Ffonc.2017.00257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muragaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, T.</span></span> <span> </span><span class="NLM_article-title">Metabolic assessment of gliomas using <sup>11</sup>C-methionine, [<sup>18</sup>F] fluorodeoxyglucose, and <sup>11</sup>C-choline positron-emission tomography</span>. <i>Am. J. Neuroradiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.3174/ajnr.A1008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.3174%2Fajnr.A1008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=18388218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BD1cznsFWgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1176-1182&author=T.+Katoauthor=J.+Shinodaauthor=N.+Nakayamaauthor=K.+Miwaauthor=A.+Okumuraauthor=H.+Yanoauthor=S.+Yoshimuraauthor=T.+Maruyamaauthor=Y.+Muragakiauthor=T.+Iwama&title=Metabolic+assessment+of+gliomas+using+11C-methionine%2C+%5B18F%5D+fluorodeoxyglucose%2C+and+11C-choline+positron-emission+tomography&doi=10.3174%2Fajnr.A1008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography</span></div><div class="casAuthors">Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T</div><div class="citationInfo"><span class="NLM_cas:title">AJNR. American journal of neuroradiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1176-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Positron-emission tomography (PET) is a useful tool in oncology.  The aim of this study was to assess the metabolic activity of gliomas using (11)C-methionine (MET), [(18)F] fluorodeoxyglucose (FDG), and (11)C-choline (CHO) PET and to explore the correlation between the metabolic activity and histopathologic features.  MATERIALS AND METHODS:  PET examinations were performed for 95 primary gliomas (37 grade II, 37 grade III, and 21 grade IV).  We measured the tumor/normal brain uptake ratio (T/N ratio) on each PET and investigated the correlations among the tracer uptake, tumor grade, tumor type, and tumor proliferation activity.  In addition, we compared the ease of visual evaluation for tumor detection.  RESULTS:  All 3 of the tracers showed positive correlations with astrocytic tumor (AT) grades (II/IV and III/IV).  The MET T/N ratio of oligodendroglial tumors (OTs) was significantly higher than that of ATs of the same grade.  The CHO T/N ratio showed a significant positive correlation with histopathologic grade in OTs.  Tumor grade and type influenced MET uptake only.  MET T/N ratios of more than 2.0 were seen in 87% of all of the gliomas.  All of the tracers showed significantly positive correlations with Mib-1 labeling index in ATs but not in OTs and oligoastrocytic tumors.  CONCLUSION:  MET PET appears to be useful in evaluating grade, type, and proliferative activity of ATs.  CHO PET may be useful in evaluating the potential malignancy of OTs.  In terms of visual evaluation of tumor localization, MET PET is superior to FDG and CHO PET in all of the gliomas, due to its straightforward detection of "hot lesions".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTT0rfhUzXSDMve_zCu79I8fW6udTcc2ebD9QNauQCuObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cznsFWgtw%253D%253D&md5=9052f6ea10d2921255b8fd32a798392e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3174%2Fajnr.A1008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3174%252Fajnr.A1008%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DShinoda%26aufirst%3DJ.%26aulast%3DNakayama%26aufirst%3DN.%26aulast%3DMiwa%26aufirst%3DK.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DS.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DMuragaki%26aufirst%3DY.%26aulast%3DIwama%26aufirst%3DT.%26atitle%3DMetabolic%2520assessment%2520of%2520gliomas%2520using%252011C-methionine%252C%2520%255B18F%255D%2520fluorodeoxyglucose%252C%2520and%252011C-choline%2520positron-emission%2520tomography%26jtitle%3DAm.%2520J.%2520Neuroradiol.%26date%3D2008%26volume%3D29%26spage%3D1176%26epage%3D1182%26doi%3D10.3174%2Fajnr.A1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singhal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantil, J.</span></span> <span> </span><span class="NLM_article-title"><sup>11</sup>C-l-methionine positron emission tomography in the clinical management of cerebral gliomas</span>. <i>Mol. Imaging. Biol</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1007/s11307-007-0115-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1007%2Fs11307-007-0115-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=17957408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FgsFSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1-18&author=T.+Singhalauthor=T.+K.+Narayananauthor=V.+Jainauthor=J.+Mukherjeeauthor=J.+Mantil&title=11C-l-methionine+positron+emission+tomography+in+the+clinical+management+of+cerebral+gliomas&doi=10.1007%2Fs11307-007-0115-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas</span></div><div class="casAuthors">Singhal Tarun; Narayanan Tanjore K; Jain Viney; Mukherjee Jogeshwar; Mantil Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Positron emission tomography (PET) using L-[methyl-(11)C]-methionine (MET) is the most popular amino acid imaging modality in oncology, although its use is restricted to PET centers with an in-house cyclotron facility.  This review focuses on the role of MET-PET in imaging of cerebral gliomas.  The biological background of tumor imaging with methionine is discussed with particular emphasis on cellular amino acid transport, amino acid utilization in brain, normal metabolism of methionine, and its alterations in cancer.  The role of MET-PET in clinical management of cerebral gliomas in initial diagnosis, differentiation of tumor recurrence from radiation injury, grading, prognostication, tumor-extent delineation, biopsy planning, surgical resection and radiotherapy planning, and assessment of response to therapy is also reviewed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5mBTKREOEAUbxh97K6Vt6fW6udTcc2eZPhaVLML5F2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FgsFSnsQ%253D%253D&md5=a3af3867449c2db379396d1902581f3c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs11307-007-0115-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-007-0115-2%26sid%3Dliteratum%253Aachs%26aulast%3DSinghal%26aufirst%3DT.%26aulast%3DNarayanan%26aufirst%3DT.%2BK.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DMukherjee%26aufirst%3DJ.%26aulast%3DMantil%26aufirst%3DJ.%26atitle%3D11C-l-methionine%2520positron%2520emission%2520tomography%2520in%2520the%2520clinical%2520management%2520of%2520cerebral%2520gliomas%26jtitle%3DMol.%2520Imaging.%2520Biol%26date%3D2008%26volume%3D10%26spage%3D1%26epage%3D18%26doi%3D10.1007%2Fs11307-007-0115-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrd, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. A.</span></span> <span> </span><span class="NLM_article-title">1-aminocyclobutane [<sup>11</sup>C] carboxylic acid, a potential tumor-seeking agent</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=231642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaL3cXptVSgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1979&pages=1055-1061&author=L.+C.+Washburnauthor=T.+T.+Sunauthor=B.+Byrdauthor=R.+L.+Hayesauthor=T.+A.+Butler&title=1-aminocyclobutane+%5B11C%5D+carboxylic+acid%2C+a+potential+tumor-seeking+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aminocyclobutane[11C]carboxylic acid, a potential tumor-seeking agent</span></div><div class="casAuthors">Washburn, Lee C.; Sun, Tan Tan; Byrd, B. L.; Hayes, Raymond L.; Butler, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1055-61</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3123</span>.
    </div><div class="casAbstract">1-Aminocyclobutane carboxylic-14C acid (I-14C) was incorporated preferentially by several tumor types in rats and hamsters.  The agent was cleared rapidly from rat blood, attaining its max. tissue concns. within 30 min after i.v. injection.  Carrier I had little effect on the tissue distribution of I-14C.  This agent showed no affinity for a Staphylococcus aureus abscess in rats.  The total excretion was low, 3.6% in 2 h.  I-11C was synthesized in amts. up to 415 mCi (55% chem. yield) using the modified Buecherer-Strecker technique.  Forty minutes were required for the 2-step synthesis and chromatog. purifn.  I was nontoxic in 3 animal species.  The radiation dose from I-11C should be minimal.  I-11C thus appears to have good potential as a tumor-seeking agent, particularly when used with a positron emission computed tomograph.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6W_GfWqO1DrVg90H21EOLACvtfcHk0ljCOSEsM--DqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXptVSgtg%253D%253D&md5=43197794e73121dbb34e20d6edeb294b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWashburn%26aufirst%3DL.%2BC.%26aulast%3DSun%26aufirst%3DT.%2BT.%26aulast%3DByrd%26aufirst%3DB.%26aulast%3DHayes%26aufirst%3DR.%2BL.%26aulast%3DButler%26aufirst%3DT.%2BA.%26atitle%3D1-aminocyclobutane%2520%255B11C%255D%2520carboxylic%2520acid%252C%2520a%2520potential%2520tumor-seeking%2520agent%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1979%26volume%3D20%26spage%3D1055%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, E. C.</span></span> <span> </span><span class="NLM_article-title">Tumor detection with 1-aminocyclopentane and 1-aminocyclobutane C-11-carboxylic acid using positron emission computerized tomography</span>. <i>Clin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1097/00003072-198106000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1097%2F00003072-198106000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=6971725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADyaL3M7oslSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1981&pages=249-252&author=K.+F.+H%C3%BCbnerauthor=S.+Kraussauthor=L.+Washburnauthor=W.+D.+Gibbsauthor=E.+C.+Holloway&title=Tumor+detection+with+1-aminocyclopentane+and+1-aminocyclobutane+C-11-carboxylic+acid+using+positron+emission+computerized+tomography&doi=10.1097%2F00003072-198106000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor detection with 1-aminocyclopentane and 1-aminocyclobutane C-11-carboxylic acid using positron emission computerized tomography</span></div><div class="casAuthors">Hubner K F; Krauss S; Washburn L C; Gibbs W D; Holloway E C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical nuclear medicine</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">249-52</span>
        ISSN:<span class="NLM_cas:issn">0363-9762</span>.
    </div><div class="casAbstract">Eight patients with proven or suspected neoplastic lesions were examined with 1-aminocyclobutane C-11-carboxylic acid and 1-aminocyclopentane C-11-carboxylic acid using positron emission computed tomography.  The results of this comparative study have shown that both of these unnatural amino acids have a high affinity for malignant tumors.  The potential of nonmetabolizable C-11-labeled amino acids as noninvasive indicators of metabolic tumor activity is demonstrated and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB8qtQ1L9IFDW1zwg2yUK5fW6udTcc2eZPhaVLML5F2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M7oslSrtQ%253D%253D&md5=7822fb7e9674589cf6abd6b7dff0a570</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1097%2F00003072-198106000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00003072-198106000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DK.%2BF.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DL.%26aulast%3DGibbs%26aufirst%3DW.%2BD.%26aulast%3DHolloway%26aufirst%3DE.%2BC.%26atitle%3DTumor%2520detection%2520with%25201-aminocyclopentane%2520and%25201-aminocyclobutane%2520C-11-carboxylic%2520acid%2520using%2520positron%2520emission%2520computerized%2520tomography%26jtitle%3DClin.%2520Nucl.%2520Med.%26date%3D1981%26volume%3D6%26spage%3D249%26epage%3D252%26doi%3D10.1097%2F00003072-198106000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turtle, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. A.</span></span> <span> </span><span class="NLM_article-title">Carboxyl-labeled <sup>11</sup>C-1-aminocyclopentanecarboxylic acid, a potential agent for cancer detection</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=180270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaE28XltFKnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1976&pages=748-751&author=R.+L.+Hayesauthor=L.+C.+Washburnauthor=B.+W.+Wielandauthor=T.+T.+Sunauthor=R.+R.+Turtleauthor=T.+A.+Butler&title=Carboxyl-labeled+11C-1-aminocyclopentanecarboxylic+acid%2C+a+potential+agent+for+cancer+detection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxyl-labeled 11C-1-aminocyclopentanecarboxylic acid, a potential agent for cancer detection</span></div><div class="casAuthors">Hayes, Raymond L.; Washburn, Lee C.; Wieland, Bruce W.; Sun, Tan Tan; Turtle, Robert R.; Butler, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">748-51</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    </div><div class="casAbstract">Carboxyl-labeled 11C-1-aminocyclopentanecarboxylic acid [60375-48-6] (11C-ACPC) was prepd. in multimillicurie amts.  The conversion of H11CN to 11C-ACPC (t1/2 = 20.4 min) was accomplished by a rapid (20 min) 2-step high-temp. modification of the Bucherer-Strecker amino acid synthesis technique.  Purifn. was by ion exchange techniques.  The tissue distribution of 11C-ACPC (750 microcurie, i.v.) in Morris 5123 C hepatoma bearing rats indicated the compd. has potential as a tumor-localizing agent for detecting cancer in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowa66SUYMJDrVg90H21EOLACvtfcHk0ljCOSEsM--DqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltFKnu78%253D&md5=e273954acf2ab297131ce7d94debc022</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DR.%2BL.%26aulast%3DWashburn%26aufirst%3DL.%2BC.%26aulast%3DWieland%26aufirst%3DB.%2BW.%26aulast%3DSun%26aufirst%3DT.%2BT.%26aulast%3DTurtle%26aufirst%3DR.%2BR.%26aulast%3DButler%26aufirst%3DT.%2BA.%26atitle%3DCarboxyl-labeled%252011C-1-aminocyclopentanecarboxylic%2520acid%252C%2520a%2520potential%2520agent%2520for%2520cancer%2520detection%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1976%26volume%3D17%26spage%3D748%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winebrenner, J. D.</span></span> <span> </span><span class="NLM_article-title">Tumor location with 1-aminocyclopentane [<sup>11</sup>C] carboxylic acid: preliminary clinical trials with single-photon detection</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=606748" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1977&pages=1215-1221&author=K.+F.+H%C3%BCbnerauthor=G.+A.+Andrewsauthor=L.+Washburnauthor=B.+W.+Wielandauthor=W.+D.+Gibbsauthor=R.+L.+Hayesauthor=T.+A.+Butlerauthor=J.+D.+Winebrenner&title=Tumor+location+with+1-aminocyclopentane+%5B11C%5D+carboxylic+acid%3A+preliminary+clinical+trials+with+single-photon+detection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DK.%2BF.%26aulast%3DAndrews%26aufirst%3DG.%2BA.%26aulast%3DWashburn%26aufirst%3DL.%26aulast%3DWieland%26aufirst%3DB.%2BW.%26aulast%3DGibbs%26aufirst%3DW.%2BD.%26aulast%3DHayes%26aufirst%3DR.%2BL.%26aulast%3DButler%26aufirst%3DT.%2BA.%26aulast%3DWinebrenner%26aufirst%3DJ.%2BD.%26atitle%3DTumor%2520location%2520with%25201-aminocyclopentane%2520%255B11C%255D%2520carboxylic%2520acid%253A%2520preliminary%2520clinical%2520trials%2520with%2520single-photon%2520detection%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1977%26volume%3D18%26spage%3D1215%26epage%3D1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarkas, N.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological properties of radiohalogenated α, α-disubstituted amino acids for PET and SPECT imaging of amino acid transporters (AATs)</span>. <i>J. Labelled Compd. Rad.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1002%2Fjlcr.3584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=29143354" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=272-290&author=M.+M.+Goodmanauthor=W.+Yuauthor=N.+Jarkas&title=Synthesis+and+biological+properties+of+radiohalogenated+%CE%B1%2C+%CE%B1-disubstituted+amino+acids+for+PET+and+SPECT+imaging+of+amino+acid+transporters+%28AATs%29&doi=10.1002%2Fjlcr.3584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3584%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DJarkas%26aufirst%3DN.%26atitle%3DSynthesis%2520and%2520biological%2520properties%2520of%2520radiohalogenated%2520%25CE%25B1%252C%2520%25CE%25B1-disubstituted%2520amino%2520acids%2520for%2520PET%2520and%2520SPECT%2520imaging%2520of%2520amino%2520acid%2520transporters%2520%2528AATs%2529%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Rad.%26date%3D2018%26volume%3D61%26spage%3D272%26epage%3D290%26doi%3D10.1002%2Fjlcr.3584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span> </span><span class="NLM_article-title">FDA approves <sup>18</sup>F-Fluciclovine
and <sup>68</sup>Ga-DOTATATE
products</span>.  <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">57</span>,  <span class="NLM_fpage">9N</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.2967%2Fjnumed.115.165316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=27697971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKitrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA+approves+18F-Fluciclovine%0Aand+68Ga-DOTATATE%0Aproducts.+J.+Nucl.+Med.+2016%2C+57%2C+9N."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-NOTA-Aca-BBN(7-14) PET/CT in healthy volunteers and glioma patients</span></div><div class="casAuthors">Zhang, Jingjing; Li, Deling; Lang, Lixin; Zhu, Zhaohui; Wang, Ling; Wu, Peilin; Niu, Gang; Li, Fang; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">This work was designed to study the safety, biodistribution, and radiation dosimetry of a gastrin-releasing peptide receptor (GRPR)- targeting, 68Ga-labeled bombesin (BBN) peptide deriv. PET tracer, NOTA-Aca-BBN(7-14) (denoted as 68Ga-BBN) in healthy volunteers and to assess the level of receptor expression in glioma patients.  Methods: Four healthy volunteers (2 male and 2 female) underwent whole-body PET/CT at multiple time points after a bolus injection of 68Ga-BBN (111 ± 148 MBq).  Regions of interest were drawn manually over major organs, and time-activity curves were obtained.  Dosimetry was calcd. using the OLINDA/EXM software.  Twelve patients with glioma diagnosed by contrast-enhanced MRI underwent PET/CT at 30-45 min after 68Ga-BBN injection.  Within 1 wk afterward, the tumor was surgically removed and immunohistochem. staining of tumor samples against GRPR was performed and correlated with the PET/ CT results.  Results: 68Ga-BBN was well tolerated in all healthy volun- teers, with no adverse symptoms being noticed or reported. 68Ga-BBN cleared rapidly from the circulation and was excreted mainly through the kidneys and urinary tract.  The total ED equiv. and ED were 0.0335 ± 0.0079 and 0.0276 ± 0.0066 mSv/MBq, resp.  In glioma patients, all MRI-identified lesions showed high signal intensity on 68Ga-BBN PET/CT.  SUVmax and SUVmean were 2.08 ± 0.58 and 1.32 ± 0.37, resp.  With normal brain tissue as back- ground, tumor-to-background ratios were 24.0 ± 8.85 and 13.4 ± 4.54 based on SUVmax and SUVmean resp.  The immunohistochem- ical staining confirmed a pos. correlation between SIN and GRPR expression level (r2 = 0.71, P < 0.001).  Conclusion: 68Ga-BBN is a PET tracer with favorable pharmacokinetics and a favorable dosimetry profile.  It has the potential to evaluate GRPR expression in glioma patients and guide GRPR-targeted therapy of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5ZdTCFW9-A7Vg90H21EOLACvtfcHk0lgR37XMbSeITg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKitrrO&md5=29fd1b8d33d638910b87ec8c24419165</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.165316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.165316%26sid%3Dliteratum%253Aachs%26atitle%3DFDA%2520approves%252018F-Fluciclovine%250Aand%252068Ga-DOTATATE%250Aproducts%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D9N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarkas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">(<i>R</i>, <i>S</i>)-Anti-1-amino-2-[<sup>18</sup>F] fluorocyclopentyl-1-carboxylic acid: synthesis from racemic 2-benzyloxycyclopentanone and biological evaluation for brain tumor imaging with positron emission tomography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6603</span>– <span class="NLM_lpage">6607</span>, <span class="refDoi"> DOI: 10.1021/jm100841m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100841m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCnsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6603-6607&author=N.+Jarkasauthor=R.+J.+Vollauthor=L.+Williamsauthor=V.+M.+Campauthor=M.+M.+Goodman&title=%28R%2C+S%29-Anti-1-amino-2-%5B18F%5D+fluorocyclopentyl-1-carboxylic+acid%3A+synthesis+from+racemic+2-benzyloxycyclopentanone+and+biological+evaluation+for+brain+tumor+imaging+with+positron+emission+tomography&doi=10.1021%2Fjm100841m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">(R,S)-anti-1-Amino-2-[18F]Fluorocyclopentyl-1-carboxylic Acid: Synthesis from Racemic 2-Benzyloxycyclopentanone and Biological Evaluation for Brain Tumor Imaging with Positron Emission Tomography</span></div><div class="casAuthors">Jarkas, Nachwa; Voll, Ronald J.; Williams, Larry; Camp, Vernon M.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6603-6607</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(R,S)-anti-1-Amino-2-fluorocyclopentyl-1-carboxylic acid (2-FACPC, 4b) was radiolabeled in 39% yield starting from cyclic sulfamidate 12.  The 9L gliosarcoma cells assays showed that 4b is mainly a substrate for the L-type amino acid transport with some affinity to the A-type.  In rats bearing 9L gliosarcoma tumors, 4b displayed high tumor to brain ratio (10:1) at 120 min after injection.  FACPC is an attractive candidate for imaging brain tumors with PET, and its isolated enantiomers are under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_TfBwv_FitLVg90H21EOLACvtfcHk0liKKsSk1gVo9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCnsLjF&md5=7ff78f1bf8ce1dc77f4030da2a97034a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm100841m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100841m%26sid%3Dliteratum%253Aachs%26aulast%3DJarkas%26aufirst%3DN.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3D%2528R%252C%2520S%2529-Anti-1-amino-2-%255B18F%255D%2520fluorocyclopentyl-1-carboxylic%2520acid%253A%2520synthesis%2520from%2520racemic%25202-benzyloxycyclopentanone%2520and%2520biological%2520evaluation%2520for%2520brain%2520tumor%2520imaging%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6603%26epage%3D6607%26doi%3D10.1021%2Fjm100841m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savir-Baruch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarkas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Master, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieh, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkar, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nye, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span> <span> </span><span class="NLM_article-title">Pilot evaluation of <i>anti</i>-1-amino-2-[<sup>18</sup> F] fluorocyclopentane-1-carboxylic acid (<i>anti</i>-2-[<sup>18</sup> F] FACPC) PET-CT in recurrent prostate carcinoma</span>. <i>Mol. Imaging. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1272</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1007/s11307-010-0445-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1007%2Fs11307-010-0445-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=20976627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC3MbnslGgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1272-1277&author=B.+Savir-Baruchauthor=D.+M.+Schusterauthor=N.+Jarkasauthor=V.+A.+Masterauthor=P.+T.+Niehauthor=R.+K.+Halkarauthor=J.+A.+Nyeauthor=M.+M.+Lewisauthor=R.+J.+Croweauthor=R.+J.+Voll&title=Pilot+evaluation+of+anti-1-amino-2-%5B18+F%5D+fluorocyclopentane-1-carboxylic+acid+%28anti-2-%5B18+F%5D+FACPC%29+PET-CT+in+recurrent+prostate+carcinoma&doi=10.1007%2Fs11307-010-0445-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma</span></div><div class="casAuthors">Savir-Baruch Bital; Schuster David M; Jarkas Nashwa; Master Viraj A; Nieh Peter T; Halkar Raghuveer K; Nye Jonathon A; Lewis Melinda M; Crowe Ronald J; Voll Ronald J; Camp Vernon M; Bellamy Leah M; Roberts David L; Goodman Mark M</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1272-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Anti-1-amino-2-[(18)F]fluorocyclopentane-1-carboxylic acid (anti-2-[(18)F]FACPC) is an unnatural alicyclic amino acid radiotracer with high uptake in the DU-145 prostate cancer cell line in vitro.  Our goal was to determine if anti-2-[(18)F]FACPC is useful in the detection of prostate carcinoma.  PROCEDURES:  Five patients with elevated PSA (1.1-20.5 ng/mL) after curative therapy for prostate carcinoma underwent 60 min dynamic positron emission tomography (PET) of the pelvis after IV injection of 193-340 MBq of anti-2-[(18)F]FACPC.  Uptake was compared against PET scans in the same patients with the leucine analog, anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid (anti-[(18)F]FACBC), at similar time points and validated via pathology, clinical, and imaging follow-up.  RESULTS:  At 5 min, average (±SD) SUVmax of malignant lesions is 4.1(±1.3) for anti-2-[(18)F] FACPC and 4.3(±1.1) for anti-[(18)F]FACBC.  Yet, blood pool activity at 5 min is significantly higher for anti-2-[(18)F]FACPC with average (±SD) lesion/blood pool SUVmax/SUVmean ratio of 1.4 (±0.5) vs. 3.0 (±0.9) for anti-[(18)F]FACBC.  At 20 min, average (±SD) SUVmax of malignant lesions is 2.6 (±1.0) for anti-2-[(18)F]FACPC and 3.4 (±0.8) for anti-[(18)F]FACBC.  Yet, bladder activity at 20 min is significantly more intense for anti-2-[(18)F] FACPC with average (±SD) lesion/bladder SUVmax/SUVmean ratio of 0.3 (±0.8) vs. 2.3 (±1.4) for anti-[(18)F]FACBC.  CONCLUSIONS:  While prostate bed lesions are visible on early imaging with anti-2-[(18)F]FACPC, there is high blood pool activity obscuring nodes.  As blood pool fades, nodal uptake decreases and high bladder activity then obscures pelvic structures.  Compared with anti-[(18)F]FACBC, imaging characteristics for anti-2-[(18)F]FACPC are unfavorable for pelvic recurrent prostate carcinoma detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvJKElpYmkLzjk2McQZ6XmfW6udTcc2eZrE1jZW-eWK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbnslGgtg%253D%253D&md5=032483b3a34be1e69653bd37e8b41b79</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs11307-010-0445-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-010-0445-3%26sid%3Dliteratum%253Aachs%26aulast%3DSavir-Baruch%26aufirst%3DB.%26aulast%3DSchuster%26aufirst%3DD.%2BM.%26aulast%3DJarkas%26aufirst%3DN.%26aulast%3DMaster%26aufirst%3DV.%2BA.%26aulast%3DNieh%26aufirst%3DP.%2BT.%26aulast%3DHalkar%26aufirst%3DR.%2BK.%26aulast%3DNye%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DCrowe%26aufirst%3DR.%2BJ.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26atitle%3DPilot%2520evaluation%2520of%2520anti-1-amino-2-%255B18%2520F%255D%2520fluorocyclopentane-1-carboxylic%2520acid%2520%2528anti-2-%255B18%2520F%255D%2520FACPC%2529%2520PET-CT%2520in%2520recurrent%2520prostate%2520carcinoma%26jtitle%3DMol.%2520Imaging.%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D1272%26epage%3D1277%26doi%3D10.1007%2Fs11307-010-0445-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casabona, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cativiela, C.</span></span> <span> </span><span class="NLM_article-title">Simple and efficient multigram scale synthesis of 1-aminocyclopent-3-ene-1-carboxylic acid</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2440</span>– <span class="NLM_lpage">2443</span>, <span class="refDoi"> DOI: 10.1055/s-2006-942458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1055%2Fs-2006-942458" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2440-2443&author=D.+Casabonaauthor=C.+Cativiela&title=Simple+and+efficient+multigram+scale+synthesis+of+1-aminocyclopent-3-ene-1-carboxylic+acid&doi=10.1055%2Fs-2006-942458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-942458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-942458%26sid%3Dliteratum%253Aachs%26aulast%3DCasabona%26aufirst%3DD.%26aulast%3DCativiela%26aufirst%3DC.%26atitle%3DSimple%2520and%2520efficient%2520multigram%2520scale%2520synthesis%2520of%25201-aminocyclopent-3-ene-1-carboxylic%2520acid%26jtitle%3DSynthesis%26date%3D2006%26volume%3D14%26spage%3D2440%26epage%3D2443%26doi%3D10.1055%2Fs-2006-942458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmstead, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, M. J.</span></span> <span> </span><span class="NLM_article-title">Diastereoselective synthesis of cyclopentanoids with hydantoin and isoxazoline substituents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1021/jo9714831</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9714831" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1cXjtFKqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=113-117&author=K.-H.+Parkauthor=M.+M.+Olmsteadauthor=M.+J.+Kurth&title=Diastereoselective+synthesis+of+cyclopentanoids+with+hydantoin+and+isoxazoline+substituents&doi=10.1021%2Fjo9714831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereoselective Synthesis of Cyclopentanoids with Hydantoin and Isoxazoline Substituents</span></div><div class="casAuthors">Park, Kyung-Ho; Olmstead, Marilyn M.; Kurth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-117</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Exploiting 1,3-dipolar cycloaddn. and urea → hydantoin cyclization transformations, novel spiro[cyclopenta[d]isoxazole-4',5-imidazolindine]s I [R1 = Pr, Me, Ph; R2 = Ph, 4-ClC6H4, 4-FC6H4] have been prepd.  The 1-amino-3-cyclopentenecarboxylate precursor was prepd. from a suitably activated/protected deriv. of glycine and the bis-alkylating agent cis-1,4-dichloro-2-butene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS1D2aqzg0iLVg90H21EOLACvtfcHk0liKKsSk1gVo9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtFKqug%253D%253D&md5=bd74b5cf34cdb77269ef7f6d4811a047</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo9714831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9714831%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.-H.%26aulast%3DOlmstead%26aufirst%3DM.%2BM.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26atitle%3DDiastereoselective%2520synthesis%2520of%2520cyclopentanoids%2520with%2520hydantoin%2520and%2520isoxazoline%2520substituents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D113%26epage%3D117%26doi%3D10.1021%2Fjo9714831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmstead, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, M. J.</span></span> <span> </span><span class="NLM_article-title">Diastereoselective solid-phase synthesis of novel hydantoin-and isoxazoline-containing heterocycles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6579</span>– <span class="NLM_lpage">6585</span>, <span class="refDoi"> DOI: 10.1021/jo9807161</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9807161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVeltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=6579-6585&author=K.-H.+Parkauthor=M.+M.+Olmsteadauthor=M.+J.+Kurth&title=Diastereoselective+solid-phase+synthesis+of+novel+hydantoin-and+isoxazoline-containing+heterocycles&doi=10.1021%2Fjo9807161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereoselective Solid-Phase Synthesis of Novel Hydantoin- and Isoxazoline-Containing Heterocycles</span></div><div class="casAuthors">Park, Kyung-Ho; Olmstead, Marilyn M.; Kurth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6579-6585</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel spirocyclic isoxazoloimidazolidinedione heterocycles were prepd. by exploiting 1,3-dipolar cycloaddn. and carbanilide cyclization transformations on solid phase starting from Merrifield resin.  Cyclopentanoid isoxazoloimidazolidinediones were obtained with complete diastereoselectivity, and cyclopropanoid isoxazoloimidazolidinediones were obtained as an ≈2:1 mixt. of diastereomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3aPjvTfalTbVg90H21EOLACvtfcHk0liOJ3OmjY2Sxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVeltbw%253D&md5=2966298cfa84ebbeab7f5e7e3d5aae44</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo9807161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9807161%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.-H.%26aulast%3DOlmstead%26aufirst%3DM.%2BM.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26atitle%3DDiastereoselective%2520solid-phase%2520synthesis%2520of%2520novel%2520hydantoin-and%2520isoxazoline-containing%2520heterocycles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D6579%26epage%3D6585%26doi%3D10.1021%2Fjo9807161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kil, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, D. H.</span></span> <span> </span><span class="NLM_article-title">A new class of SN2 reactions catalyzed by protic solvents: facile fluorination for isotopic labeling of diagnostic molecules</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">16394</span>– <span class="NLM_lpage">16397</span>, <span class="refDoi"> DOI: 10.1021/ja0646895</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0646895" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16394-16397&author=D.+W.+Kimauthor=D.-S.+Ahnauthor=Y.-H.+Ohauthor=S.+Leeauthor=H.+S.+Kilauthor=S.+J.+Ohauthor=S.+J.+Leeauthor=J.+S.+Kimauthor=J.+S.+Ryuauthor=D.+H.+Moon&title=A+new+class+of+SN2+reactions+catalyzed+by+protic+solvents%3A+facile+fluorination+for+isotopic+labeling+of+diagnostic+molecules&doi=10.1021%2Fja0646895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A New Class of SN2 Reactions Catalyzed by Protic Solvents: Facile Fluorination for Isotopic Labeling of Diagnostic Molecules</span></div><div class="casAuthors">Kim, Dong Wook; Ahn, Doo-Sik; Oh, Young-Ho; Lee, Sungyul; Kil, Hee Seup; Oh, Seung Jun; Lee, Sang Ju; Kim, Jae Seung; Ryu, Jin Sook; Moon, Dae Hyuk; Chi, Dae Yoon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">16394-16397</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aprotic solvents are usually preferred for the SN2 reactions, because nucleophilicity and hence SN2 reactivity are severely retarded by the influence of the partial pos. charge of protic solvents.  In this work, we introduce a remarkable effect of using tertiary alcs. as a reaction medium for nucleophilic fluorination with alkali metal fluorides.  In this novel synthetic method, the nonpolar protic tert-alc. enhances the nucleophilicity of the fluoride ion dramatically in the absence of any kind of catalyst, greatly increasing the rate of the nucleophilic fluorination and reducing formation of byproducts (such as alkenes, alcs., or ethers) compared with conventional methods using dipolar aprotic solvents.  The great efficacy of this method is a particular advantage in labeling radiopharmaceuticals with [18F]fluorine (t1/2 = 110 min) for positron emission tomog. (PET) imaging, and it is illustrated by the synthesis of four [18F]fluoride-radiolabeled mol. imaging probes - [18F]FDG, [18F]FLT, [18F]FP-CIT, and [18F]FMISO - in high yield and purity and in shorter times compared to conventional syntheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquNXNekSmcFbVg90H21EOLACvtfcHk0liOJ3OmjY2Sxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs73P&md5=3a87d1f61cfe5f9b566f92e3c347a725</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja0646895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0646895%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BW.%26aulast%3DAhn%26aufirst%3DD.-S.%26aulast%3DOh%26aufirst%3DY.-H.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKil%26aufirst%3DH.%2BS.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DRyu%26aufirst%3DJ.%2BS.%26aulast%3DMoon%26aufirst%3DD.%2BH.%26atitle%3DA%2520new%2520class%2520of%2520SN2%2520reactions%2520catalyzed%2520by%2520protic%2520solvents%253A%2520facile%2520fluorination%2520for%2520isotopic%2520labeling%2520of%2520diagnostic%2520molecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D16394%26epage%3D16397%26doi%3D10.1021%2Fja0646895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Improved synthesis of <i>anti</i>-[<sup>18</sup>F] FACBC: improved preparation of labeling precursor and automated radiosynthesis</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1016/S0969-8043(03)00029-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2FS0969-8043%2803%2900029-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=12798374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVGgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=657-666&author=J.+McConathyauthor=R.+J.+Vollauthor=W.+Yuauthor=R.+J.+Croweauthor=M.+M.+Goodman&title=Improved+synthesis+of+anti-%5B18F%5D+FACBC%3A+improved+preparation+of+labeling+precursor+and+automated+radiosynthesis&doi=10.1016%2FS0969-8043%2803%2900029-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis</span></div><div class="casAuthors">McConathy, Jonathan; Voll, Ronald J.; Yu, Weiping; Crowe, Ronald J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-666</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The non-natural amino acid anti-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid (FACBC) has shown promise for tumor imaging with positron emission tomog.  An improved synthesis of the precursor of anti-[18F]FACBC has been devised which demonstrates high stereoselectivity and suitability for large-scale prepns.  An automated radiosynthesis has been developed which provides anti-[18F]FACBC in 24% decay-cor. yield.  Addnl., the major non-radioactive species present in doses of anti-[18F]FACBC has been identified as anti-1-amino-3-hydroxycyclobutane-1-carboxylic acid.  Together, these results are important steps towards the routine prodn. of anti-[18F]FACBC for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSt-lARoXN-bVg90H21EOLACvtfcHk0liOJ3OmjY2Sxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVGgs74%253D&md5=74f4bbe27f432814ee59fc8e75a1e768</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2803%2900029-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252803%252900029-0%26sid%3Dliteratum%253Aachs%26aulast%3DMcConathy%26aufirst%3DJ.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCrowe%26aufirst%3DR.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DImproved%2520synthesis%2520of%2520anti-%255B18F%255D%2520FACBC%253A%2520improved%2520preparation%2520of%2520labeling%2520precursor%2520and%2520automated%2520radiosynthesis%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2003%26volume%3D58%26spage%3D657%26epage%3D666%26doi%3D10.1016%2FS0969-8043%2803%2900029-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, Y.</span></span> <span> </span><span class="NLM_article-title">Comparative evaluation of transport mechanisms of <i>trans</i>-1-amino-3-[<sup>18</sup>F] fluorocyclobutanecarboxylic acid and L-[methyl-<sup>11</sup>C] methionine in human glioma cell lines</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1535</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2013.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2Fj.brainres.2013.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=23994214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVegs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1535&publication_year=2013&pages=24-37&author=M.+Onoauthor=S.+Okaauthor=H.+Okudairaauthor=D.+M.+Schusterauthor=M.+M.+Goodmanauthor=K.+Kawaiauthor=Y.+Shirakami&title=Comparative+evaluation+of+transport+mechanisms+of+trans-1-amino-3-%5B18F%5D+fluorocyclobutanecarboxylic+acid+and+L-%5Bmethyl-11C%5D+methionine+in+human+glioma+cell+lines&doi=10.1016%2Fj.brainres.2013.08.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines</span></div><div class="casAuthors">Ono, Masahiro; Oka, Shuntaro; Okudaira, Hiroyuki; Schuster, David M.; Goodman, Mark M.; Kawai, Keiichi; Shirakami, Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1535</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-37</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) with amino acid tracers is useful for the visualization and assessment of therapeutic effects on gliomas.  Our purpose is to elucidate the transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) and l-[methyl-11C]methionine ([11C]Met) in normal human astrocytes (NHA), low-grade (Hs683, SW1088), and high-grade (U87MG, T98G) human glioma cell lines.  Because the short half-lives of fluorine-18 and carbon-11 are inconvenient for in vitro expts., trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid (anti-[14C]FACBC) and l-[methyl-14C]methionine ([14C]Met) were used instead of the PET tracers.  Time-course uptake expts. showed that uptake of anti-[14C]FACBC was 1.4-2.6 times higher than that of [14C]Met in NHA and low-grade glioma cells, and was almost equal to that of [14C]Met in high-grade glioma cells.  To identify the amino acid transporters (AATs) involved in the transport of anti-[14C]FACBC and [14C]Met, we carried out competitive inhibition expts. using synthetic/naturally-occurring amino acids as inhibitors.  We found that anti-[14C]FACBC uptake in the presence of Na+ was strongly inhibited by l-glutamine and l-serine (the substrates for ASC system AATs), whereas l-phenylalanine and 2-amino-bicyclo[2,2,1]heptane-2-carboxylic acid (BCH, the substrates for L system AATs) robustly inhibited Na+-independent anti-[14C]FACBC uptake.  Regardless of Na+, [14C]Met uptake was inhibited strongly by l-phenylalanine and BCH.  Moreover, the exchange transport activity of l-glutamine for anti-[14C]FACBC was stronger than that of BCH in the presence of Na+, whereas that for [14C]Met was almost equal to BCH.  These results demonstrate that ASC and L are important transport systems for anti-[18F]FACBC uptake, while system L is predominantly involved in [11C]Met transport in human astrocytes and glioma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhTv4ugHG6NbVg90H21EOLACvtfcHk0lidFfjXsfgc5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVegs7rJ&md5=bce14deb59d5deb7986a66342fd3152f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2013.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2013.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DOka%26aufirst%3DS.%26aulast%3DOkudaira%26aufirst%3DH.%26aulast%3DSchuster%26aufirst%3DD.%2BM.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DShirakami%26aufirst%3DY.%26atitle%3DComparative%2520evaluation%2520of%2520transport%2520mechanisms%2520of%2520trans-1-amino-3-%255B18F%255D%2520fluorocyclobutanecarboxylic%2520acid%2520and%2520L-%255Bmethyl-11C%255D%2520methionine%2520in%2520human%2520glioma%2520cell%2520lines%26jtitle%3DBrain%2520Res.%26date%3D2013%26volume%3D1535%26spage%3D24%26epage%3D37%26doi%3D10.1016%2Fj.brainres.2013.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, Y.</span></span> <span> </span><span class="NLM_article-title">Differences in transport mechanisms of <i>trans</i>-1-amino-3-[<sup>18</sup> F] fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[Methyl-<sup>11</sup> C] methionine and 2-deoxy-2-[<sup>18</sup> F] fluoro-D-glucose</span>. <i>Mol. Imaging. Biol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1007/s11307-013-0693-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1007%2Fs11307-013-0693-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=24136390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FntlGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=322-329&author=S.+Okaauthor=H.+Okudairaauthor=M.+Onoauthor=D.+M.+Schusterauthor=M.+M.+Goodmanauthor=K.+Kawaiauthor=Y.+Shirakami&title=Differences+in+transport+mechanisms+of+trans-1-amino-3-%5B18+F%5D+fluorocyclobutanecarboxylic+acid+in+inflammation%2C+prostate+cancer%2C+and+glioma+cells%3A+comparison+with+L-%5BMethyl-11+C%5D+methionine+and+2-deoxy-2-%5B18+F%5D+fluoro-D-glucose&doi=10.1007%2Fs11307-013-0693-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose</span></div><div class="casAuthors">Oka Shuntaro; Okudaira Hiroyuki; Ono Masahiro; Schuster David M; Goodman Mark M; Kawai Keiichi; Shirakami Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">322-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We aimed to elucidate trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid (anti-[(18)F]FACBC) uptake mechanisms in inflammatory and tumor cells, in comparison with those of L-[methyl-(11)C]methionine ([(11)C]Met) and 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG).  PROCEDURES:  Using carbon-14-labeled tracers, in vitro time-course, pH dependence, and competitive inhibition uptake experiments were performed in rat inflammatory (T cells, B cells, granulocytes, macrophages), prostate cancer (MLLB2), and glioma (C6) cells.  RESULTS:  Anti-[(14)C]FACBC uptake ratios of T/B cells to tumor cells were comparable, while those of granulocytes/macrophages to tumor cells were lower than those for [(14)C]FDG.  Over half of anti-[(14)C]FACBC uptake by T/B and tumor cells was mediated by Na(+)-dependent amino acid transporters (system ASC), whereas most [(14)C]Met transport in all cells was mediated by Na(+)-independent carriers (system L).  CONCLUSIONS:  The low anti-[(18)F]FACBC accumulation in granulocytes/macrophages may be advantageous in discriminating inflamed regions from tumors.  The significant anti-[(18)F]FACBC uptake in T/B cells may cause false-positives in some cancer patients who undergo FACBC-positron emission tomography (PET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnAPlPEQnWVxe4jJGKT5N0fW6udTcc2ebl0YSPDRVQ2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FntlGqsw%253D%253D&md5=c71493cad47a55915455a9047d36d22a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0693-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0693-0%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DS.%26aulast%3DOkudaira%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DD.%2BM.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DShirakami%26aufirst%3DY.%26atitle%3DDifferences%2520in%2520transport%2520mechanisms%2520of%2520trans-1-amino-3-%255B18%2520F%255D%2520fluorocyclobutanecarboxylic%2520acid%2520in%2520inflammation%252C%2520prostate%2520cancer%252C%2520and%2520glioma%2520cells%253A%2520comparison%2520with%2520L-%255BMethyl-11%2520C%255D%2520methionine%2520and%25202-deoxy-2-%255B18%2520F%255D%2520fluoro-D-glucose%26jtitle%3DMol.%2520Imaging.%2520Biol%26date%3D2014%26volume%3D16%26spage%3D322%26epage%3D329%26doi%3D10.1007%2Fs11307-013-0693-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arvanitis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">The blood–brain barrier and blood–tumour barrier in brain tumours and metastases</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1038/s41568-019-0205-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1038%2Fs41568-019-0205-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=30532011" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=1-16&author=C.+D.+Arvanitisauthor=G.+B.+Ferraroauthor=R.+K.+Jain&title=The+blood%E2%80%93brain+barrier+and+blood%E2%80%93tumour+barrier+in+brain+tumours+and+metastases&doi=10.1038%2Fs41568-019-0205-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41568-019-0205-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41568-019-0205-x%26sid%3Dliteratum%253Aachs%26aulast%3DArvanitis%26aufirst%3DC.%2BD.%26aulast%3DFerraro%26aufirst%3DG.%2BB.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520blood%25E2%2580%2593tumour%2520barrier%2520in%2520brain%2520tumours%2520and%2520metastases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2019%26spage%3D1%26epage%3D16%26doi%3D10.1038%2Fs41568-019-0205-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Still, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, A.</span></span> <span> </span><span class="NLM_article-title">Rapid chromatographic technique for preparative separations with moderate resolution</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2923</span>– <span class="NLM_lpage">2925</span>, <span class="refDoi"> DOI: 10.1021/jo00408a041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00408a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2923-2925&author=W.+C.+Stillauthor=M.+Kahnauthor=A.+Mitra&title=Rapid+chromatographic+technique+for+preparative+separations+with+moderate+resolution&doi=10.1021%2Fjo00408a041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid chromatographic technique for preparative separations with moderate resolution</span></div><div class="casAuthors">Still, W. Clark; Kahn, Michael; Mitra, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2923-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A simple adsorption chromatog. technique has been developed for rapid (<15 min) sepns.  The technique uses a short (e.g., 5 in.) column of 40-63-μm silica gel and operates at high flow rates (2.0 vertical in./min) to allow the sepn. of multigram quantities of compds. which are resolved on anal. TLC by as little as ΔRf 0.15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsgCIAoC4VbVg90H21EOLACvtfcHk0lidFfjXsfgc5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D&md5=34e721c237babee0665e2f9c6f6a3999</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00408a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00408a041%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DA.%26atitle%3DRapid%2520chromatographic%2520technique%2520for%2520preparative%2520separations%2520with%2520moderate%2520resolution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D2923%26epage%3D2925%26doi%3D10.1021%2Fjo00408a041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">System A amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[<sup>18</sup> F] fluoro-2-methylpropanoic acid and 3-[<sup>18</sup> F] fluoro-2-methyl-2-(methylamino) propanoic acid</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2Fj.nucmedbio.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=25263130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GmsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=8-18&author=W.+Yuauthor=J.+McConathyauthor=J.+J.+Olsonauthor=M.+M.+Goodman&title=System+A+amino+acid+transport-targeted+brain+and+systemic+tumor+PET+imaging+agents+2-amino-3-%5B18+F%5D+fluoro-2-methylpropanoic+acid+and+3-%5B18+F%5D+fluoro-2-methyl-2-%28methylamino%29+propanoic+acid&doi=10.1016%2Fj.nucmedbio.2014.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[18 F]fluoro-2-methylpropanoic acid and 3-[18 F]fluoro-2-methyl-2-(methylamino)propanoic acid</span></div><div class="casAuthors">Yu, Weiping; McConathy, Jonathan; Olson, Jeffrey J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-18</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amino acid based radiotracers target tumor cells through increased uptake by membrane-assocd. amino acid transport (AAT) systems.  In the present study, four structurally related non-natural 18 F-labeled amino acids, (R)- and (S)-[18 F]FAMP 1 and (R)- and (S)-[18 F]MeFAMP 2 have been prepd. and evaluated in vitro and in vivo for their potential utility in brain and systemic tumor imaging based upon primarily system A transport with positron emission tomog. (PET).  The transport of enantiomers of [18 F]FAMP 1 and [18 F]MeFAMP 2 was measured through in vitro uptake assays in human derived cancer cells including A549 (lung), DU145 (prostate), SKOV3 (ovary), MDA MB468 (breast) and U87 (brain) in the presence and absence of amino acid transporter inhibitors.  The in vivo biodistribution of these tracers was evaluated using tumor mice xenografts at 15, 30, 60 and 120 min post injection.  All four tracers showed moderate to high levels of uptake (1-9%ID/5 × 105 cells) by the cancer cell lines tested in vitro.  AAT cell inhibition assays demonstrated that (R)-[18 F]1 and (S)-[18 F]1 entered these tumor cells via mixed AATs, likely but not limited to system A and system L.  In contrast, (R)-[18 F]2 and (S)-[18 F]2 showed high selectivity for system A AAT.  Similar to the results of in vitro cell studies, the tumor uptake of all four tracers was good to high and persisted over the 2 h time course of in vivo studies.  The accumulation of these tracers was higher in tumor than most normal tissues including blood, brain, muscle, bone, heart, and lung, and the tracers with the highest in vitro selectivity for system A AAT generally demonstrated the best tumor imaging properties.  Higher uptake of these tracers was obsd. in the pancreas, kidney and spleen compared to tumors.  These preclin. studies demonstrate good imaging properties in a wide range of tumors for all four amino acids evaluated with (R)-[18 F]2 having the highest selectivity for system A AAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGompJpM4Ru7LbVg90H21EOLACvtfcHk0ljLq1bbezWLlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GmsLrE&md5=f754f9dab45db87c046d372ae1df5892</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMcConathy%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSystem%2520A%2520amino%2520acid%2520transport-targeted%2520brain%2520and%2520systemic%2520tumor%2520PET%2520imaging%2520agents%25202-amino-3-%255B18%2520F%255D%2520fluoro-2-methylpropanoic%2520acid%2520and%25203-%255B18%2520F%255D%2520fluoro-2-methyl-2-%2528methylamino%2529%2520propanoic%2520acid%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2015%26volume%3D42%26spage%3D8%26epage%3D18%26doi%3D10.1016%2Fj.nucmedbio.2014.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malveaux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis and biological evaluation of syn-1-amino-3-[<sup>18</sup>F] fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1982</span>– <span class="NLM_lpage">1990</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2Fj.bmc.2009.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=19216081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1Cjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1982-1990&author=W.+Yuauthor=L.+Williamsauthor=V.+M.+Campauthor=E.+Malveauxauthor=J.+J.+Olsonauthor=M.+M.+Goodman&title=Stereoselective+synthesis+and+biological+evaluation+of+syn-1-amino-3-%5B18F%5D+fluorocyclobutyl-1-carboxylic+acid+as+a+potential+positron+emission+tomography+brain+tumor+imaging+agent&doi=10.1016%2Fj.bmc.2009.01.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent</span></div><div class="casAuthors">Yu, Weiping; Williams, Larry; Camp, Vernon M.; Malveaux, Eugene; Olson, Jeffrey J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1982-1990</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amino acid syn-1-amino-3-fluoro-cyclobutyl-1-carboxylic acid (syn-FACBC) 12, the isomer of anti-FACBC, has been selectively synthesized and [18F] radiofluorinated in 52% decay-cor. yield using no-carrier-added [18F]fluoride.  The key step in the synthesis of the desired isomer involved stereoselective redn. using lithium alkylborohydride/zinc chloride, which improved the ratio of anti-alc. to syn-alc. from 17:83 to 97:3. syn-FACBC 12 entered rat 9L gliosarcoma cells primarily via L-type amino acid transport in vitro with high uptake of 16% injected dose per 5 × 105 cells.  Biodistribution studies in rats with 9L gliosarcoma brain tumors demonstrated high tumor to brain ratio of 12:1 at 30 min post injection.  In this model, amino acid syn-[18F]FACBC 12 is a promising metabolically based radiotracer for positron emission tomog. brain tumor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBf4Eel3lLQbVg90H21EOLACvtfcHk0ljLq1bbezWLlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1Cjurc%253D&md5=11350a8e2967cf3304fc831c6322c884</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DMalveaux%26aufirst%3DE.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DStereoselective%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520syn-1-amino-3-%255B18F%255D%2520fluorocyclobutyl-1-carboxylic%2520acid%2520as%2520a%2520potential%2520positron%2520emission%2520tomography%2520brain%2520tumor%2520imaging%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1982%26epage%3D1990%26doi%3D10.1016%2Fj.bmc.2009.01.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoup, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votaw, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshima, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshima, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stabin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votaw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of [<sup>18</sup>F] 1-amino-3-fluorocyclobutane 1-carboxylic acid to image brain tumors</span>. <i>Therapy</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=2&author=T.+M.+Shoupauthor=J.+Olsonauthor=J.+M.+Hoffmanauthor=J.+Votawauthor=D.+Eshimaauthor=L.+Eshimaauthor=V.+M.+Campauthor=M.+Stabinauthor=D.+Votawauthor=M.+M.+Goodman&title=Synthesis+and+evaluation+of+%5B18F%5D+1-amino-3-fluorocyclobutane+1-carboxylic+acid+to+image+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoup%26aufirst%3DT.%2BM.%26aulast%3DOlson%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DJ.%2BM.%26aulast%3DVotaw%26aufirst%3DJ.%26aulast%3DEshima%26aufirst%3DD.%26aulast%3DEshima%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DStabin%26aufirst%3DM.%26aulast%3DVotaw%26aufirst%3DD.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B18F%255D%25201-amino-3-fluorocyclobutane%25201-carboxylic%2520acid%2520to%2520image%2520brain%2520tumors%26jtitle%3DTherapy%26date%3D1999%26volume%3D1%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malveaux, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, radiolabeling, and biological evaluation of (<i>R</i>)-and (<i>S</i>)-2-amino-3-[<sup>18</sup>F] fluoro-2-methylpropanoic acid (FAMP) and (<i>R</i>)-and (<i>S</i>)-3-[<sup>18</sup>F] fluoro-2-methyl-2-N-(methylamino) propanoic acid (<i>N</i> MeFAMP) as potential PET radioligands for imaging brain tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1021/jm900556s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900556s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2jsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=876-886&author=W.+Yuauthor=J.+McConathyauthor=L.+Williamsauthor=V.+M.+Campauthor=E.+J.+Malveauxauthor=Z.+Zhangauthor=J.+J.+Olsonauthor=M.+M.+Goodman&title=Synthesis%2C+radiolabeling%2C+and+biological+evaluation+of+%28R%29-and+%28S%29-2-amino-3-%5B18F%5D+fluoro-2-methylpropanoic+acid+%28FAMP%29+and+%28R%29-and+%28S%29-3-%5B18F%5D+fluoro-2-methyl-2-N-%28methylamino%29+propanoic+acid+%28N+MeFAMP%29+as+potential+PET+radioligands+for+imaging+brain+tumors&doi=10.1021%2Fjm900556s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-3-[18F]Fluoro-2-Methylpropanoic Acid (FAMP) and (R)- and (S)-3-[18F]Fluoro-2-Methyl-2-N-(Methylamino)propanoic Acid (NMeFAMP) as Potential PET Radioligands for Imaging Brain Tumors</span></div><div class="casAuthors">Yu, Weiping; McConathy, Jonathan; Williams, Larry; Camp, Vernon M.; Malveaux, Eugene J.; Zhang, Zhaobin; Olson, Jeffrey J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">876-886</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The non-natural amino acids (R)- and (S)-2-amino-3-fluoro-2-methylpropanoic acid 5 and (R)- and (S)-3-fluoro-2-methyl-2-N-(methylamino)propanoic acid 8 were synthesized in shorter reaction sequences than in the original report starting from enantiomerically pure (S)- and (R)-α-methyl-serine, resp.  The reaction sequence provided the cyclic sulfamidate precursors for radiosynthesis of (R)- and (S)-[18F]5 and (R)- and (S)-[18F]8 in fewer steps than in the original report.  (R)- and (S)-[18F]5 and(R)- and (S)-[18F]8 were synthesized by no-carrier-added nucleophilic [18F]fluorination in 52-66% decay-cor. yields with radiochem. purity over 99%.  The cell assays showed that all four compds. were substrates for amino acid transport and enter 9L rat gliosarcoma cells in vitro at least in part by system A amino acid transport.  The biodistribution studies demonstrated that in vivo tumor to normal brain ratios for all compds. were high with ratios of 20:1 to 115:1 in rats with intracranial 9L tumors.  The (R)-enantiomers of [18F]5 and [18F]8 demonstrated higher tumor uptake in vivo compared to the (S)-enantiomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz2oCzWet68rVg90H21EOLACvtfcHk0ljii6I2OMT2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2jsrvK&md5=09654549414a136109767db7e2c44398</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm900556s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900556s%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMcConathy%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DMalveaux%26aufirst%3DE.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSynthesis%252C%2520radiolabeling%252C%2520and%2520biological%2520evaluation%2520of%2520%2528R%2529-and%2520%2528S%2529-2-amino-3-%255B18F%255D%2520fluoro-2-methylpropanoic%2520acid%2520%2528FAMP%2529%2520and%2520%2528R%2529-and%2520%2528S%2529-3-%255B18F%255D%2520fluoro-2-methyl-2-N-%2528methylamino%2529%2520propanoic%2520acid%2520%2528N%2520MeFAMP%2529%2520as%2520potential%2520PET%2520radioligands%2520for%2520imaging%2520brain%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D876%26epage%3D886%26doi%3D10.1021%2Fjm900556s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pippin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Radiochemical synthesis and evaluation of <sup>13</sup>N-labeled 5-aminolevulinic acid for PET imaging of gliomas</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1236-1240&author=A.+B.+Pippinauthor=R.+J.+Vollauthor=Y.+Liauthor=H.+Wuauthor=H.+Maoauthor=M.+M.+Goodman&title=Radiochemical+synthesis+and+evaluation+of+13N-labeled+5-aminolevulinic+acid+for+PET+imaging+of+gliomas&doi=10.1021%2Facsmedchemlett.7b00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical Synthesis and Evaluation of 13N-Labeled 5-Aminolevulinic Acid for PET Imaging of Gliomas</span></div><div class="casAuthors">Pippin, Adam B.; Voll, Ronald J.; Li, Yuancheng; Wu, Hui; Mao, Hui; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1236-1240</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The endogenous amino acid, 5-aminolevulinic acid (5-ALA), has received significant attention as an imaging agent, including ongoing clin. trials for image-guided tumor resection due to its selective uptake and subsequent accumulation of the fluorescent protoporphyrin IX in tumor cells.  Based on the widely reported selectivity of 5-ALA, a new positron emission tomog. imaging probe was developed by reacting Me 5-bromolevulinate with [13N] ammonia.  The radiotracer, [13N] 5-ALA, was produced in high radiochem. yield (65%) in 10 min and could be purified using only solid phase cartridges.  In vivo testing in rats bearing intracranial 9L glioblastoma showed peak tumor uptake occurred within 10 min of radiotracer administration.  Immunohistochem. staining and fluorescent imaging was used to confirm the tumor location and accumulation of the tracer seen from the PET images.  The quick synthesis and rapid tumor specific uptake of [13N] 5-ALA makes it a potential novel clin. applicable radiotracer for detecting and monitoring tumors noninvasively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAdh-MNQRQB7Vg90H21EOLACvtfcHk0ljii6I2OMT2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvP&md5=ffcad09317343b9a8feb9c3ac41535b0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00311%26sid%3Dliteratum%253Aachs%26aulast%3DPippin%26aufirst%3DA.%2BB.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DRadiochemical%2520synthesis%2520and%2520evaluation%2520of%252013N-labeled%25205-aminolevulinic%2520acid%2520for%2520PET%2520imaging%2520of%2520gliomas%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1236%26epage%3D1240%26doi%3D10.1021%2Facsmedchemlett.7b00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Thomas C. Pickel, Gouthami Pashikanti, Ronald J. Voll, Weiping Yu, Zhaobin Zhang, Jonathon A. Nye, John Bacsa, Jeffrey J. Olson, Lanny S. Liebeskind, <span class="NLM_string-name hlFld-ContribAuthor">Mark M. Goodman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Radiolabeling, and Biological Evaluation of the trans-Stereoisomers of 1-Amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (3)
                                     , 1195-1203. <a href="https://doi.org/10.1021/acsptsci.1c00062" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00062%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DSynthesis%25252C%252BRadiolabeling%25252C%252Band%252BBiological%252BEvaluation%252Bof%252Bthe%252Btrans-Stereoisomers%252Bof%252B1-Amino-3-%252528fluoro-18F%252529-4-fluorocyclopentane-1-carboxylic%252BAcid%252Bas%252BPET%252BImaging%252BAgents%26aulast%3DPickel%26aufirst%3DThomas%2BC.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25022021%26date%3D05042021%26volume%3D4%26issue%3D3%26spage%3D1195%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of <b>9.</b> Atom labels are as follows: white = hydrogen, black = carbon, red = oxygen, blue = nitrogen, light green = fluorine, and dark green = chlorine. CCDC: 2024890.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>anti</i>-<i>cis</i>-3,4-DFACPC Cold Standard (<b>9</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Boc Fluorohydrin (<b>12</b>) from <i>N</i>-Benzamide Fluorohydrin (<b>9</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Triflate Precursor (<b>19</b>) to <b>[<sup>18</sup>F]9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Failed Route to <i>syn</i>-<i>cis</i>-3,4-DFACPC</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <i>syn</i>-<i>cis</i>-3,4-DFACPC (<b>28</b>). Atom labels are as follows: white = hydrogen, black = carbon, red = oxygen, blue = nitrogen, light green = fluorine, and dark green = chlorine. CCDC: 2024887.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>syn</i>-<i>cis</i>-3,4-DFACPC (<b>28</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>[<sup>18</sup>F]9</b> (<i>anti</i>-<i>cis</i>-3,4-[<sup>18</sup>F]-DFACPC)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>[<sup>18</sup>F]28</b> (<i>syn</i>-<i>cis</i>-3,4-[<sup>18</sup>F]-DFACPC)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative PET image acquired with <b>[<sup>18</sup>F]9, s</b>ummed from 30–60 min post injection. Activity is expressed in standard uptake values (SUV).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/medium/jm0c01302_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative PET image acquired with <b>[<sup>18</sup>F]28, s</b>ummed from 30–60 min post injection. Activity is expressed in standard uptake values (SUV).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-20/acs.jmedchem.0c01302/20201019/images/large/jm0c01302_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01302&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography imaging of cancer biology: current status and future prospects</span>. <i>Semin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1053/j.seminoncol.2010.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1053%2Fj.seminoncol.2010.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=21362517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC3M3jtVSlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=70-86&author=K.+Chenauthor=X.+Chen&title=Positron+emission+tomography+imaging+of+cancer+biology%3A+current+status+and+future+prospects&doi=10.1053%2Fj.seminoncol.2010.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography imaging of cancer biology: current status and future prospects</span></div><div class="casAuthors">Chen Kai; Chen Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Positron emission tomography (PET) is one of the most rapidly growing areas of medical imaging, with many applications in the clinical management of patients with cancer.  The principal goal of PET imaging is to visualize, characterize, and measure biological processes at the cellular, subcellular, and molecular levels in living subjects using noninvasive procedures.  PET imaging takes advantage of the traditional diagnostic imaging techniques and introduces positron-emitting probes to determine the expression of indicative molecular targets at different stages of cancer progression.  Although [(18)F]fluorodeoxyglucose ([(18)F]FDG)-PET has been widely utilized for staging and restaging of cancer, evaluation of response to treatment, differentiation of post-therapy alterations from residual or recurrent tumor, and assessment of prognosis, [(18)F]FDG is not a target-specific PET tracer.  Over the last decade, numerous target-specific PET tracers have been developed and evaluated in preclinical and clinical studies.  This review provides an overview of the current status and trends in the development of non-[(18)F]FDG PET probes in oncology and their application in the investigation of cancer biology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAGONGFVJZmzToTC3aBaesfW6udTcc2eZTs0Sm0n_CQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3jtVSlsg%253D%253D&md5=04fa5dbe375a168456211153d2ed29ee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2010.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2010.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DPositron%2520emission%2520tomography%2520imaging%2520of%2520cancer%2520biology%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DSemin.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3D70%26epage%3D86%26doi%3D10.1053%2Fj.seminoncol.2010.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilien, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grafton, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bading, J. R.</span></span> <span> </span><span class="NLM_article-title">PET and [<sup>18</sup>F]-FDG in oncology: a clinical update</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1016/0969-8051(96)00074-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2F0969-8051%2896%2900074-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=8940714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADyaK2s%252FpsFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=717-735&author=P.+S.+Contiauthor=D.+L.+Lilienauthor=K.+Hawleyauthor=J.+Kepplerauthor=S.+T.+Graftonauthor=J.+R.+Bading&title=PET+and+%5B18F%5D-FDG+in+oncology%3A+a+clinical+update&doi=10.1016%2F0969-8051%2896%2900074-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PET and [18F]-FDG in oncology: a clinical update</span></div><div class="casAuthors">Conti P S; Lilien D L; Hawley K; Keppler J; Grafton S T; Bading J R</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine and biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">717-35</span>
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    </div><div class="casAbstract">Positron emission tomography (PET) has become a very useful adjunct to anatomic imaging techniques, adding unique information to the characterization of disease.  The whole-body PET FDG technique developed over the last few years has surpassed most expectations with respect to its utility in clinical oncology.  The large spectrum of neoplasms that now can be studied with this approach makes it an essential clinical imaging tool in diagnosis and management for many patients with cancer.  The metabolic information provided by this technique is complementary to results from standard clinical and morphological examinations.  It may be anticipated that through application of the multi-modality imaging approach, significant advances in medical care will come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnIJlXbpBSxkNHe_gFldTbfW6udTcc2eb3uSEDxYTTAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FpsFersw%253D%253D&md5=a4694fe552d570b4cb91969efdb75441</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2896%2900074-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252896%252900074-1%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DP.%2BS.%26aulast%3DLilien%26aufirst%3DD.%2BL.%26aulast%3DHawley%26aufirst%3DK.%26aulast%3DKeppler%26aufirst%3DJ.%26aulast%3DGrafton%26aufirst%3DS.%2BT.%26aulast%3DBading%26aufirst%3DJ.%2BR.%26atitle%3DPET%2520and%2520%255B18F%255D-FDG%2520in%2520oncology%253A%2520a%2520clinical%2520update%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1996%26volume%3D23%26spage%3D717%26epage%3D735%26doi%3D10.1016%2F0969-8051%2896%2900074-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelloff, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shaughnessy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyton, K. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankoff, D. A.</span></span> <span> </span><span class="NLM_article-title">Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2808</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-2626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1158%2F1078-0432.CCR-04-2626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=15837727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2785-2808&author=G.+J.+Kelloffauthor=J.+M.+Hoffmanauthor=B.+Johnsonauthor=H.+I.+Scherauthor=B.+A.+Siegelauthor=E.+Y.+Chengauthor=B.+D.+Chesonauthor=J.+O%E2%80%99Shaughnessyauthor=K.+Z.+Guytonauthor=D.+A.+Mankoff&title=Progress+and+promise+of+FDG-PET+imaging+for+cancer+patient+management+and+oncologic+drug+development&doi=10.1158%2F1078-0432.CCR-04-2626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development</span></div><div class="casAuthors">Kelloff, Gary J.; Hoffman, John M.; Johnson, Bruce; Scher, Howard I.; Siegel, Barry A.; Cheng, Edward Y.; Cheson, Bruce D.; O'Shaughnessy, Joyce; Guyton, Kathryn Z.; Mankoff, David A.; Shankar, Lalitha; Larson, Steven M.; Sigman, Caroline C.; Schilsky, Richard L.; Sullivan, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2785-2808</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  2-[18F]Fluoro-2-deoxyglucose positron emission tomog. (FDG-PET) assesses a fundamental property of neoplasia, the Warburg effect.  This mol. imaging technique offers a complementary approach to anat. imaging that is more sensitive and specific in certain cancers.  FDG-PET has been widely applied in oncol. primarily as a staging and restaging tool that can guide patient care.  However, because it accurately detects recurrent or residual disease, FDG-PET also has significant potential for assessing therapy response.  In this regard, it can improve patient management by identifying responders early, before tumor size is reduced; nonresponders could discontinue futile therapy.  Moreover, a redn. in the FDG-PET signal within days or weeks of initiating therapy (e.g., in lymphoma, non-small cell lung, and esophageal cancer) significantly correlates with prolonged survival and other clin. end points now used in drug approvals.  These findings suggest that FDG-PET could facilitate drug development as an early surrogate of clin. benefit.  This article reviews the scientific basis of FDG-PET and its development and application as a valuable oncol. imaging tool.  Its potential to facilitate drug development in seven oncol. settings (lung, lymphoma, breast, prostate, sarcoma, colorectal, and ovary) is addressed.  Recommendations include initial validation against approved therapies, retrospective analyses to define the magnitude of change indicative of response, further prospective validation as a surrogate of clin. benefit, and application as a phase II/III trial end point to accelerate evaluation and approval of novel regimens and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPazHqWsA0srVg90H21EOLACvtfcHk0lhT7uQU436XzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejsbY%253D&md5=21f119abac76df4a875dd570bb459af8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2626%26sid%3Dliteratum%253Aachs%26aulast%3DKelloff%26aufirst%3DG.%2BJ.%26aulast%3DHoffman%26aufirst%3DJ.%2BM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DSiegel%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DE.%2BY.%26aulast%3DCheson%26aufirst%3DB.%2BD.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DJ.%26aulast%3DGuyton%26aufirst%3DK.%2BZ.%26aulast%3DMankoff%26aufirst%3DD.%2BA.%26atitle%3DProgress%2520and%2520promise%2520of%2520FDG-PET%2520imaging%2520for%2520cancer%2520patient%2520management%2520and%2520oncologic%2520drug%2520development%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2785%26epage%3D2808%26doi%3D10.1158%2F1078-0432.CCR-04-2626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barentsz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudkerk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mali, W.</span></span> <span> </span><span class="NLM_article-title">Commonly used imaging techniques for diagnosis and staging</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3234</span>– <span class="NLM_lpage">3244</span>, <span class="refDoi"> DOI: 10.1200/JCO.2006.06.5946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1200%2FJCO.2006.06.5946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=16829647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1yiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=3234-3244&author=J.+Barentszauthor=S.+Takahashiauthor=W.+Oyenauthor=R.+Musauthor=P.+De+Mulderauthor=R.+Reznekauthor=M.+Oudkerkauthor=W.+Mali&title=Commonly+used+imaging+techniques+for+diagnosis+and+staging&doi=10.1200%2FJCO.2006.06.5946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Commonly used imaging techniques for diagnosis and staging</span></div><div class="casAuthors">Barentsz, Jelle; Takahashi, Satoru; Oyen, Wim; Mus, Roel; De Mulder, Pieter; Reznek, Rodney; Oudkerk, Matthijs; Mali, Wim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3234-3244</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Imaging plays a vital role in the management of patients with cancer.  Not only is it important for diagnosis, indicating sites of abnormality, and guiding biopsies, but it is also crucial in assessing disease extent and thereby detg. treatment.  In this review, conventional imaging techniques such as ultrasound, computed tomog., magnetic resonance imaging, and [18F]fluorodeoxyglucose-positron emission tomog. are described, with attention to their mechanisms of action, and their strengths and weaknesses in diagnosis and staging of tumors.  New developments are addressed and radiation safety issues are highlighted.  In addn., we describe current and expected future uses of imaging techniques in oncol.  Given that each technique has its inherent strengths and weaknesses, the combination of the methods will result in improved diagnosis, staging, and treatment prediction and monitoring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnLV4WFVwpbVg90H21EOLACvtfcHk0ljixQSqJHmGfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1yiu7c%253D&md5=eed2539d199114b4015310f0df382c88</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.06.5946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.06.5946%26sid%3Dliteratum%253Aachs%26aulast%3DBarentsz%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DOyen%26aufirst%3DW.%26aulast%3DMus%26aufirst%3DR.%26aulast%3DDe%2BMulder%26aufirst%3DP.%26aulast%3DReznek%26aufirst%3DR.%26aulast%3DOudkerk%26aufirst%3DM.%26aulast%3DMali%26aufirst%3DW.%26atitle%3DCommonly%2520used%2520imaging%2520techniques%2520for%2520diagnosis%2520and%2520staging%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D3234%26epage%3D3244%26doi%3D10.1200%2FJCO.2006.06.5946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCready, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguignon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maziere, B.</span></span> <span> </span><span class="NLM_article-title">FDG accumulation and tumor biology</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1016/S0969-8051(97)00226-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2FS0969-8051%2897%2900226-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=9639291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1cXjtV2ksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=317-322&author=E.+Pauwelsauthor=M.+Ribeiroauthor=J.+Stootauthor=V.+McCreadyauthor=M.+Bourguignonauthor=B.+Maziere&title=FDG+accumulation+and+tumor+biology&doi=10.1016%2FS0969-8051%2897%2900226-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FDG accumulation and tumor biology</span></div><div class="casAuthors">Pauwels, E. K. J.; Ribeiro, M. J.; Stoot, J. H. M. B.; Mccready, V. R.; Bourguignon, M.; Maziere, B.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-322</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 54 refs.  The tumoral uptake of fluorine-18-deoxyglucose (FDG) is based upon enhanced glycolysis.  Following injection, FDG is phosphorylated and trapped intracellularly.  An important mechanism to transport FDG into the transformed cell is based upon the action of glucose transporter proteins; furthermore, highly active hexokinase bound to tumor mitochondria helps to trap FDG into the cell.  In addn., enhanced FDG uptake may be due to relative hypoxia in tumor masses, which activates the anaerobic glycolytic pathway.  In spite of these processes, FDG uptake is relatively aspecific since all living cells need glucose.  Clin. use is therefore recommended in carefully selected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokP4a7X2C8AbVg90H21EOLACvtfcHk0ljixQSqJHmGfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtV2ksbo%253D&md5=58f882cdf05fe58e66a825f4586e5341</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2897%2900226-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252897%252900226-6%26sid%3Dliteratum%253Aachs%26aulast%3DPauwels%26aufirst%3DE.%26aulast%3DRibeiro%26aufirst%3DM.%26aulast%3DStoot%26aufirst%3DJ.%26aulast%3DMcCready%26aufirst%3DV.%26aulast%3DBourguignon%26aufirst%3DM.%26aulast%3DMaziere%26aufirst%3DB.%26atitle%3DFDG%2520accumulation%2520and%2520tumor%2520biology%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1998%26volume%3D25%26spage%3D317%26epage%3D322%26doi%3D10.1016%2FS0969-8051%2897%2900226-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhajosula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solnes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhajosula, B.</span></span> <span> </span><span class="NLM_article-title">A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?</span>. <i>Semin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1053/j.semnuclmed.2011.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1053%2Fj.semnuclmed.2011.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=21624560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC3MrmtFKrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=246-264&author=S.+Vallabhajosulaauthor=L.+Solnesauthor=B.+Vallabhajosula&title=A+broad+overview+of+positron+emission+tomography+radiopharmaceuticals+and+clinical+applications%3A+what+is+new%3F&doi=10.1053%2Fj.semnuclmed.2011.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?</span></div><div class="casAuthors">Vallabhajosula Shankar; Solnes Lilja; Vallabhajosula Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">246-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Positron emission tomography (PET)/computed tomography (CT) is a rapidly expanding imaging modality, thanks to the availability of compact medical cyclotrons and automated chemistry synthesis modules for the production of PET radiopharmaceuticals.  Despite the availability of many radiotracers, [(18)F]fluorodeoxyglucose (FDG) is currently the most widely used radiopharmaceutical in PET, and the field of molecular imaging is anxiously awaiting the introduction of new PET radiopharmaceuticals for routine clinical use.  During the last five years, several proprietary PET radiopharmaceuticals have been developed by major companies, and these new agents are in different stages of clinical evaluation.  These new PET drugs are designed for imaging brain beta amyloid, myocardial perfusion, amino acid transport, angiogenesis, and tumor antigen expression.  In addition, the National Cancer Institute, Society of Nuclear Medicine Clinical Trials Network, and the American College of Radiology Imaging Network have been conducting multicenter clinical trials with several nonproprietary PET drugs such as sodium [(18)F]fluoride, [(18)F]fluorothymidine, [(18)F]fluoromisonidazole, and (64)Cu-labeled diacetyl-bis (N(4)-methylthiosemicarbazone.  All new PET radiopharmaceuticals, like any other drugs, must be manufactured under current good manufacturing practices as required by the Food and Drug Administration before clinical evaluation (phases I, II, and III) and submission of new drug application.  This review briefly describes the chemistry, mechanisms(s) of localization, and clinical application of both proprietary and nonproprietary new PET drugs under multicenter clinical evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSx0TQEvkbtqmHOrQ6qeX-mfW6udTcc2ebi9iWr5pVmdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrmtFKrsQ%253D%253D&md5=54f2b8a6143405e6bdac4a8360aefec9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2011.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2011.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhajosula%26aufirst%3DS.%26aulast%3DSolnes%26aufirst%3DL.%26aulast%3DVallabhajosula%26aufirst%3DB.%26atitle%3DA%2520broad%2520overview%2520of%2520positron%2520emission%2520tomography%2520radiopharmaceuticals%2520and%2520clinical%2520applications%253A%2520what%2520is%2520new%253F%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D41%26spage%3D246%26epage%3D264%26doi%3D10.1053%2Fj.semnuclmed.2011.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jager, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaalburg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langen, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piers, D. A.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled amino acids: basic aspects and clinical applications in oncology</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=11337520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFOqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=432-445&author=P.+L.+Jagerauthor=W.+Vaalburgauthor=J.+Pruimauthor=E.+G.+de+Vriesauthor=K.-J.+Langenauthor=D.+A.+Piers&title=Radiolabeled+amino+acids%3A+basic+aspects+and+clinical+applications+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled amino acids: basic aspects and clinical applications in oncology</span></div><div class="casAuthors">Jager, Pieter L.; Vaalburg, Willem; Pruim, Jan; De Vries, Elisabeth G. E.; Langen, Karl-Josef; Piers, D. Albertus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">432-445</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  As the applications of metabolic imaging are expanding, radiolabeled amino acids may gain increased clin. interest.  This review first describes the basic aspects of amino acid metab., then continues with basic aspects of radiolabeled amino acids, and finally describes clin. applications, with an emphasis on diagnostic value.  A special focus is on 11C-methionine, 11C-tyrosine, and 123I-iodomethyltyrosine, because these have been most used clin., although their common affinity for the L-transport systems may limit generalization to other classes of amino acids.  The theoretic and preclin. background of amino acid imaging is sound and supports clin. applications.  The fact that amino acid imaging is less influenced by inflammation may be advantageous in comparison with 18F-FDG PET imaging, although tumor specificity is not abs.  In brain tumor imaging, the use of radiolabeled amino acids is established, the diagnostic accuracy of amino acid imaging seems adequate, and the diagnostic value seems advantageous.  The general feasibility of amino acid imaging in other tumor types has sufficiently been shown, but more research is required in larger patient series and in well-defined clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjW7aS26BMpLVg90H21EOLACvtfcHk0lgaF0poSqIpZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFOqt7k%253D&md5=38a3cae2a881bc7b4eee0d6d44521ab2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJager%26aufirst%3DP.%2BL.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3DPruim%26aufirst%3DJ.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%26aulast%3DLangen%26aufirst%3DK.-J.%26aulast%3DPiers%26aufirst%3DD.%2BA.%26atitle%3DRadiolabeled%2520amino%2520acids%253A%2520basic%2520aspects%2520and%2520clinical%2520applications%2520in%2520oncology%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D432%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled amino acids for oncologic imaging</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.2967/jnumed.112.113100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.2967%2Fjnumed.112.113100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=23708197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Witr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1007-1010&author=C.+Huangauthor=J.+McConathy&title=Radiolabeled+amino+acids+for+oncologic+imaging&doi=10.2967%2Fjnumed.112.113100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled amino acids for oncologic imaging</span></div><div class="casAuthors">Huang, Chaofeng; McConathy, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">A review.  Radiolabeled amino acids (AAs) are an important class of imaging agents for PET and SPECT that target the increased levels of AA transport by many tumor cells.  System L AA transport has been a major focus of tracer development, and work in this field has led to several tracers that are effective for imaging brain tumors.  Emerging data also support the use of certain radiolabeled Ms for neuroendocrine tumors and prostate cancer.  Recently, new 18F-labeled AAs have been developed that target transporters other than system L, including system A, glutamine, xCT, and cationic AA transporters.  This review provides an overview of this class of mol. imaging agents and highlights the current status of oncol. imaging with radiolabeled AAs in terms of tracer considerations and key clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquSsTwSABzP7Vg90H21EOLACvtfcHk0lgaF0poSqIpZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Witr%252FK&md5=31c0e6c7273ebe4e956a7f51ffb9b283</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.113100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.113100%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcConathy%26aufirst%3DJ.%26atitle%3DRadiolabeled%2520amino%2520acids%2520for%2520oncologic%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1007%26epage%3D1010%26doi%3D10.2967%2Fjnumed.112.113100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, H. N.</span></span> <span> </span><span class="NLM_article-title">Role of amino acid transport and countertransport in nutrition and metabolism</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1152/physrev.1990.70.1.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1152%2Fphysrev.1990.70.1.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=2404290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK3cXpsF2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1990&pages=43-77&author=H.+N.+Christensen&title=Role+of+amino+acid+transport+and+countertransport+in+nutrition+and+metabolism&doi=10.1152%2Fphysrev.1990.70.1.43"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Role of amino acid transport and countertransport in nutrition and metabolism</span></div><div class="casAuthors">Christensen, Halvor N.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-77</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    </div><div class="casAbstract">A review with 195 refs., on general aspects of amino acid transport (specificity, interaction between transport systems), and factors that detn. amino acid flow among tissues including dietary influences on brain nutrition by amino acids and maternofetal transport of amino acids.  The question of attenuation of transcription as a basis for regulation of amino acid transport across biomembranes is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgX3LhFUAyjbVg90H21EOLACvtfcHk0lgaF0poSqIpZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXpsF2hsQ%253D%253D&md5=f0a0ab8f5a91504173f321c7238d497c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1990.70.1.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1990.70.1.43%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DH.%2BN.%26atitle%3DRole%2520of%2520amino%2520acid%2520transport%2520and%2520countertransport%2520in%2520nutrition%2520and%2520metabolism%26jtitle%3DPhysiol.%2520Rev.%26date%3D1990%26volume%3D70%26spage%3D43%26epage%3D77%26doi%3D10.1152%2Fphysrev.1990.70.1.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boado, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardridge, W. M.</span></span> <span> </span><span class="NLM_article-title">Selective expression of the large neutral amino acid transporter at the blood–brain barrier</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">12079</span>– <span class="NLM_lpage">12084</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.21.12079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1073%2Fpnas.96.21.12079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10518579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVGjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12079-12084&author=R.+J.+Boadoauthor=J.+Y.+Liauthor=M.+Nagayaauthor=C.+Zhangauthor=W.+M.+Pardridge&title=Selective+expression+of+the+large+neutral+amino+acid+transporter+at+the+blood%E2%80%93brain+barrier&doi=10.1073%2Fpnas.96.21.12079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Selective expression of the large neutral amino acid transporter at the blood-brain barrier</span></div><div class="casAuthors">Boado, Ruben J.; Li, Jian Yi; Nagaya, Marie; Zhang, Crystal; Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12079-12084</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amino acid supply in brain is regulated by the activity of the large neutral amino acid transporter (LAT) at the brain capillary endothelial cell, which forms the blood-brain barrier (BBB) in vivo.  Bovine BBB poly(A)+ RNA was isolated from 2.0 kg of fresh bovine brain and size fractionated on a sucrose d. gradient, and a size-fractionated bovine BBB cDNA library in the pSPORT vector was prepd.  The full-length cDNA encoding the bovine BBB LAT was isolated from this library, and the predicted amino acid sequence was 89-92% identical to the LAT1 isoform.  The bovine BBB LAT1 mRNA produced a 10-fold enhancement in tryptophan transport into frog oocytes coinjected with bovine BBB LAT1 mRNA and the mRNA for 4F2hc, which encodes the heavy chain of the heterodimer.  Tryptophan transport into the mRNA-injected oocytes was sodium independent and was specifically inhibited by other large neutral amino acids, and the Km of tryptophan transport was 31.5 ± 5.5 μM.  Northern blotting with the bovine BBB LAT1 cDNA showed that the LAT1 mRNA is 100-fold higher in isolated bovine brain capillaries compared with C6 rat glioma cells or rat brain, and the LAT1 mRNA was not detected in rat liver, heart, lung, or kidney.  These studies show that the LAT1 transcript is selectively expressed at the BBB compared with other tissues, and the abundance of the LAT1 mRNA at the BBB is many-fold higher than that of transcripts such as the 4F2hc antigen, actin, or the Glut1 glucose transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT5sHBGe-IgrVg90H21EOLACvtfcHk0lhDPQEieZmIqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVGjtrw%253D&md5=ea63480977562f0ac0f4b9f7d20726c2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.21.12079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.21.12079%26sid%3Dliteratum%253Aachs%26aulast%3DBoado%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DNagaya%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DSelective%2520expression%2520of%2520the%2520large%2520neutral%2520amino%2520acid%2520transporter%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D96%26spage%3D12079%26epage%3D12084%26doi%3D10.1073%2Fpnas.96.21.12079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massager, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandesteene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levivier, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of <sup>18</sup>F-FDG and <sup>11</sup>C-methionine for PET-guided stereotactic brain biopsy of gliomas</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=15299051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFSmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1293-1298&author=B.+Pirotteauthor=S.+Goldmanauthor=N.+Massagerauthor=P.+Davidauthor=D.+Wiklerauthor=A.+Vandesteeneauthor=I.+Salmonauthor=J.+Brotchiauthor=M.+Levivier&title=Comparison+of+18F-FDG+and+11C-methionine+for+PET-guided+stereotactic+brain+biopsy+of+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas</span></div><div class="casAuthors">Pirotte, Benoit; Goldman, Serge; Massager, Nicolas; David, Philippe; Wikler, David; Vandesteene, Arlette; Salmon, Isabelle; Brotchi, Jacques; Levivier, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1293-1298</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">We compared the contributions of the labeled tracers 11C-methionine (Met) and 18F-FDG for PET-guided stereotactic biopsy of brain gliomas.  Methods: In 32 patients with glioma, stereotactic Met PET and 18F-FDG PET were integrated in the planning of stereotactic brain biopsy.  PET images were analyzed to det. which tracer offered the best information for target definition.  The stereotactic coregistration of PET images allowed accurate comparison of the level, distribution, and extent of uptake for both tracers according to tumor location and grade.  Results: A histol. diagnosis was obtained for all patients.  All gliomas had an area of abnormal Met uptake, and 27 showed abnormal 18F-FDG uptake.  18F-FDG was used for target selection when its uptake was higher in tumor than in gray matter (14 gliomas).  Seven were in the basal ganglia or brain stem.  Met was used for target selection when there was no 18F-FDG uptake or when 18F-FDG uptake was equiv. to that in the gray matter (18 gliomas).  Thirteen were in the cortex.  Sixty-one of the 70 stereotactic trajectories obtained from the 32 patients were based on PET-defined targets and had an area of abnormal Met uptake.  These 61 Met-pos. trajectories always yielded a diagnosis of tumor.  All nondiagnostic trajectories (n = 9) were obtained in areas with no increased uptake of Met.  In all patients with increased uptake of both tracers, the focus of highest Met uptake corresponded to the focus of highest 18F-FDG uptake.  However, the extent of uptake of both tracers was variable.  Conclusion: Distributions of highest Met and 18F-FDG uptake are similar in brain gliomas.  Because Met provides a more sensitive signal, it is the mol. of choice for single-tracer PET-guided neurosurgical procedures in gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmcL6JafqJOLVg90H21EOLACvtfcHk0lhDPQEieZmIqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFSmur0%253D&md5=6ff4c7e981a979f8daac1bb73904cf6b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DGoldman%26aufirst%3DS.%26aulast%3DMassager%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DP.%26aulast%3DWikler%26aufirst%3DD.%26aulast%3DVandesteene%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DI.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DLevivier%26aufirst%3DM.%26atitle%3DComparison%2520of%252018F-FDG%2520and%252011C-methionine%2520for%2520PET-guided%2520stereotactic%2520brain%2520biopsy%2520of%2520gliomas%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D45%26spage%3D1293%26epage%3D1298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palanichamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, A.</span></span> <span> </span><span class="NLM_article-title">Diagnostic and prognostic significance of methionine uptake and methionine positron emission tomography imaging in gliomas</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">257</span>, <span class="refDoi"> DOI: 10.3389/fonc.2017.00257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.3389%2Ffonc.2017.00257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=29164057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC1M3jvVeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=257&author=K.+Palanichamyauthor=A.+Chakravarti&title=Diagnostic+and+prognostic+significance+of+methionine+uptake+and+methionine+positron+emission+tomography+imaging+in+gliomas&doi=10.3389%2Ffonc.2017.00257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnostic and Prognostic Significance of Methionine Uptake and Methionine Positron Emission Tomography Imaging in Gliomas</span></div><div class="casAuthors">Palanichamy Kamalakannan; Chakravarti Arnab</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">The present most common image diagnostic tracer in clinical practice for glioma is (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for brain tumors diagnosis and prognosis.  PET is a promising molecular imaging technique, which provides real-time information on the metabolic behavior of the tracer.  The diffusive nature of glioblastoma (GBM) and heterogeneity often make the radiographic detection by FDG-PET inaccurate, and there is no gold standard.  FDG-PET often leads to several controversies in making clinical decisions due to their uptake by normal surrounding tissues, and pose a challenge in delineating treatment-induced necrosis, edema, inflammation, and pseudoprogression.  Thus, it is imperative to find new criteria independent of conventional morphological diagnosis to demarcate normal and tumor tissues.  We have provided proof of concept studies for (11)C methionine-PET (MET-PET) imaging of gliomas, along with prognostic and diagnostic significance.  MET-PET is not widely used in the United States, though clinical trials from Japan and Germany suggesting the diagnostic ability of MET-PET imaging are superior to FDG-PET imaging for brain tumors.  A major impediment is the availability of the onsite cyclotron and isotopic carbon chemistry facilities.  In this article, we have provided the scientific rationale and advantages of the use of MET-PET as GBM tracers.  We extend our discussion on the expected pitfalls of using MET-PET and ways to overcome them by incorporating a translational component of profiling gene status in the methionine metabolic pathway.  This translational correlative component to the MET-PET clinical trials can lead to a better understanding of the existing controversies and can enhance our knowledge for future randomization of GBM patients based on their tumor gene signatures to achieve better prognosis and treatment outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRx9429BdJqznthwrmtH4OBfW6udTcc2eY4gKu0v2ic_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3jvVeltQ%253D%253D&md5=a86b4e55195a92b7f6cef62b1e3c0f48</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2017.00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2017.00257%26sid%3Dliteratum%253Aachs%26aulast%3DPalanichamy%26aufirst%3DK.%26aulast%3DChakravarti%26aufirst%3DA.%26atitle%3DDiagnostic%2520and%2520prognostic%2520significance%2520of%2520methionine%2520uptake%2520and%2520methionine%2520positron%2520emission%2520tomography%2520imaging%2520in%2520gliomas%26jtitle%3DFront.%2520Oncol.%26date%3D2017%26volume%3D7%26spage%3D257%26doi%3D10.3389%2Ffonc.2017.00257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muragaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, T.</span></span> <span> </span><span class="NLM_article-title">Metabolic assessment of gliomas using <sup>11</sup>C-methionine, [<sup>18</sup>F] fluorodeoxyglucose, and <sup>11</sup>C-choline positron-emission tomography</span>. <i>Am. J. Neuroradiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.3174/ajnr.A1008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.3174%2Fajnr.A1008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=18388218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BD1cznsFWgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1176-1182&author=T.+Katoauthor=J.+Shinodaauthor=N.+Nakayamaauthor=K.+Miwaauthor=A.+Okumuraauthor=H.+Yanoauthor=S.+Yoshimuraauthor=T.+Maruyamaauthor=Y.+Muragakiauthor=T.+Iwama&title=Metabolic+assessment+of+gliomas+using+11C-methionine%2C+%5B18F%5D+fluorodeoxyglucose%2C+and+11C-choline+positron-emission+tomography&doi=10.3174%2Fajnr.A1008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography</span></div><div class="casAuthors">Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T</div><div class="citationInfo"><span class="NLM_cas:title">AJNR. American journal of neuroradiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1176-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Positron-emission tomography (PET) is a useful tool in oncology.  The aim of this study was to assess the metabolic activity of gliomas using (11)C-methionine (MET), [(18)F] fluorodeoxyglucose (FDG), and (11)C-choline (CHO) PET and to explore the correlation between the metabolic activity and histopathologic features.  MATERIALS AND METHODS:  PET examinations were performed for 95 primary gliomas (37 grade II, 37 grade III, and 21 grade IV).  We measured the tumor/normal brain uptake ratio (T/N ratio) on each PET and investigated the correlations among the tracer uptake, tumor grade, tumor type, and tumor proliferation activity.  In addition, we compared the ease of visual evaluation for tumor detection.  RESULTS:  All 3 of the tracers showed positive correlations with astrocytic tumor (AT) grades (II/IV and III/IV).  The MET T/N ratio of oligodendroglial tumors (OTs) was significantly higher than that of ATs of the same grade.  The CHO T/N ratio showed a significant positive correlation with histopathologic grade in OTs.  Tumor grade and type influenced MET uptake only.  MET T/N ratios of more than 2.0 were seen in 87% of all of the gliomas.  All of the tracers showed significantly positive correlations with Mib-1 labeling index in ATs but not in OTs and oligoastrocytic tumors.  CONCLUSION:  MET PET appears to be useful in evaluating grade, type, and proliferative activity of ATs.  CHO PET may be useful in evaluating the potential malignancy of OTs.  In terms of visual evaluation of tumor localization, MET PET is superior to FDG and CHO PET in all of the gliomas, due to its straightforward detection of "hot lesions".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTT0rfhUzXSDMve_zCu79I8fW6udTcc2eY4gKu0v2ic_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cznsFWgtw%253D%253D&md5=9052f6ea10d2921255b8fd32a798392e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3174%2Fajnr.A1008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3174%252Fajnr.A1008%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DShinoda%26aufirst%3DJ.%26aulast%3DNakayama%26aufirst%3DN.%26aulast%3DMiwa%26aufirst%3DK.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DS.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DMuragaki%26aufirst%3DY.%26aulast%3DIwama%26aufirst%3DT.%26atitle%3DMetabolic%2520assessment%2520of%2520gliomas%2520using%252011C-methionine%252C%2520%255B18F%255D%2520fluorodeoxyglucose%252C%2520and%252011C-choline%2520positron-emission%2520tomography%26jtitle%3DAm.%2520J.%2520Neuroradiol.%26date%3D2008%26volume%3D29%26spage%3D1176%26epage%3D1182%26doi%3D10.3174%2Fajnr.A1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singhal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantil, J.</span></span> <span> </span><span class="NLM_article-title"><sup>11</sup>C-l-methionine positron emission tomography in the clinical management of cerebral gliomas</span>. <i>Mol. Imaging. Biol</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1007/s11307-007-0115-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1007%2Fs11307-007-0115-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=17957408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FgsFSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1-18&author=T.+Singhalauthor=T.+K.+Narayananauthor=V.+Jainauthor=J.+Mukherjeeauthor=J.+Mantil&title=11C-l-methionine+positron+emission+tomography+in+the+clinical+management+of+cerebral+gliomas&doi=10.1007%2Fs11307-007-0115-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas</span></div><div class="casAuthors">Singhal Tarun; Narayanan Tanjore K; Jain Viney; Mukherjee Jogeshwar; Mantil Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Positron emission tomography (PET) using L-[methyl-(11)C]-methionine (MET) is the most popular amino acid imaging modality in oncology, although its use is restricted to PET centers with an in-house cyclotron facility.  This review focuses on the role of MET-PET in imaging of cerebral gliomas.  The biological background of tumor imaging with methionine is discussed with particular emphasis on cellular amino acid transport, amino acid utilization in brain, normal metabolism of methionine, and its alterations in cancer.  The role of MET-PET in clinical management of cerebral gliomas in initial diagnosis, differentiation of tumor recurrence from radiation injury, grading, prognostication, tumor-extent delineation, biopsy planning, surgical resection and radiotherapy planning, and assessment of response to therapy is also reviewed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5mBTKREOEAUbxh97K6Vt6fW6udTcc2eaOicNwLZVh3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FgsFSnsQ%253D%253D&md5=a3af3867449c2db379396d1902581f3c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs11307-007-0115-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-007-0115-2%26sid%3Dliteratum%253Aachs%26aulast%3DSinghal%26aufirst%3DT.%26aulast%3DNarayanan%26aufirst%3DT.%2BK.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DMukherjee%26aufirst%3DJ.%26aulast%3DMantil%26aufirst%3DJ.%26atitle%3D11C-l-methionine%2520positron%2520emission%2520tomography%2520in%2520the%2520clinical%2520management%2520of%2520cerebral%2520gliomas%26jtitle%3DMol.%2520Imaging.%2520Biol%26date%3D2008%26volume%3D10%26spage%3D1%26epage%3D18%26doi%3D10.1007%2Fs11307-007-0115-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrd, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. A.</span></span> <span> </span><span class="NLM_article-title">1-aminocyclobutane [<sup>11</sup>C] carboxylic acid, a potential tumor-seeking agent</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=231642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaL3cXptVSgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1979&pages=1055-1061&author=L.+C.+Washburnauthor=T.+T.+Sunauthor=B.+Byrdauthor=R.+L.+Hayesauthor=T.+A.+Butler&title=1-aminocyclobutane+%5B11C%5D+carboxylic+acid%2C+a+potential+tumor-seeking+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aminocyclobutane[11C]carboxylic acid, a potential tumor-seeking agent</span></div><div class="casAuthors">Washburn, Lee C.; Sun, Tan Tan; Byrd, B. L.; Hayes, Raymond L.; Butler, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1055-61</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3123</span>.
    </div><div class="casAbstract">1-Aminocyclobutane carboxylic-14C acid (I-14C) was incorporated preferentially by several tumor types in rats and hamsters.  The agent was cleared rapidly from rat blood, attaining its max. tissue concns. within 30 min after i.v. injection.  Carrier I had little effect on the tissue distribution of I-14C.  This agent showed no affinity for a Staphylococcus aureus abscess in rats.  The total excretion was low, 3.6% in 2 h.  I-11C was synthesized in amts. up to 415 mCi (55% chem. yield) using the modified Buecherer-Strecker technique.  Forty minutes were required for the 2-step synthesis and chromatog. purifn.  I was nontoxic in 3 animal species.  The radiation dose from I-11C should be minimal.  I-11C thus appears to have good potential as a tumor-seeking agent, particularly when used with a positron emission computed tomograph.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6W_GfWqO1DrVg90H21EOLACvtfcHk0limRSx68xteog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXptVSgtg%253D%253D&md5=43197794e73121dbb34e20d6edeb294b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWashburn%26aufirst%3DL.%2BC.%26aulast%3DSun%26aufirst%3DT.%2BT.%26aulast%3DByrd%26aufirst%3DB.%26aulast%3DHayes%26aufirst%3DR.%2BL.%26aulast%3DButler%26aufirst%3DT.%2BA.%26atitle%3D1-aminocyclobutane%2520%255B11C%255D%2520carboxylic%2520acid%252C%2520a%2520potential%2520tumor-seeking%2520agent%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1979%26volume%3D20%26spage%3D1055%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, E. C.</span></span> <span> </span><span class="NLM_article-title">Tumor detection with 1-aminocyclopentane and 1-aminocyclobutane C-11-carboxylic acid using positron emission computerized tomography</span>. <i>Clin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1097/00003072-198106000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1097%2F00003072-198106000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=6971725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADyaL3M7oslSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1981&pages=249-252&author=K.+F.+H%C3%BCbnerauthor=S.+Kraussauthor=L.+Washburnauthor=W.+D.+Gibbsauthor=E.+C.+Holloway&title=Tumor+detection+with+1-aminocyclopentane+and+1-aminocyclobutane+C-11-carboxylic+acid+using+positron+emission+computerized+tomography&doi=10.1097%2F00003072-198106000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor detection with 1-aminocyclopentane and 1-aminocyclobutane C-11-carboxylic acid using positron emission computerized tomography</span></div><div class="casAuthors">Hubner K F; Krauss S; Washburn L C; Gibbs W D; Holloway E C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical nuclear medicine</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">249-52</span>
        ISSN:<span class="NLM_cas:issn">0363-9762</span>.
    </div><div class="casAbstract">Eight patients with proven or suspected neoplastic lesions were examined with 1-aminocyclobutane C-11-carboxylic acid and 1-aminocyclopentane C-11-carboxylic acid using positron emission computed tomography.  The results of this comparative study have shown that both of these unnatural amino acids have a high affinity for malignant tumors.  The potential of nonmetabolizable C-11-labeled amino acids as noninvasive indicators of metabolic tumor activity is demonstrated and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB8qtQ1L9IFDW1zwg2yUK5fW6udTcc2eaOicNwLZVh3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M7oslSrtQ%253D%253D&md5=7822fb7e9674589cf6abd6b7dff0a570</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1097%2F00003072-198106000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00003072-198106000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DK.%2BF.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DL.%26aulast%3DGibbs%26aufirst%3DW.%2BD.%26aulast%3DHolloway%26aufirst%3DE.%2BC.%26atitle%3DTumor%2520detection%2520with%25201-aminocyclopentane%2520and%25201-aminocyclobutane%2520C-11-carboxylic%2520acid%2520using%2520positron%2520emission%2520computerized%2520tomography%26jtitle%3DClin.%2520Nucl.%2520Med.%26date%3D1981%26volume%3D6%26spage%3D249%26epage%3D252%26doi%3D10.1097%2F00003072-198106000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turtle, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. A.</span></span> <span> </span><span class="NLM_article-title">Carboxyl-labeled <sup>11</sup>C-1-aminocyclopentanecarboxylic acid, a potential agent for cancer detection</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=180270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaE28XltFKnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1976&pages=748-751&author=R.+L.+Hayesauthor=L.+C.+Washburnauthor=B.+W.+Wielandauthor=T.+T.+Sunauthor=R.+R.+Turtleauthor=T.+A.+Butler&title=Carboxyl-labeled+11C-1-aminocyclopentanecarboxylic+acid%2C+a+potential+agent+for+cancer+detection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxyl-labeled 11C-1-aminocyclopentanecarboxylic acid, a potential agent for cancer detection</span></div><div class="casAuthors">Hayes, Raymond L.; Washburn, Lee C.; Wieland, Bruce W.; Sun, Tan Tan; Turtle, Robert R.; Butler, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">748-51</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    </div><div class="casAbstract">Carboxyl-labeled 11C-1-aminocyclopentanecarboxylic acid [60375-48-6] (11C-ACPC) was prepd. in multimillicurie amts.  The conversion of H11CN to 11C-ACPC (t1/2 = 20.4 min) was accomplished by a rapid (20 min) 2-step high-temp. modification of the Bucherer-Strecker amino acid synthesis technique.  Purifn. was by ion exchange techniques.  The tissue distribution of 11C-ACPC (750 microcurie, i.v.) in Morris 5123 C hepatoma bearing rats indicated the compd. has potential as a tumor-localizing agent for detecting cancer in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowa66SUYMJDrVg90H21EOLACvtfcHk0lifgiriCSHhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltFKnu78%253D&md5=e273954acf2ab297131ce7d94debc022</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DR.%2BL.%26aulast%3DWashburn%26aufirst%3DL.%2BC.%26aulast%3DWieland%26aufirst%3DB.%2BW.%26aulast%3DSun%26aufirst%3DT.%2BT.%26aulast%3DTurtle%26aufirst%3DR.%2BR.%26aulast%3DButler%26aufirst%3DT.%2BA.%26atitle%3DCarboxyl-labeled%252011C-1-aminocyclopentanecarboxylic%2520acid%252C%2520a%2520potential%2520agent%2520for%2520cancer%2520detection%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1976%26volume%3D17%26spage%3D748%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winebrenner, J. D.</span></span> <span> </span><span class="NLM_article-title">Tumor location with 1-aminocyclopentane [<sup>11</sup>C] carboxylic acid: preliminary clinical trials with single-photon detection</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=606748" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1977&pages=1215-1221&author=K.+F.+H%C3%BCbnerauthor=G.+A.+Andrewsauthor=L.+Washburnauthor=B.+W.+Wielandauthor=W.+D.+Gibbsauthor=R.+L.+Hayesauthor=T.+A.+Butlerauthor=J.+D.+Winebrenner&title=Tumor+location+with+1-aminocyclopentane+%5B11C%5D+carboxylic+acid%3A+preliminary+clinical+trials+with+single-photon+detection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DK.%2BF.%26aulast%3DAndrews%26aufirst%3DG.%2BA.%26aulast%3DWashburn%26aufirst%3DL.%26aulast%3DWieland%26aufirst%3DB.%2BW.%26aulast%3DGibbs%26aufirst%3DW.%2BD.%26aulast%3DHayes%26aufirst%3DR.%2BL.%26aulast%3DButler%26aufirst%3DT.%2BA.%26aulast%3DWinebrenner%26aufirst%3DJ.%2BD.%26atitle%3DTumor%2520location%2520with%25201-aminocyclopentane%2520%255B11C%255D%2520carboxylic%2520acid%253A%2520preliminary%2520clinical%2520trials%2520with%2520single-photon%2520detection%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1977%26volume%3D18%26spage%3D1215%26epage%3D1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarkas, N.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological properties of radiohalogenated α, α-disubstituted amino acids for PET and SPECT imaging of amino acid transporters (AATs)</span>. <i>J. Labelled Compd. Rad.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1002%2Fjlcr.3584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=29143354" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=272-290&author=M.+M.+Goodmanauthor=W.+Yuauthor=N.+Jarkas&title=Synthesis+and+biological+properties+of+radiohalogenated+%CE%B1%2C+%CE%B1-disubstituted+amino+acids+for+PET+and+SPECT+imaging+of+amino+acid+transporters+%28AATs%29&doi=10.1002%2Fjlcr.3584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3584%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DJarkas%26aufirst%3DN.%26atitle%3DSynthesis%2520and%2520biological%2520properties%2520of%2520radiohalogenated%2520%25CE%25B1%252C%2520%25CE%25B1-disubstituted%2520amino%2520acids%2520for%2520PET%2520and%2520SPECT%2520imaging%2520of%2520amino%2520acid%2520transporters%2520%2528AATs%2529%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Rad.%26date%3D2018%26volume%3D61%26spage%3D272%26epage%3D290%26doi%3D10.1002%2Fjlcr.3584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span> </span><span class="NLM_article-title">FDA approves <sup>18</sup>F-Fluciclovine
and <sup>68</sup>Ga-DOTATATE
products</span>.  <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">57</span>,  <span class="NLM_fpage">9N</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.2967%2Fjnumed.115.165316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=27697971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKitrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA+approves+18F-Fluciclovine%0Aand+68Ga-DOTATATE%0Aproducts.+J.+Nucl.+Med.+2016%2C+57%2C+9N."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-NOTA-Aca-BBN(7-14) PET/CT in healthy volunteers and glioma patients</span></div><div class="casAuthors">Zhang, Jingjing; Li, Deling; Lang, Lixin; Zhu, Zhaohui; Wang, Ling; Wu, Peilin; Niu, Gang; Li, Fang; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">This work was designed to study the safety, biodistribution, and radiation dosimetry of a gastrin-releasing peptide receptor (GRPR)- targeting, 68Ga-labeled bombesin (BBN) peptide deriv. PET tracer, NOTA-Aca-BBN(7-14) (denoted as 68Ga-BBN) in healthy volunteers and to assess the level of receptor expression in glioma patients.  Methods: Four healthy volunteers (2 male and 2 female) underwent whole-body PET/CT at multiple time points after a bolus injection of 68Ga-BBN (111 ± 148 MBq).  Regions of interest were drawn manually over major organs, and time-activity curves were obtained.  Dosimetry was calcd. using the OLINDA/EXM software.  Twelve patients with glioma diagnosed by contrast-enhanced MRI underwent PET/CT at 30-45 min after 68Ga-BBN injection.  Within 1 wk afterward, the tumor was surgically removed and immunohistochem. staining of tumor samples against GRPR was performed and correlated with the PET/ CT results.  Results: 68Ga-BBN was well tolerated in all healthy volun- teers, with no adverse symptoms being noticed or reported. 68Ga-BBN cleared rapidly from the circulation and was excreted mainly through the kidneys and urinary tract.  The total ED equiv. and ED were 0.0335 ± 0.0079 and 0.0276 ± 0.0066 mSv/MBq, resp.  In glioma patients, all MRI-identified lesions showed high signal intensity on 68Ga-BBN PET/CT.  SUVmax and SUVmean were 2.08 ± 0.58 and 1.32 ± 0.37, resp.  With normal brain tissue as back- ground, tumor-to-background ratios were 24.0 ± 8.85 and 13.4 ± 4.54 based on SUVmax and SUVmean resp.  The immunohistochem- ical staining confirmed a pos. correlation between SIN and GRPR expression level (r2 = 0.71, P < 0.001).  Conclusion: 68Ga-BBN is a PET tracer with favorable pharmacokinetics and a favorable dosimetry profile.  It has the potential to evaluate GRPR expression in glioma patients and guide GRPR-targeted therapy of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5ZdTCFW9-A7Vg90H21EOLACvtfcHk0lifgiriCSHhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKitrrO&md5=29fd1b8d33d638910b87ec8c24419165</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.165316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.165316%26sid%3Dliteratum%253Aachs%26atitle%3DFDA%2520approves%252018F-Fluciclovine%250Aand%252068Ga-DOTATATE%250Aproducts%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D9N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarkas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">(<i>R</i>, <i>S</i>)-Anti-1-amino-2-[<sup>18</sup>F] fluorocyclopentyl-1-carboxylic acid: synthesis from racemic 2-benzyloxycyclopentanone and biological evaluation for brain tumor imaging with positron emission tomography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6603</span>– <span class="NLM_lpage">6607</span>, <span class="refDoi"> DOI: 10.1021/jm100841m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100841m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCnsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6603-6607&author=N.+Jarkasauthor=R.+J.+Vollauthor=L.+Williamsauthor=V.+M.+Campauthor=M.+M.+Goodman&title=%28R%2C+S%29-Anti-1-amino-2-%5B18F%5D+fluorocyclopentyl-1-carboxylic+acid%3A+synthesis+from+racemic+2-benzyloxycyclopentanone+and+biological+evaluation+for+brain+tumor+imaging+with+positron+emission+tomography&doi=10.1021%2Fjm100841m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">(R,S)-anti-1-Amino-2-[18F]Fluorocyclopentyl-1-carboxylic Acid: Synthesis from Racemic 2-Benzyloxycyclopentanone and Biological Evaluation for Brain Tumor Imaging with Positron Emission Tomography</span></div><div class="casAuthors">Jarkas, Nachwa; Voll, Ronald J.; Williams, Larry; Camp, Vernon M.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6603-6607</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(R,S)-anti-1-Amino-2-fluorocyclopentyl-1-carboxylic acid (2-FACPC, 4b) was radiolabeled in 39% yield starting from cyclic sulfamidate 12.  The 9L gliosarcoma cells assays showed that 4b is mainly a substrate for the L-type amino acid transport with some affinity to the A-type.  In rats bearing 9L gliosarcoma tumors, 4b displayed high tumor to brain ratio (10:1) at 120 min after injection.  FACPC is an attractive candidate for imaging brain tumors with PET, and its isolated enantiomers are under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_TfBwv_FitLVg90H21EOLACvtfcHk0lj7HyuT_mrN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCnsLjF&md5=7ff78f1bf8ce1dc77f4030da2a97034a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm100841m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100841m%26sid%3Dliteratum%253Aachs%26aulast%3DJarkas%26aufirst%3DN.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3D%2528R%252C%2520S%2529-Anti-1-amino-2-%255B18F%255D%2520fluorocyclopentyl-1-carboxylic%2520acid%253A%2520synthesis%2520from%2520racemic%25202-benzyloxycyclopentanone%2520and%2520biological%2520evaluation%2520for%2520brain%2520tumor%2520imaging%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6603%26epage%3D6607%26doi%3D10.1021%2Fjm100841m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savir-Baruch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarkas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Master, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieh, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkar, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nye, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span> <span> </span><span class="NLM_article-title">Pilot evaluation of <i>anti</i>-1-amino-2-[<sup>18</sup> F] fluorocyclopentane-1-carboxylic acid (<i>anti</i>-2-[<sup>18</sup> F] FACPC) PET-CT in recurrent prostate carcinoma</span>. <i>Mol. Imaging. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1272</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1007/s11307-010-0445-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1007%2Fs11307-010-0445-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=20976627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC3MbnslGgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1272-1277&author=B.+Savir-Baruchauthor=D.+M.+Schusterauthor=N.+Jarkasauthor=V.+A.+Masterauthor=P.+T.+Niehauthor=R.+K.+Halkarauthor=J.+A.+Nyeauthor=M.+M.+Lewisauthor=R.+J.+Croweauthor=R.+J.+Voll&title=Pilot+evaluation+of+anti-1-amino-2-%5B18+F%5D+fluorocyclopentane-1-carboxylic+acid+%28anti-2-%5B18+F%5D+FACPC%29+PET-CT+in+recurrent+prostate+carcinoma&doi=10.1007%2Fs11307-010-0445-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma</span></div><div class="casAuthors">Savir-Baruch Bital; Schuster David M; Jarkas Nashwa; Master Viraj A; Nieh Peter T; Halkar Raghuveer K; Nye Jonathon A; Lewis Melinda M; Crowe Ronald J; Voll Ronald J; Camp Vernon M; Bellamy Leah M; Roberts David L; Goodman Mark M</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1272-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Anti-1-amino-2-[(18)F]fluorocyclopentane-1-carboxylic acid (anti-2-[(18)F]FACPC) is an unnatural alicyclic amino acid radiotracer with high uptake in the DU-145 prostate cancer cell line in vitro.  Our goal was to determine if anti-2-[(18)F]FACPC is useful in the detection of prostate carcinoma.  PROCEDURES:  Five patients with elevated PSA (1.1-20.5 ng/mL) after curative therapy for prostate carcinoma underwent 60 min dynamic positron emission tomography (PET) of the pelvis after IV injection of 193-340 MBq of anti-2-[(18)F]FACPC.  Uptake was compared against PET scans in the same patients with the leucine analog, anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid (anti-[(18)F]FACBC), at similar time points and validated via pathology, clinical, and imaging follow-up.  RESULTS:  At 5 min, average (±SD) SUVmax of malignant lesions is 4.1(±1.3) for anti-2-[(18)F] FACPC and 4.3(±1.1) for anti-[(18)F]FACBC.  Yet, blood pool activity at 5 min is significantly higher for anti-2-[(18)F]FACPC with average (±SD) lesion/blood pool SUVmax/SUVmean ratio of 1.4 (±0.5) vs. 3.0 (±0.9) for anti-[(18)F]FACBC.  At 20 min, average (±SD) SUVmax of malignant lesions is 2.6 (±1.0) for anti-2-[(18)F]FACPC and 3.4 (±0.8) for anti-[(18)F]FACBC.  Yet, bladder activity at 20 min is significantly more intense for anti-2-[(18)F] FACPC with average (±SD) lesion/bladder SUVmax/SUVmean ratio of 0.3 (±0.8) vs. 2.3 (±1.4) for anti-[(18)F]FACBC.  CONCLUSIONS:  While prostate bed lesions are visible on early imaging with anti-2-[(18)F]FACPC, there is high blood pool activity obscuring nodes.  As blood pool fades, nodal uptake decreases and high bladder activity then obscures pelvic structures.  Compared with anti-[(18)F]FACBC, imaging characteristics for anti-2-[(18)F]FACPC are unfavorable for pelvic recurrent prostate carcinoma detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvJKElpYmkLzjk2McQZ6XmfW6udTcc2eajXpF9ycydKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbnslGgtg%253D%253D&md5=032483b3a34be1e69653bd37e8b41b79</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs11307-010-0445-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-010-0445-3%26sid%3Dliteratum%253Aachs%26aulast%3DSavir-Baruch%26aufirst%3DB.%26aulast%3DSchuster%26aufirst%3DD.%2BM.%26aulast%3DJarkas%26aufirst%3DN.%26aulast%3DMaster%26aufirst%3DV.%2BA.%26aulast%3DNieh%26aufirst%3DP.%2BT.%26aulast%3DHalkar%26aufirst%3DR.%2BK.%26aulast%3DNye%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DCrowe%26aufirst%3DR.%2BJ.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26atitle%3DPilot%2520evaluation%2520of%2520anti-1-amino-2-%255B18%2520F%255D%2520fluorocyclopentane-1-carboxylic%2520acid%2520%2528anti-2-%255B18%2520F%255D%2520FACPC%2529%2520PET-CT%2520in%2520recurrent%2520prostate%2520carcinoma%26jtitle%3DMol.%2520Imaging.%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D1272%26epage%3D1277%26doi%3D10.1007%2Fs11307-010-0445-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casabona, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cativiela, C.</span></span> <span> </span><span class="NLM_article-title">Simple and efficient multigram scale synthesis of 1-aminocyclopent-3-ene-1-carboxylic acid</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2440</span>– <span class="NLM_lpage">2443</span>, <span class="refDoi"> DOI: 10.1055/s-2006-942458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1055%2Fs-2006-942458" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2440-2443&author=D.+Casabonaauthor=C.+Cativiela&title=Simple+and+efficient+multigram+scale+synthesis+of+1-aminocyclopent-3-ene-1-carboxylic+acid&doi=10.1055%2Fs-2006-942458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-942458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-942458%26sid%3Dliteratum%253Aachs%26aulast%3DCasabona%26aufirst%3DD.%26aulast%3DCativiela%26aufirst%3DC.%26atitle%3DSimple%2520and%2520efficient%2520multigram%2520scale%2520synthesis%2520of%25201-aminocyclopent-3-ene-1-carboxylic%2520acid%26jtitle%3DSynthesis%26date%3D2006%26volume%3D14%26spage%3D2440%26epage%3D2443%26doi%3D10.1055%2Fs-2006-942458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmstead, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, M. J.</span></span> <span> </span><span class="NLM_article-title">Diastereoselective synthesis of cyclopentanoids with hydantoin and isoxazoline substituents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1021/jo9714831</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9714831" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1cXjtFKqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=113-117&author=K.-H.+Parkauthor=M.+M.+Olmsteadauthor=M.+J.+Kurth&title=Diastereoselective+synthesis+of+cyclopentanoids+with+hydantoin+and+isoxazoline+substituents&doi=10.1021%2Fjo9714831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereoselective Synthesis of Cyclopentanoids with Hydantoin and Isoxazoline Substituents</span></div><div class="casAuthors">Park, Kyung-Ho; Olmstead, Marilyn M.; Kurth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-117</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Exploiting 1,3-dipolar cycloaddn. and urea → hydantoin cyclization transformations, novel spiro[cyclopenta[d]isoxazole-4',5-imidazolindine]s I [R1 = Pr, Me, Ph; R2 = Ph, 4-ClC6H4, 4-FC6H4] have been prepd.  The 1-amino-3-cyclopentenecarboxylate precursor was prepd. from a suitably activated/protected deriv. of glycine and the bis-alkylating agent cis-1,4-dichloro-2-butene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS1D2aqzg0iLVg90H21EOLACvtfcHk0lj7HyuT_mrN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtFKqug%253D%253D&md5=bd74b5cf34cdb77269ef7f6d4811a047</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo9714831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9714831%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.-H.%26aulast%3DOlmstead%26aufirst%3DM.%2BM.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26atitle%3DDiastereoselective%2520synthesis%2520of%2520cyclopentanoids%2520with%2520hydantoin%2520and%2520isoxazoline%2520substituents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D113%26epage%3D117%26doi%3D10.1021%2Fjo9714831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmstead, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, M. J.</span></span> <span> </span><span class="NLM_article-title">Diastereoselective solid-phase synthesis of novel hydantoin-and isoxazoline-containing heterocycles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6579</span>– <span class="NLM_lpage">6585</span>, <span class="refDoi"> DOI: 10.1021/jo9807161</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9807161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVeltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=6579-6585&author=K.-H.+Parkauthor=M.+M.+Olmsteadauthor=M.+J.+Kurth&title=Diastereoselective+solid-phase+synthesis+of+novel+hydantoin-and+isoxazoline-containing+heterocycles&doi=10.1021%2Fjo9807161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereoselective Solid-Phase Synthesis of Novel Hydantoin- and Isoxazoline-Containing Heterocycles</span></div><div class="casAuthors">Park, Kyung-Ho; Olmstead, Marilyn M.; Kurth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6579-6585</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel spirocyclic isoxazoloimidazolidinedione heterocycles were prepd. by exploiting 1,3-dipolar cycloaddn. and carbanilide cyclization transformations on solid phase starting from Merrifield resin.  Cyclopentanoid isoxazoloimidazolidinediones were obtained with complete diastereoselectivity, and cyclopropanoid isoxazoloimidazolidinediones were obtained as an ≈2:1 mixt. of diastereomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3aPjvTfalTbVg90H21EOLACvtfcHk0li68xBox-WLtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVeltbw%253D&md5=2966298cfa84ebbeab7f5e7e3d5aae44</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo9807161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9807161%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.-H.%26aulast%3DOlmstead%26aufirst%3DM.%2BM.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26atitle%3DDiastereoselective%2520solid-phase%2520synthesis%2520of%2520novel%2520hydantoin-and%2520isoxazoline-containing%2520heterocycles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D6579%26epage%3D6585%26doi%3D10.1021%2Fjo9807161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kil, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, D. H.</span></span> <span> </span><span class="NLM_article-title">A new class of SN2 reactions catalyzed by protic solvents: facile fluorination for isotopic labeling of diagnostic molecules</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">16394</span>– <span class="NLM_lpage">16397</span>, <span class="refDoi"> DOI: 10.1021/ja0646895</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0646895" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16394-16397&author=D.+W.+Kimauthor=D.-S.+Ahnauthor=Y.-H.+Ohauthor=S.+Leeauthor=H.+S.+Kilauthor=S.+J.+Ohauthor=S.+J.+Leeauthor=J.+S.+Kimauthor=J.+S.+Ryuauthor=D.+H.+Moon&title=A+new+class+of+SN2+reactions+catalyzed+by+protic+solvents%3A+facile+fluorination+for+isotopic+labeling+of+diagnostic+molecules&doi=10.1021%2Fja0646895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A New Class of SN2 Reactions Catalyzed by Protic Solvents: Facile Fluorination for Isotopic Labeling of Diagnostic Molecules</span></div><div class="casAuthors">Kim, Dong Wook; Ahn, Doo-Sik; Oh, Young-Ho; Lee, Sungyul; Kil, Hee Seup; Oh, Seung Jun; Lee, Sang Ju; Kim, Jae Seung; Ryu, Jin Sook; Moon, Dae Hyuk; Chi, Dae Yoon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">16394-16397</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aprotic solvents are usually preferred for the SN2 reactions, because nucleophilicity and hence SN2 reactivity are severely retarded by the influence of the partial pos. charge of protic solvents.  In this work, we introduce a remarkable effect of using tertiary alcs. as a reaction medium for nucleophilic fluorination with alkali metal fluorides.  In this novel synthetic method, the nonpolar protic tert-alc. enhances the nucleophilicity of the fluoride ion dramatically in the absence of any kind of catalyst, greatly increasing the rate of the nucleophilic fluorination and reducing formation of byproducts (such as alkenes, alcs., or ethers) compared with conventional methods using dipolar aprotic solvents.  The great efficacy of this method is a particular advantage in labeling radiopharmaceuticals with [18F]fluorine (t1/2 = 110 min) for positron emission tomog. (PET) imaging, and it is illustrated by the synthesis of four [18F]fluoride-radiolabeled mol. imaging probes - [18F]FDG, [18F]FLT, [18F]FP-CIT, and [18F]FMISO - in high yield and purity and in shorter times compared to conventional syntheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquNXNekSmcFbVg90H21EOLACvtfcHk0li68xBox-WLtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs73P&md5=3a87d1f61cfe5f9b566f92e3c347a725</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja0646895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0646895%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BW.%26aulast%3DAhn%26aufirst%3DD.-S.%26aulast%3DOh%26aufirst%3DY.-H.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKil%26aufirst%3DH.%2BS.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DRyu%26aufirst%3DJ.%2BS.%26aulast%3DMoon%26aufirst%3DD.%2BH.%26atitle%3DA%2520new%2520class%2520of%2520SN2%2520reactions%2520catalyzed%2520by%2520protic%2520solvents%253A%2520facile%2520fluorination%2520for%2520isotopic%2520labeling%2520of%2520diagnostic%2520molecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D16394%26epage%3D16397%26doi%3D10.1021%2Fja0646895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Improved synthesis of <i>anti</i>-[<sup>18</sup>F] FACBC: improved preparation of labeling precursor and automated radiosynthesis</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1016/S0969-8043(03)00029-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2FS0969-8043%2803%2900029-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=12798374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVGgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=657-666&author=J.+McConathyauthor=R.+J.+Vollauthor=W.+Yuauthor=R.+J.+Croweauthor=M.+M.+Goodman&title=Improved+synthesis+of+anti-%5B18F%5D+FACBC%3A+improved+preparation+of+labeling+precursor+and+automated+radiosynthesis&doi=10.1016%2FS0969-8043%2803%2900029-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis</span></div><div class="casAuthors">McConathy, Jonathan; Voll, Ronald J.; Yu, Weiping; Crowe, Ronald J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-666</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The non-natural amino acid anti-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid (FACBC) has shown promise for tumor imaging with positron emission tomog.  An improved synthesis of the precursor of anti-[18F]FACBC has been devised which demonstrates high stereoselectivity and suitability for large-scale prepns.  An automated radiosynthesis has been developed which provides anti-[18F]FACBC in 24% decay-cor. yield.  Addnl., the major non-radioactive species present in doses of anti-[18F]FACBC has been identified as anti-1-amino-3-hydroxycyclobutane-1-carboxylic acid.  Together, these results are important steps towards the routine prodn. of anti-[18F]FACBC for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSt-lARoXN-bVg90H21EOLACvtfcHk0li68xBox-WLtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVGgs74%253D&md5=74f4bbe27f432814ee59fc8e75a1e768</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2803%2900029-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252803%252900029-0%26sid%3Dliteratum%253Aachs%26aulast%3DMcConathy%26aufirst%3DJ.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DCrowe%26aufirst%3DR.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DImproved%2520synthesis%2520of%2520anti-%255B18F%255D%2520FACBC%253A%2520improved%2520preparation%2520of%2520labeling%2520precursor%2520and%2520automated%2520radiosynthesis%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2003%26volume%3D58%26spage%3D657%26epage%3D666%26doi%3D10.1016%2FS0969-8043%2803%2900029-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, Y.</span></span> <span> </span><span class="NLM_article-title">Comparative evaluation of transport mechanisms of <i>trans</i>-1-amino-3-[<sup>18</sup>F] fluorocyclobutanecarboxylic acid and L-[methyl-<sup>11</sup>C] methionine in human glioma cell lines</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1535</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2013.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2Fj.brainres.2013.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=23994214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVegs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1535&publication_year=2013&pages=24-37&author=M.+Onoauthor=S.+Okaauthor=H.+Okudairaauthor=D.+M.+Schusterauthor=M.+M.+Goodmanauthor=K.+Kawaiauthor=Y.+Shirakami&title=Comparative+evaluation+of+transport+mechanisms+of+trans-1-amino-3-%5B18F%5D+fluorocyclobutanecarboxylic+acid+and+L-%5Bmethyl-11C%5D+methionine+in+human+glioma+cell+lines&doi=10.1016%2Fj.brainres.2013.08.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines</span></div><div class="casAuthors">Ono, Masahiro; Oka, Shuntaro; Okudaira, Hiroyuki; Schuster, David M.; Goodman, Mark M.; Kawai, Keiichi; Shirakami, Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1535</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-37</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) with amino acid tracers is useful for the visualization and assessment of therapeutic effects on gliomas.  Our purpose is to elucidate the transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) and l-[methyl-11C]methionine ([11C]Met) in normal human astrocytes (NHA), low-grade (Hs683, SW1088), and high-grade (U87MG, T98G) human glioma cell lines.  Because the short half-lives of fluorine-18 and carbon-11 are inconvenient for in vitro expts., trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid (anti-[14C]FACBC) and l-[methyl-14C]methionine ([14C]Met) were used instead of the PET tracers.  Time-course uptake expts. showed that uptake of anti-[14C]FACBC was 1.4-2.6 times higher than that of [14C]Met in NHA and low-grade glioma cells, and was almost equal to that of [14C]Met in high-grade glioma cells.  To identify the amino acid transporters (AATs) involved in the transport of anti-[14C]FACBC and [14C]Met, we carried out competitive inhibition expts. using synthetic/naturally-occurring amino acids as inhibitors.  We found that anti-[14C]FACBC uptake in the presence of Na+ was strongly inhibited by l-glutamine and l-serine (the substrates for ASC system AATs), whereas l-phenylalanine and 2-amino-bicyclo[2,2,1]heptane-2-carboxylic acid (BCH, the substrates for L system AATs) robustly inhibited Na+-independent anti-[14C]FACBC uptake.  Regardless of Na+, [14C]Met uptake was inhibited strongly by l-phenylalanine and BCH.  Moreover, the exchange transport activity of l-glutamine for anti-[14C]FACBC was stronger than that of BCH in the presence of Na+, whereas that for [14C]Met was almost equal to BCH.  These results demonstrate that ASC and L are important transport systems for anti-[18F]FACBC uptake, while system L is predominantly involved in [11C]Met transport in human astrocytes and glioma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhTv4ugHG6NbVg90H21EOLACvtfcHk0ljEK-8VmBRx5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVegs7rJ&md5=bce14deb59d5deb7986a66342fd3152f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2013.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2013.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DOka%26aufirst%3DS.%26aulast%3DOkudaira%26aufirst%3DH.%26aulast%3DSchuster%26aufirst%3DD.%2BM.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DShirakami%26aufirst%3DY.%26atitle%3DComparative%2520evaluation%2520of%2520transport%2520mechanisms%2520of%2520trans-1-amino-3-%255B18F%255D%2520fluorocyclobutanecarboxylic%2520acid%2520and%2520L-%255Bmethyl-11C%255D%2520methionine%2520in%2520human%2520glioma%2520cell%2520lines%26jtitle%3DBrain%2520Res.%26date%3D2013%26volume%3D1535%26spage%3D24%26epage%3D37%26doi%3D10.1016%2Fj.brainres.2013.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, Y.</span></span> <span> </span><span class="NLM_article-title">Differences in transport mechanisms of <i>trans</i>-1-amino-3-[<sup>18</sup> F] fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[Methyl-<sup>11</sup> C] methionine and 2-deoxy-2-[<sup>18</sup> F] fluoro-D-glucose</span>. <i>Mol. Imaging. Biol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1007/s11307-013-0693-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1007%2Fs11307-013-0693-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=24136390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FntlGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=322-329&author=S.+Okaauthor=H.+Okudairaauthor=M.+Onoauthor=D.+M.+Schusterauthor=M.+M.+Goodmanauthor=K.+Kawaiauthor=Y.+Shirakami&title=Differences+in+transport+mechanisms+of+trans-1-amino-3-%5B18+F%5D+fluorocyclobutanecarboxylic+acid+in+inflammation%2C+prostate+cancer%2C+and+glioma+cells%3A+comparison+with+L-%5BMethyl-11+C%5D+methionine+and+2-deoxy-2-%5B18+F%5D+fluoro-D-glucose&doi=10.1007%2Fs11307-013-0693-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose</span></div><div class="casAuthors">Oka Shuntaro; Okudaira Hiroyuki; Ono Masahiro; Schuster David M; Goodman Mark M; Kawai Keiichi; Shirakami Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">322-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We aimed to elucidate trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid (anti-[(18)F]FACBC) uptake mechanisms in inflammatory and tumor cells, in comparison with those of L-[methyl-(11)C]methionine ([(11)C]Met) and 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG).  PROCEDURES:  Using carbon-14-labeled tracers, in vitro time-course, pH dependence, and competitive inhibition uptake experiments were performed in rat inflammatory (T cells, B cells, granulocytes, macrophages), prostate cancer (MLLB2), and glioma (C6) cells.  RESULTS:  Anti-[(14)C]FACBC uptake ratios of T/B cells to tumor cells were comparable, while those of granulocytes/macrophages to tumor cells were lower than those for [(14)C]FDG.  Over half of anti-[(14)C]FACBC uptake by T/B and tumor cells was mediated by Na(+)-dependent amino acid transporters (system ASC), whereas most [(14)C]Met transport in all cells was mediated by Na(+)-independent carriers (system L).  CONCLUSIONS:  The low anti-[(18)F]FACBC accumulation in granulocytes/macrophages may be advantageous in discriminating inflamed regions from tumors.  The significant anti-[(18)F]FACBC uptake in T/B cells may cause false-positives in some cancer patients who undergo FACBC-positron emission tomography (PET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnAPlPEQnWVxe4jJGKT5N0fW6udTcc2eYDqfE0efTUSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FntlGqsw%253D%253D&md5=c71493cad47a55915455a9047d36d22a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0693-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0693-0%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DS.%26aulast%3DOkudaira%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DD.%2BM.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DShirakami%26aufirst%3DY.%26atitle%3DDifferences%2520in%2520transport%2520mechanisms%2520of%2520trans-1-amino-3-%255B18%2520F%255D%2520fluorocyclobutanecarboxylic%2520acid%2520in%2520inflammation%252C%2520prostate%2520cancer%252C%2520and%2520glioma%2520cells%253A%2520comparison%2520with%2520L-%255BMethyl-11%2520C%255D%2520methionine%2520and%25202-deoxy-2-%255B18%2520F%255D%2520fluoro-D-glucose%26jtitle%3DMol.%2520Imaging.%2520Biol%26date%3D2014%26volume%3D16%26spage%3D322%26epage%3D329%26doi%3D10.1007%2Fs11307-013-0693-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arvanitis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">The blood–brain barrier and blood–tumour barrier in brain tumours and metastases</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1038/s41568-019-0205-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1038%2Fs41568-019-0205-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=30532011" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=1-16&author=C.+D.+Arvanitisauthor=G.+B.+Ferraroauthor=R.+K.+Jain&title=The+blood%E2%80%93brain+barrier+and+blood%E2%80%93tumour+barrier+in+brain+tumours+and+metastases&doi=10.1038%2Fs41568-019-0205-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41568-019-0205-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41568-019-0205-x%26sid%3Dliteratum%253Aachs%26aulast%3DArvanitis%26aufirst%3DC.%2BD.%26aulast%3DFerraro%26aufirst%3DG.%2BB.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520blood%25E2%2580%2593tumour%2520barrier%2520in%2520brain%2520tumours%2520and%2520metastases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2019%26spage%3D1%26epage%3D16%26doi%3D10.1038%2Fs41568-019-0205-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Still, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, A.</span></span> <span> </span><span class="NLM_article-title">Rapid chromatographic technique for preparative separations with moderate resolution</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2923</span>– <span class="NLM_lpage">2925</span>, <span class="refDoi"> DOI: 10.1021/jo00408a041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00408a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2923-2925&author=W.+C.+Stillauthor=M.+Kahnauthor=A.+Mitra&title=Rapid+chromatographic+technique+for+preparative+separations+with+moderate+resolution&doi=10.1021%2Fjo00408a041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid chromatographic technique for preparative separations with moderate resolution</span></div><div class="casAuthors">Still, W. Clark; Kahn, Michael; Mitra, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2923-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A simple adsorption chromatog. technique has been developed for rapid (<15 min) sepns.  The technique uses a short (e.g., 5 in.) column of 40-63-μm silica gel and operates at high flow rates (2.0 vertical in./min) to allow the sepn. of multigram quantities of compds. which are resolved on anal. TLC by as little as ΔRf 0.15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsgCIAoC4VbVg90H21EOLACvtfcHk0ljEK-8VmBRx5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D&md5=34e721c237babee0665e2f9c6f6a3999</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00408a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00408a041%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DA.%26atitle%3DRapid%2520chromatographic%2520technique%2520for%2520preparative%2520separations%2520with%2520moderate%2520resolution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D2923%26epage%3D2925%26doi%3D10.1021%2Fjo00408a041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">System A amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[<sup>18</sup> F] fluoro-2-methylpropanoic acid and 3-[<sup>18</sup> F] fluoro-2-methyl-2-(methylamino) propanoic acid</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2Fj.nucmedbio.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=25263130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GmsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=8-18&author=W.+Yuauthor=J.+McConathyauthor=J.+J.+Olsonauthor=M.+M.+Goodman&title=System+A+amino+acid+transport-targeted+brain+and+systemic+tumor+PET+imaging+agents+2-amino-3-%5B18+F%5D+fluoro-2-methylpropanoic+acid+and+3-%5B18+F%5D+fluoro-2-methyl-2-%28methylamino%29+propanoic+acid&doi=10.1016%2Fj.nucmedbio.2014.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[18 F]fluoro-2-methylpropanoic acid and 3-[18 F]fluoro-2-methyl-2-(methylamino)propanoic acid</span></div><div class="casAuthors">Yu, Weiping; McConathy, Jonathan; Olson, Jeffrey J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-18</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amino acid based radiotracers target tumor cells through increased uptake by membrane-assocd. amino acid transport (AAT) systems.  In the present study, four structurally related non-natural 18 F-labeled amino acids, (R)- and (S)-[18 F]FAMP 1 and (R)- and (S)-[18 F]MeFAMP 2 have been prepd. and evaluated in vitro and in vivo for their potential utility in brain and systemic tumor imaging based upon primarily system A transport with positron emission tomog. (PET).  The transport of enantiomers of [18 F]FAMP 1 and [18 F]MeFAMP 2 was measured through in vitro uptake assays in human derived cancer cells including A549 (lung), DU145 (prostate), SKOV3 (ovary), MDA MB468 (breast) and U87 (brain) in the presence and absence of amino acid transporter inhibitors.  The in vivo biodistribution of these tracers was evaluated using tumor mice xenografts at 15, 30, 60 and 120 min post injection.  All four tracers showed moderate to high levels of uptake (1-9%ID/5 × 105 cells) by the cancer cell lines tested in vitro.  AAT cell inhibition assays demonstrated that (R)-[18 F]1 and (S)-[18 F]1 entered these tumor cells via mixed AATs, likely but not limited to system A and system L.  In contrast, (R)-[18 F]2 and (S)-[18 F]2 showed high selectivity for system A AAT.  Similar to the results of in vitro cell studies, the tumor uptake of all four tracers was good to high and persisted over the 2 h time course of in vivo studies.  The accumulation of these tracers was higher in tumor than most normal tissues including blood, brain, muscle, bone, heart, and lung, and the tracers with the highest in vitro selectivity for system A AAT generally demonstrated the best tumor imaging properties.  Higher uptake of these tracers was obsd. in the pancreas, kidney and spleen compared to tumors.  These preclin. studies demonstrate good imaging properties in a wide range of tumors for all four amino acids evaluated with (R)-[18 F]2 having the highest selectivity for system A AAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGompJpM4Ru7LbVg90H21EOLACvtfcHk0lgJjeCKnAr8Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GmsLrE&md5=f754f9dab45db87c046d372ae1df5892</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMcConathy%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSystem%2520A%2520amino%2520acid%2520transport-targeted%2520brain%2520and%2520systemic%2520tumor%2520PET%2520imaging%2520agents%25202-amino-3-%255B18%2520F%255D%2520fluoro-2-methylpropanoic%2520acid%2520and%25203-%255B18%2520F%255D%2520fluoro-2-methyl-2-%2528methylamino%2529%2520propanoic%2520acid%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2015%26volume%3D42%26spage%3D8%26epage%3D18%26doi%3D10.1016%2Fj.nucmedbio.2014.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malveaux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis and biological evaluation of syn-1-amino-3-[<sup>18</sup>F] fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1982</span>– <span class="NLM_lpage">1990</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=10.1016%2Fj.bmc.2009.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=19216081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1Cjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1982-1990&author=W.+Yuauthor=L.+Williamsauthor=V.+M.+Campauthor=E.+Malveauxauthor=J.+J.+Olsonauthor=M.+M.+Goodman&title=Stereoselective+synthesis+and+biological+evaluation+of+syn-1-amino-3-%5B18F%5D+fluorocyclobutyl-1-carboxylic+acid+as+a+potential+positron+emission+tomography+brain+tumor+imaging+agent&doi=10.1016%2Fj.bmc.2009.01.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent</span></div><div class="casAuthors">Yu, Weiping; Williams, Larry; Camp, Vernon M.; Malveaux, Eugene; Olson, Jeffrey J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1982-1990</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amino acid syn-1-amino-3-fluoro-cyclobutyl-1-carboxylic acid (syn-FACBC) 12, the isomer of anti-FACBC, has been selectively synthesized and [18F] radiofluorinated in 52% decay-cor. yield using no-carrier-added [18F]fluoride.  The key step in the synthesis of the desired isomer involved stereoselective redn. using lithium alkylborohydride/zinc chloride, which improved the ratio of anti-alc. to syn-alc. from 17:83 to 97:3. syn-FACBC 12 entered rat 9L gliosarcoma cells primarily via L-type amino acid transport in vitro with high uptake of 16% injected dose per 5 × 105 cells.  Biodistribution studies in rats with 9L gliosarcoma brain tumors demonstrated high tumor to brain ratio of 12:1 at 30 min post injection.  In this model, amino acid syn-[18F]FACBC 12 is a promising metabolically based radiotracer for positron emission tomog. brain tumor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBf4Eel3lLQbVg90H21EOLACvtfcHk0lgJjeCKnAr8Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1Cjurc%253D&md5=11350a8e2967cf3304fc831c6322c884</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DMalveaux%26aufirst%3DE.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DStereoselective%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520syn-1-amino-3-%255B18F%255D%2520fluorocyclobutyl-1-carboxylic%2520acid%2520as%2520a%2520potential%2520positron%2520emission%2520tomography%2520brain%2520tumor%2520imaging%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1982%26epage%3D1990%26doi%3D10.1016%2Fj.bmc.2009.01.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoup, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votaw, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshima, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshima, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stabin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votaw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of [<sup>18</sup>F] 1-amino-3-fluorocyclobutane 1-carboxylic acid to image brain tumors</span>. <i>Therapy</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=2&author=T.+M.+Shoupauthor=J.+Olsonauthor=J.+M.+Hoffmanauthor=J.+Votawauthor=D.+Eshimaauthor=L.+Eshimaauthor=V.+M.+Campauthor=M.+Stabinauthor=D.+Votawauthor=M.+M.+Goodman&title=Synthesis+and+evaluation+of+%5B18F%5D+1-amino-3-fluorocyclobutane+1-carboxylic+acid+to+image+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoup%26aufirst%3DT.%2BM.%26aulast%3DOlson%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DJ.%2BM.%26aulast%3DVotaw%26aufirst%3DJ.%26aulast%3DEshima%26aufirst%3DD.%26aulast%3DEshima%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DStabin%26aufirst%3DM.%26aulast%3DVotaw%26aufirst%3DD.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B18F%255D%25201-amino-3-fluorocyclobutane%25201-carboxylic%2520acid%2520to%2520image%2520brain%2520tumors%26jtitle%3DTherapy%26date%3D1999%26volume%3D1%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConathy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malveaux, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, radiolabeling, and biological evaluation of (<i>R</i>)-and (<i>S</i>)-2-amino-3-[<sup>18</sup>F] fluoro-2-methylpropanoic acid (FAMP) and (<i>R</i>)-and (<i>S</i>)-3-[<sup>18</sup>F] fluoro-2-methyl-2-N-(methylamino) propanoic acid (<i>N</i> MeFAMP) as potential PET radioligands for imaging brain tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1021/jm900556s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900556s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2jsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=876-886&author=W.+Yuauthor=J.+McConathyauthor=L.+Williamsauthor=V.+M.+Campauthor=E.+J.+Malveauxauthor=Z.+Zhangauthor=J.+J.+Olsonauthor=M.+M.+Goodman&title=Synthesis%2C+radiolabeling%2C+and+biological+evaluation+of+%28R%29-and+%28S%29-2-amino-3-%5B18F%5D+fluoro-2-methylpropanoic+acid+%28FAMP%29+and+%28R%29-and+%28S%29-3-%5B18F%5D+fluoro-2-methyl-2-N-%28methylamino%29+propanoic+acid+%28N+MeFAMP%29+as+potential+PET+radioligands+for+imaging+brain+tumors&doi=10.1021%2Fjm900556s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-3-[18F]Fluoro-2-Methylpropanoic Acid (FAMP) and (R)- and (S)-3-[18F]Fluoro-2-Methyl-2-N-(Methylamino)propanoic Acid (NMeFAMP) as Potential PET Radioligands for Imaging Brain Tumors</span></div><div class="casAuthors">Yu, Weiping; McConathy, Jonathan; Williams, Larry; Camp, Vernon M.; Malveaux, Eugene J.; Zhang, Zhaobin; Olson, Jeffrey J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">876-886</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The non-natural amino acids (R)- and (S)-2-amino-3-fluoro-2-methylpropanoic acid 5 and (R)- and (S)-3-fluoro-2-methyl-2-N-(methylamino)propanoic acid 8 were synthesized in shorter reaction sequences than in the original report starting from enantiomerically pure (S)- and (R)-α-methyl-serine, resp.  The reaction sequence provided the cyclic sulfamidate precursors for radiosynthesis of (R)- and (S)-[18F]5 and (R)- and (S)-[18F]8 in fewer steps than in the original report.  (R)- and (S)-[18F]5 and(R)- and (S)-[18F]8 were synthesized by no-carrier-added nucleophilic [18F]fluorination in 52-66% decay-cor. yields with radiochem. purity over 99%.  The cell assays showed that all four compds. were substrates for amino acid transport and enter 9L rat gliosarcoma cells in vitro at least in part by system A amino acid transport.  The biodistribution studies demonstrated that in vivo tumor to normal brain ratios for all compds. were high with ratios of 20:1 to 115:1 in rats with intracranial 9L tumors.  The (R)-enantiomers of [18F]5 and [18F]8 demonstrated higher tumor uptake in vivo compared to the (S)-enantiomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz2oCzWet68rVg90H21EOLACvtfcHk0lj7NYvaZzyl9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2jsrvK&md5=09654549414a136109767db7e2c44398</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm900556s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900556s%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMcConathy%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCamp%26aufirst%3DV.%2BM.%26aulast%3DMalveaux%26aufirst%3DE.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSynthesis%252C%2520radiolabeling%252C%2520and%2520biological%2520evaluation%2520of%2520%2528R%2529-and%2520%2528S%2529-2-amino-3-%255B18F%255D%2520fluoro-2-methylpropanoic%2520acid%2520%2528FAMP%2529%2520and%2520%2528R%2529-and%2520%2528S%2529-3-%255B18F%255D%2520fluoro-2-methyl-2-N-%2528methylamino%2529%2520propanoic%2520acid%2520%2528N%2520MeFAMP%2529%2520as%2520potential%2520PET%2520radioligands%2520for%2520imaging%2520brain%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D876%26epage%3D886%26doi%3D10.1021%2Fjm900556s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pippin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Radiochemical synthesis and evaluation of <sup>13</sup>N-labeled 5-aminolevulinic acid for PET imaging of gliomas</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1236-1240&author=A.+B.+Pippinauthor=R.+J.+Vollauthor=Y.+Liauthor=H.+Wuauthor=H.+Maoauthor=M.+M.+Goodman&title=Radiochemical+synthesis+and+evaluation+of+13N-labeled+5-aminolevulinic+acid+for+PET+imaging+of+gliomas&doi=10.1021%2Facsmedchemlett.7b00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical Synthesis and Evaluation of 13N-Labeled 5-Aminolevulinic Acid for PET Imaging of Gliomas</span></div><div class="casAuthors">Pippin, Adam B.; Voll, Ronald J.; Li, Yuancheng; Wu, Hui; Mao, Hui; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1236-1240</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The endogenous amino acid, 5-aminolevulinic acid (5-ALA), has received significant attention as an imaging agent, including ongoing clin. trials for image-guided tumor resection due to its selective uptake and subsequent accumulation of the fluorescent protoporphyrin IX in tumor cells.  Based on the widely reported selectivity of 5-ALA, a new positron emission tomog. imaging probe was developed by reacting Me 5-bromolevulinate with [13N] ammonia.  The radiotracer, [13N] 5-ALA, was produced in high radiochem. yield (65%) in 10 min and could be purified using only solid phase cartridges.  In vivo testing in rats bearing intracranial 9L glioblastoma showed peak tumor uptake occurred within 10 min of radiotracer administration.  Immunohistochem. staining and fluorescent imaging was used to confirm the tumor location and accumulation of the tracer seen from the PET images.  The quick synthesis and rapid tumor specific uptake of [13N] 5-ALA makes it a potential novel clin. applicable radiotracer for detecting and monitoring tumors noninvasively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAdh-MNQRQB7Vg90H21EOLACvtfcHk0ljThFeudn09BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvP&md5=ffcad09317343b9a8feb9c3ac41535b0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00311%26sid%3Dliteratum%253Aachs%26aulast%3DPippin%26aufirst%3DA.%2BB.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DRadiochemical%2520synthesis%2520and%2520evaluation%2520of%252013N-labeled%25205-aminolevulinic%2520acid%2520for%2520PET%2520imaging%2520of%2520gliomas%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1236%26epage%3D1240%26doi%3D10.1021%2Facsmedchemlett.7b00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01302">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15515"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01302?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01302</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, and when possible, <sup>19</sup>F NMR spectra for all previously unreported compounds, X-ray crystallography data for compounds <b>[<sup>19</sup>F]9</b> and <b>[<sup>19</sup>F]28</b>, time-activity curves for PET data in Tables 4, 5, 6, and 7, radiometric TLC data for compound <b>[<sup>18</sup>F]9</b> and radiometric HPLC data for <b>[<sup>18</sup>F]28</b>, and molecular formula strings; X-ray data for <b>[<sup>19</sup>F]9</b> and <b>[<sup>19</sup>F]28</b> has been deposited with the CSD, and atomic coordinates are provided in the Supporting Information (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_001.pdf">jm0c01302_si_001.pdf (12.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01302/suppl_file/jm0c01302_si_002.csv">jm0c01302_si_002.csv (0.77 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01302&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-20%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01302%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01302" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9efb8fac2398","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
